tsawon wane lokaci ne wadannan cututtukan suka kasance?
kuma dole ne a bi da ciwon kirji kamar haka, musamman a shekarunka
da kuma zazzabi
kuma kana bukatar ka duba yawan cholesterol da kuma karfin jini
kuma kana da zazzabi a yanzu?
kuma yana da ciwon kirji a yanzu?
kuma ka yi wahala ka numfasa?
kuma za ka iya gaya mini wasu alamun da kake fuskanta banda wannan?
kuma nawa ne zafin jikinka?
kuma ina kuma tari
kuma ina da sanyi da kuma tari
kuma ina da ciwo mai zafi a kirji a yau
Wannan lokaci ne da ya dace don yin fitsari
kuma yana da ciwo a kirji
kuma ina ganin ina da zazzabi
kuma ina so ka bayyana inda ciwon kirji yake
kuma suna da zazzabi ma
da kuma tarihin ciwon sukari
kuma, ka sani, sai dai na ga kirji na zai fashe
Kuma, ka sani, mutane suna tari a kaina a duk lokacin
kuma kuna da ciwon kirji
kuma ka ce akwai matsa lamba a kirjinka
wani a cikin iyalinka yana da matsalar zuciya, ko kuma ciwon zuciya, ko kuma ya taɓa samun ciwon zuciya, ko kuma yana da babban cholesterol ko kuma hawan jini?
wani alama ko matsala da kake lura da ita game da ciwon tsoka?
Kana da mutane da yawa marasa lafiya a gidanka da irin wannan alamun?
Shin akwai wasu alamun cutar?
Shin, ba ka da iska?
Har yanzu kana da ciwon kirji?
Domin wannan shine lokacin mura
Amma kuma ba za mu iya kawar da ciwon kirji daga zuciya ba.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
amma ina da wahalar numfashi
Amma na san mutane da yawa sun yi tari a kaina
Amma dole ne mu bi da duk wani ciwon kirji da tsanani.
amma yanzu zaka iya numfashi sosai, ba ka iya ba?
Saboda wannan ciwon kirji na manta da ni gaba daya
Shin, ƙirjinka yana daɗa ƙaruwa?
Har yanzu ina jin ƙarancin iska
Shin suna da'awar cewa suna da rashin lafiya tare da irin wannan alamun?
kuna da wani yanayi na kullum, kamar hawan jini?
kuna da wata cuta ko cuta mai tsanani banda ciwon sukari?
Shin, kun yi rashin numfashi, ban da wannan ciwon kirji?
kana da karfin jini?
Kuna jin rashin numfashi tare da wannan?
Ka san irin alamun da take da shi?
Kuna ganin hoton?
Ka sha ruwa sosai yau
A halin yanzu, ina yin gwajin ciwon sukari.
Amma, ta na da alamun da suka yi kama da na.
Yaya zafin jikinka yake?
Yaya za ka ji?
idan ka ci gaba da samun zazzabi mai zafi
idan kuna da zazzabi mai digiri 38 ko fiye
idan ka ga cewa alamun ka da matsalolinka suna bukatar ƙarin kulawa
Na yi zazzabi jiya
Na yi zazzabi, ma
Na yi zazzabi jiya
Ina da ciwo mai tsanani a kirji a nan
Ina da wahalar numfashi, ma
Zan aika muku da hoto
Ina da ciwo a kirji a yau
Ina da ciwon kai da zazzabi yau
A ganina, wannan shi ne mura.
A ganina, wannan kawai mura ce.
Kana ganin kamar wani mutum ne mai nauyi yana zaune a kirjinka?
Ya fara ne da ciwon kai da zazzabi, a lokaci guda
ciwon yana tsakiyar kirji na
Yana da matsa lamba, kamar yana ciwon kirji
Yana cikin kirji na
Yana cikin ƙirjina
Yana cikin tsakiyar kirji
Ina jin zafi a kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka bayyana min wannan ciwon kirji
kamar hawan jini ko ciwon sukari
a tsakiyar kirji
Idan kana da zazzabi, zaka iya shan paracetamol
Maria, kwanaki nawa ne ka sha irin waɗannan cututtuka?
Ka ce kana da ciwon kirji
Ina jin zafi a kirji a wasu lokatai
Shin, kuna da wasu alamun bayyanar cututtuka a cikin wannan, banda ciwo?
ko kuma wani yana zaune a kirjinka?
Ainihin haka yake da zazzabi, tari, ciwon kai da kuma ciwon tsoka.
a tsakiyar ƙirjina
nuna min wannan hoton inda kake jin zafi
tun da yake kana da zazzabi
To, kuna ganin wasu daga cikin wadannan cututtukan na iya danganta da lokacin da kuka yi ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mani game da ciwon kirjinka
zazzabi ya tashi da dare
zazzabin da na samu a cikin kwanaki biyu da suka gabata
zazzabin ya fara tashi a daren jiya
Wannan shi ne Dr. Porter a cibiyar bincike ta gaggawa.
To, za ka iya gaya mini game da ciwon kirjinka?
Na ji zafi a gaban jikina, a nan a kirji
Na ji zafi sosai a kirji
To, idan ina da wannan ciwo a kirji
wane irin ciwo kake da shi a kirjinka?
A lokacin da wannan ciwon kirji ya fara?
ina ne ciwon kirjinka?
inda kake jin wannan ciwon kirji
kana jin wani matsawa a kirjinka
Na yi ciwon sukari da irin wannan
Ka ce kana da wannan ciwon kirji
Kasancewar cutar coronavirus (COVID-19) a cikin Turai da Yankin Tattalin Arziki na Turai da kuma United Kingdom, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai/Yankin Tattalin Arziki na Turai da kuma Burtaniya, yana tabbatar da cewa duk da cewa yana cikin wani mataki daban-daban dangane da ƙasa, cutar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, dole ne kasashe, asibitoci da UTIs su kara shirya kansu don barkewar cutar COVID-19 da za su bukaci kulawa da kuma musamman ma magani mai tsanani.
A ranar 31 ga watan Disamba na shekarar 2019, an samu rahoton wasu cututtukan cutar huhu da ba a san asalinsa ba a Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar China ta sanar da mai haifar da cutar a matsayin sabon coronavirus, wanda yanzu ake kira coronavirus 2 na cututtukan numfashi mai tsanani (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ta haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
Dalilin da aka samu a yanzu shine cewa kashi 80 cikin dari na mutanen da ke fama da cutar COVID-19 suna da wata nau'i mai sauƙi na cutar, wato kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin su suna warkewa.
A cikin kusan kashi 14 cikin dari na shari'o'in, COVID-19 ya ci gaba zuwa wani mummunan cuta, yana buƙatar asibiti, yayin da sauran kashi 6 cikin dari na shari'o'in suka ci gaba zuwa wani mummunan cuta, yana buƙatar kulawa mai tsanani.
Yawan marasa lafiya da ke asibiti sakamakon COVID-19 ya kai kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin da ake samu na COVID-19 a kowace ƙasa ta Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Birtaniya kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta yawan mutanen da suka kamu da cutar COVID-19 a kasashen EU/EEA da Birtaniya da na Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Kasashen EU/EEA da na Burtaniya sun kamu da COVID-19
Bayan China, COVID-19 ta bazu a wurare daban-daban, kuma motsin annobar COVID-19 a sauran duniya a halin yanzu yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, babban darektan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na 2020 na Eurosurveillance, Spiteri et al. sun ba da rahoton farkon tabbatar da COVID-19 a Turai, bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon cututtukan guda uku a ranar 24 ga Janairu, 2020 a cikin mutanen da ke dawowa daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an riga an gano shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da Burtaniya, kuma a tsakanin 31 ga Disamba, 2019 da kwanan wata da aka ambata a sama, an ruwaito shari'o'i 39,768 da mutuwar 1,727 tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kawai.
Samun adadi na COVID-19 da kuma adadi na adadi na COVID-19
A Cibiyar Tsare-tsare ta Turai don Rigakafin Cututtuka (ECDC), adadin adadin mutanen da aka ruwaito na COVID-19 a kowace ƙasa a duniya, wanda aka samo daga tushen hukuma kawai, kamar Ma'aikatar Lafiya ta ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, ana sabunta su kowace rana da karfe 8:00.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya, kuma a kwatanta su da na Italiya.
A matsayin kwatancen yawan mutanen da ke kamuwa da cutar COVID-19, mun ƙididdige jimlar kwanaki 14 na kamuwa da cutar COVID-19, saboda haka muna la'akari da yanayin yanayin COVID-19 a kowace ƙasa ta EU/EEA da Burtaniya, a tsakanin Janairu 1 zuwa Maris 15, 2020.
Mun kuma gabatar da jimlar adadin adadin da aka ruwaito daga kowace ƙasa zuwa 15 ga Maris, 2020 da karfe 8 na safe, kuma mun kwatanta da na Italiya na tsawon 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da Birtaniya
Yanayin da aka samu a cikin kwanaki 14 na kamuwa da cutar COVID-19 a cikin ƙasashen EU/EEA da Birtaniya gaba ɗaya ya biyo bayan na lardin Hubei, China (Figure 1).
A gaba ɗaya, ga EU/EEA da United Kingdom, jimlar cutar COVID-19 ta fara ƙaruwa a ranar 21 ga Fabrairu kuma ta ƙaru sosai daga nan zuwa ranar 28 ga Fabrairu, 2020 (ƙarin bayani).
Wannan ya faru ne musamman saboda saurin karuwar shari'o'in da aka ruwaito a Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan karuwar yanayin COVID-19 (abubuwan da ke tattare da su).
Hoton 2 ya nuna jimlar adadin shari'o'in COVID-19 a cikin ƙasashen EU/EEA da Burtaniya idan aka kwatanta da na Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya ce, a ranar 15 ga Maris da ƙarfe 8 na safe, wasu ƙasashen EU/EEA 15 da kuma Birtaniya sun riga sun ba da rahoton adadin adadin da ya yi daidai da na Italiya makonni uku ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka samu a rahoton COVID-19 suna ƙaruwa cikin sauri a cikin EU/EEA da Birtaniya.
Hanyoyin da aka lura a cikin yawan cutar COVID-19 sun nuna cewa annobar tana ci gaba da sauri a kowace ƙasa.
Wannan ya faru ne duk da cewa kasashe suna cikin matakai daban-daban, canje-canje a ayyukan tsarin kiwon lafiya na jama'a na ƙasa, kuma mai yiwuwa, bambancin yanayin ƙayyadaddun lokuta a cikin ƙasashe da kuma yarjejeniyoyi daban-daban don zaɓar marasa lafiya waɗanda za a gwada su don tabbatar da COVID-19, gami da gwaji don sabuntawa.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10 cikin dari na marasa lafiya da ke fama da COVID-19 ke bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun ruwaito cewa asibitoci da wuraren kula da gaggawa a yankunan sun riga sun kai ga iyakar ƙarfin su.
Bayanai game da shigar da COVID-19 a asibiti da/ko a UTI a halin yanzu suna samuwa a matakin EU/EEA don kawai 6% da 1% na shari'o'in, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su a cikin tsari don haɓaka bayanan kulawa na yanzu tare da mayar da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
Wani bincike da aka yi a tsakanin shekara ta 2010 zuwa 2011 ya nuna cewa akwai bambancin da ya faru a yawan gado na ICU da na sashin ICU a Turai, daga gado 29.2 a Jamus zuwa gado 4.2 a Portugal ga kowane mutane 100,000.
Wannan yana nufin cewa ƙasashe za su iya samun albarkatu fiye da Italiya (12.5 ICU da kuma magani na rabin-karfi ga yawan mutane 100,000 a tsakanin 2010 zuwa 2011).
An samar da yanayin da aka tsara game da cikawar iyawar tsarin kiwon lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da Burtaniya na yawan asibitin COVID-19 da ke hade da haɗarin sama da kashi 90% na ƙarfin gado na ICU, a cikin sabuntawar shida na ECDC's COVID-19 Rapid Risk Assessment.
Tun da yake har zuwa yanzu akwai wasu yankuna a cikin EU/EEA da United Kingdom da yawa da kuma asibitoci da wuraren kula da gaggawa suna yawanci kula da wani yanki na yawan mutane, ya kamata a ba da bayani game da yanayin kula da gaggawa da kuma gado a cikin Nomenclature na Ƙungiyoyin Ƙasa don Dalilin Lissafi 2 (NUTS-2).
Misali na Italiya da kuma yanayin da ke faruwa a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Birtaniya.
Saboda haka, dole ne kasashe, asibitoci da UTIs su shirya kansu don yanayin watsawar SARS-CoV-2 na ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci da ci da ci da ci a cikin ciwon da ciwon da ciwon da ciwon da ciwon da cutar.
Kamar yadda aka nuna a cikin ECDC's Rapid Risk Assessment, hanzari, mai aiki, da kuma cikakkiyar hanyar da za a bi don jinkirta yaduwar SARS-CoV-2 tare da sauya tsarin riƙewa zuwa tsarin ragewa, saboda ƙididdigar hanzari da ake tsammani na yawan lokuta na iya ba da isasshen lokaci ga masu yanke shawara da asibitoci don fahimta, yarda da daidaita ayyukan su yadda ya kamata idan ba a aiwatar da su a gaba ba.
Har ila yau, saurin tantance haɗari yana lissafa matakan kiwon lafiya na jama'a don rage tasirin cutar.
Akwai karamin taga na dama inda kasashe ke da damar kara karfafa ayyukan sarrafa su na rage yaduwar SARS-CoV-2 da kuma rage matsin lamba a tsarin kiwon lafiya.
Idan ba su yi nasara ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA na iya samun barkewar cutar marasa lafiya da ke bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus 2 (SARS-CoV-2) ta haifar da cutar ta hanyar numfashi mai tsanani (SARS), ta kashe mutane sama da dubu 3 kuma ta kamu da fiye da dubu 80 a China da sauran duniya, wanda ya haifar da bala'i ga jama'a.
Kamar yadda yake da ƙwayar cutar SARS-CoV, wadda ta haifar da SARS a dubban mutane a 2003, SARS-CoV-2 na iya kamuwa da cutar daga bats kuma yana haifar da irin waɗannan alamun ta hanyar irin wannan tsari.
Koyaya, COVID-19 tana da ƙananan tsanani da mutuwa fiye da SARS, amma yana da yawa fiye da watsawa, kuma yana shafar tsofaffi fiye da matasa, kuma maza fiye da mata.
A sakamakon haka, an yi amfani da wannan labarin don samar da cikakken bayani game da yanayin da ake ciki, wanda ke faruwa a cikin sauri.
Za mu tattauna game da muhimman abubuwan da ke tattare da cututtuka, cututtuka, cututtuka, ganewa, magani, tsinkaye da kuma rigakafin cutar.
Ko da yake tambayoyi da yawa suna bukatar amsoshi, muna fata wannan binciken zai taimaka wajen fahimtar wannan cuta mai banƙyama da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa na musamman da ba za a iya mantawa da shi ba ga duk Sinawa waɗanda aka tilasta su kasance cikin kulle-kullen hutu da kuma makonni da yawa a gaba saboda annobar sabuwar cutar kwayar cuta.
Wannan cutar tana da kamanceceniya da cutar coronavirus (CoV) wacce ta haifar da annobar cutar ta SARS mai tsanani a shekara ta 2003; saboda haka, an kira shi SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma an kira cutar ta COVID-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a fadin kasar da kuma kusan kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta haifar da fiye da mutane 80,000 da aka tabbatar da COVID-19, tare da fiye da mutane 40,000 da suka warke da kuma fiye da mutane 3,000 da suka mutu.
Hukumar ta duniya ta ce COVID-19 ita ce "maƙiyi na farko", kuma tana da iko fiye da ta'addanci.
A cikin kasa da watanni biyu, an wallafa labarai sama da 200 game da COVID-19, gami da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Wannan talifin yana taƙaita ci gaban bincike a wannan sabon yanki mai saurin ci gaba.
A duk inda ya dace, za mu kwatanta COVID-19 da SARS da kuma wani cuta da COVID ke haifarwa, cuta ta numfashi ta Gabas ta Tsakiya (MERS, annobar shekara ta 2012).
Za mu kuma tattauna abin da muka koya game da rigakafi da kuma tsinkaya na cutar, da kuma sauran batutuwa masu gaggawa.
An yi la'akari da cewa CoVs ba su da lahani ga mutane, kuma suna haddasa kusan kashi 15 cikin 100 na mura.
Amma a wannan karni, mun sami cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta COVID a tarihin ɗan adam.
A cikin rahoton da aka bayar a ranar 31 ga watan Disamba na 2019, an bayar da rahoton wasu cututtukan cutar pneumonia da ba a san asalin su ba a Wuhan.
Bayan kwana bakwai, an wallafa bayanan da suka nuna cewa an gano cutar.
A ranar 15 ga Janairu, 2020, an bayar da rahoton mutuwar farko a Wuhan.
A lokacin, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu makwabtaka.
A ranar 20 ga Janairu, an sanar da cewa an kamu da cutar daga ma'aikatan kiwon lafiya, wanda ya nuna cewa za a iya watsa ta tsakanin mutane.
A ranar 23 ga watan Janairu, birnin Wuhan ya shiga cikin wani yanayi na kewaye, tare da dakatar da duk jigilar jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti game da cutar ya ruwaito cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar 'ya'yan itacen teku ta Wuhan, wanda aka yi la'akari da wurin da cutar ta fara daga wata sanannen tushe na dabba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta bayyana annobar a matsayin gaggawa a duniya.
A halin yanzu, cutar ta riga ta bazu a kasar Sin da kuma kusan ƙasashe 50 a duniya (Fig.
Tun da yanayin ya yi muni sosai, har yanzu ana bukatar a ƙayyade girman cutar da kuma yadda za ta yi muni.
A ranar 11 ga Fabrairu, 2020, wani binciken da aka yi a cibiyoyin da dama tare da marasa lafiya 8,866, ciki har da marasa lafiya 4,021 da aka tabbatar da COVID-19, ya gabatar da ƙarin bayani game da annobar, kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, musamman a tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun fi shekara 50, wasu sun fi shekara 20, kuma 14 ne kawai suka fi shekara 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100.000) fiye da mata (0.27/100.000).
COVID-19 ta bazu cikin rukuni, musamman a Hubei da kewaye da ita.
COVID-19 ta samu matsakaicin kwanaki 5 (2 zuwa 9) don ganewar asali bisa bayyanar cututtuka.
Matsakaicin lokacin yin amfani da ita ya kai kwanaki 4.8 (3.0 zuwa 7.2).
Matsakaicin lokacin mutuwa bisa ga bayyanar cututtuka ya kai kwanaki 9.5 (4.8 zuwa 13)
Ƙarin adadin da aka yi amfani da shi (R0) ya kasance 3,77 (95% CI: 3,51 zuwa 4,05), kuma an daidaita R0 daga 2,23 zuwa 4,82.
Yawan mutanen da suka kamu da cutar sun karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin jigilar kaya kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1.44% (95% CI: 1.10% zuwa 1.86%), kuma daidaitaccen mutuwar dukan marasa lafiya ya kasance 3.06% (95% CI: 2.02% zuwa 4.59%).
Babban abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (sama da shekaru 60), da kuma mummunan cutar huhu.
CoVs babban ƙwayar cuta ne mai ƙunshe da RNA mai ƙunshe da ƙunshe da ƙunshe da ƙunshe da ƙunshe.
Ana iya rarraba su zuwa nau'i hudu, wato alpha, beta, gamma da delta, wanda aka sani alpha-coronavirus da beta-coronavirus ke kamuwa da mutane.
A cikin takarda, glycoprotein spike (S) yana haɗuwa da masu karɓar kwayoyin halitta na angiotensin 2 (ECA2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, kuma a sakamakon haka membrane fusion ya faru.
An saki RNA na kwayar cuta a cikin cytoplasm; bayan an sake kwayar kwayar cuta, RNA na kwayar cuta tare da glycoproteins da nucleocapsid proteins suna samar da ƙwayoyin cuta da ke dauke da ƙwayoyin cuta, waɗanda ke haɗuwa da membrane na jini kuma suna sakin kwayar cuta.
An fara samun labarin farkon tsarin SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 sabon nau'in betacoronavirus ne wanda ya fi 99.98% na asalin kwayoyin halitta tsakanin samfurori 10 da aka tattara daga wurin da cutar ta fara, kasuwar 'ya'yan itacen teku ta Huanan, Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscope na lantarki na watsawa, an gano ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan epithelium na hanyoyin iska na mutum.
An gano cewa ECA2 na mutum mai karɓar SARS-CoV-2 ne, da SARS-CoV.
Duk da haka, SARS-CoV-2 S Protein ya haɗu da furotin ECA2 na mutum a cikin rauni fiye da SARS-CoV Protein, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cutar da ta fi muni a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya kuma samar da sabon ƙaramin furotin da aka yi wa lambar orf3b da kuma furotin da aka yi wa lambar orf8.
Ko da yake SARS-CoV-2 orf3b na iya taka rawa wajen cutar ta kwayar cuta da hana bayyanar IFNβ, amma orf8 ba ya dauke da wani sanannen yanki ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., ya ba da rahoton tsarin ECA2 na ɗan adam na tsawon ECA2 zuwa ƙuduri na 2,9 Å a cikin wani tsari tare da mai ɗaukar amino acid B0AT1.
An gano cewa wannan fili, wanda ya kasance a buɗe da kuma rufe, an haɗa shi a matsayin dimer, kuma ECA2-B0AT1 zai iya haɗa sunadarai biyu na S, wanda ke ba da shaida don ganowa da kamuwa da cutar ta CoV.
B0AT1 na iya zama maganin maganin maganin maganin maganin cutar SARS-CoV-2.
Mai masaukin da ya zo da kuma mai ba da izini
An san cewa SARS-CoV da MERS-CoV sun fito ne daga bats kuma an watsa su ga mutane ta hanyar raƙuma da raƙuma, bi da bi.
Ta hanyar kwatancen ilimin halittu na SARS-CoV-2 da sauran CoVs, an dauki bats a matsayin masu masaukin SARS-CoV-2 na asali, saboda sabon cutar ta kasance 96% daidai da CoVs guda biyu na SARS-kamar bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san ko wane ne ya taimaka wa cutar ta ƙetare iyakar jinsuna kuma ta kamu da mutane ba, kuma har yanzu ba a gano hanyar watsawa ba.
Ji da sauransu sun ce macizai suna daukar kwayar cutar daga bats zuwa mutane, wanda ya shafi sake hada kwayoyin halitta a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun nuna cewa pangolins, dabbobin da ke da dogon sashin da ke cin abinci daga kuraje kuma ana amfani da su sau da yawa a cikin maganin gargajiya na kasar Sin, sune masu ba da izini na SARS-CoV-2, bisa ga daidaiton kwayoyin halitta na 99% tsakanin CoV da aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka, bambanci na 1% a cikin kwayoyin halitta biyu babban bambanci ne; saboda haka, ana jiran sakamako mai kyau don gwaji na musamman (Fig.
Har yanzu ba a san yawancin halaye na jiki da sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV suna iya rayuwa a cikin in vitro na tsawon sa'o'i 48 a cikin yanayi mai bushe har zuwa kwanaki 5 a ƙasa da 20 °C tare da zafi na 40% zuwa 50%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito cewa SARS-CoV-2 yana da ƙarancin haske da zafin jiki na 56 °C na minti 30; ether, ethanol 75%, chlorine disinfectant, peracetic acid, chlorophorium da sauran kwayoyin halitta masu narkewa amma ba chlorhexidine ba, suna da tasiri wajen kashe cutar.
Gabaɗaya, duk mutanen da ke cikin duniya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu babu wani cikakken bincike da aka bayar game da amsa rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya duba binciken da aka yi a baya game da sauran CoVs, musamman game da SARS-CoV da MERS-CoV (Fig. (Fig.4).
A kullum, bayan wani ƙwayar cuta ta shiga cikin mai masaukin, an fara gane shi ta hanyar tsarin rigakafin mutum na cikin gida ta hanyar masu karɓar karɓar ƙirar (PRRs), ciki har da masu karɓar lectin irin C, mai karɓar Toll irin (TLR), mai karɓar NOD irin (NLR), da mai karɓar RIG-I irin (RLR).
Ta hanyoyi daban-daban, ƙwayar cuta tana haifar da bayyanar cututtuka, ƙwayoyin dendritic da kuma haɗuwa da interferons na nau'i na I (IFNs), wanda ke iyakance yaduwar ƙwayar cuta kuma yana hanzarta phagocytosis na macrophages na maganin rigakafi na ƙwayar cuta.
Duk da haka, furotin N na SARS-CoV na iya taimaka wa ƙwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, maganin rigakafi na daidaitawa ya shiga cikin yaƙi da cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa wajen kare kansu.
Kwayoyin T na CD4+ suna sa kwayoyin B su samar da rigakafin da suka shafi ƙwayar cuta, kuma kwayoyin T na CD8+ suna kashe ƙwayoyin da suka kamu da cutar kai tsaye.
Kwayoyin T masu haɗin kai suna samar da cytokines masu ƙonewa don taimakawa wajen kare ƙwayoyin.
Koyaya, CoV na iya hana T cell aiki ta hanyar haifar da apoptosis na T cell.
Humi immunity, ciki har da kari kamar C3a da C5a antibodies, kuma yana da muhimmanci ga yaki da kamuwa da cuta.
Alal misali, an kashe MERS-CoV ta hanyar amfani da kwayoyin rigakafi na mutum da ya warke.
A wani ɓangare kuma, tsarin rigakafi na jiki yana haifar da ƙwayoyin cuta masu yawa da ke cikin gida waɗanda za su iya haifar da mummunan lahani ga huhu da sauran gabobin jiki, kuma a mafi munin yanayin, ɓarna da gabobin jiki da yawa, har ma da mutuwa.
Cutar SARS-CoV-2, wadda ta ƙunshi bayyanar cututtuka a cikin mutane, ta fi shafar tsofaffi masu fama da ciwon ciki da mata masu juna biyu.
Mutane da yawa da suka kamu da ƙwayoyin cuta ko kuma waɗanda tsarin rigakafi na jiki ya lalace suna da mafi yawan zarafi fiye da sauran mutane.
Matsakaicin lokacin yin incubation na SARS-CoV-2 shine kwanaki 1 zuwa 14 kuma mafi yawan lokuta kwanaki 3 zuwa 7, bisa ga nazarin farkon shari'o'i 425 a Wuhan.
Amma, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa an yi kwanaki 3 a matsakaita, kuma an yi kwanaki 0 zuwa 24.
Wani bincike na kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin yin wanka ya kai kwanaki 4.8 (3.0 zuwa 7.2) bisa alƙaluma na shari'o'i 8,866.
Yana da mahimmanci cewa hukumomin kiwon lafiya su daidaita ainihin lokacin killacewa bisa ga mafi kyawun lokacin yin incuba, don haka hana mutanen da suka kamu da cutar da ba su da alamun cutar watsa cutar ga wasu mutane.
A matsayinka na al'ada, mutane da suka kamu da cutar ko kuma suka kamu da ita, yawanci suna bukatar su keɓe kansu na kwanaki 14.
Shin za a kara tsawon kwanaki 24 a cikin lokacin killacewa?
Zazzabi yawanci shine farkon kuma babban alamar COVID-19, wanda zai iya zuwa shi kaɗai ko tare da wasu alamomi kamar tari, rashin numfashi, ciwon tsoka, wartsakewa, ciwon kai, ciwon wuya, ciwon kirji, ciwon kirji, fitsari, ƙishirwa da kuma amai.
Wasu marasa lafiya sun sami rashin barci da/ ko hypoxemia mako guda bayan bayyanar cututtukan.
A cikin matsanancin hali, marasa lafiya sun ci gaba da ci gaba zuwa ciwon huhu mai tsanani, bugun jini, ƙwayar cuta, da kuma ciwon jini.
Marasa lafiya da zazzabi da kuma alamun numfashi da kuma zazzabi mai tsanani, ko da ba su da wani abu da ya sa a gane cutar ta hanyar hotunan huhu, ya kamata a yi musu gwajin cutar don a gane su a wuri.
Wani bincike na alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa yawan alamun cututtukan sun kasance kashi 98% don zazzabi, kashi 76% don tari, kashi 55% don dyspnea, da 3% don fitsari; kashi 8% na marasa lafiya suna buƙatar goyon bayan numfashi.
An samu irin wannan sakamako a cikin bincike guda biyu na baya-bayan nan na wani iyali da kuma wani mutum da ya kamu da rashin bayyanar cututtuka.
A kwatanta, wani binciken alƙaluma a shekara ta 2012 ya nuna cewa marasa lafiya da ke fama da cutar MERS-CoV sun kuma sami zazzabi (98%), tari mai bushe (47%) da kuma rashin barci (55%) a matsayin manyan alamun cututtuka.
Amma, kashi 80 cikin dari na marasa lafiya sun bukaci taimakon numfashi, fiye da marasa lafiya na COVID-19, wanda ya ƙunshi mafi yawan mutuwar MERS idan aka kwatanta da COVID-19.
An kuma lura da ciwon hanci (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya da ke fama da cutar MERS.
A cikin marasa lafiya da ke fama da SARS, an nuna cewa zazzabi (99-100%), tari mai bushewa (29% zuwa 75%), dyspnea (40-42%), diarrhea (20-25%) da ciwon wuya (13% zuwa 25%) sune manyan alamun bayyanar cututtuka, kuma ana buƙatar goyon bayan numfashi ga kimanin 14% zuwa 20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2 cikin ɗari, lokacin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatanta, mutuwar SARS zuwa Nuwamba 2002 ya kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
A cikin wani bincike na alƙaluma na watan Yuni na 2012, MERS ta samu kashi 37 cikin 100 na mutane 2,494 da aka tabbatar da cutar.
Wani binciken da aka yi kwanan nan ya ruwaito cewa yawan R0 na SARS-CoV-2 ya kai 6.47 tare da wani matsakaici na dogara (IC) na 95%, 5.71 zuwa 7.23, yayin da R0 na SARS-CoV ya bambanta daga 2 zuwa 4 kawai.
Ana ba da kwatancen SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da bayyanar cututtukan su, mutuwa da R0 a cikin Table 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 na da damar yadawa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari fiye da waɗannan biyun.
Saboda haka, yana da matukar kalubale a sarrafa cutar SARS-CoV-2 fiye da cutar MERS-CoV da ta SARS-CoV.
A yawancin lokaci, bayyanar cututtuka a cikin iyali ɗaya ko kuma a cikin gari ɗaya, kamar jirgin ruwa.
A yawancin lokuta, marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da suka shafi cutar, ko kuma sun sadu da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu kafin bayyanar cututtuka.
Amma, an ruwaito cewa mutane za su iya ɗaukar cutar fiye da makonni biyu ba tare da bayyanar cututtuka ba, kuma marasa lafiya da aka warkar da su daga asibitoci za su iya sake kamuwa da cutar, wanda zai haifar da faɗakarwa don tsawaita lokacin killacewa.
A farkon lokaci, marasa lafiya suna da yawan fararen jini (mafi yawan kwayoyin lymphocytes) da suka kasance a cikin jiki ko kuma a rage.
Alal misali, an gano lymphopenia da ƙididdigar ƙwayoyin fari a ƙasa da 4 x 109/L ciki har da ƙididdigar ƙwayoyin lymphocytes a ƙasa da 1 x 109/L, da kuma matakan aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 da ke fama da COVID-19.
Ƙarfin ƙwayoyin cuta da na myoglobin a cikin tsoka da hanta ya karu a cikin jinin wasu marasa lafiya, kuma an ƙara ƙwayoyin C-reactive da kuma sedimentation na erythrocyte a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin dimer-D, wanda ya haifar da lalata fibrin a cikin jini, ya kasance mai girma, kuma yawan lymphocytes ya ragu.
Abubuwan da ba a saba gani a cikin hotunan hoton kirji na kirji suna faruwa a yawancin marasa lafiya da COVID-19, kuma suna nuna inuwa mara kyau ko kuma duhu a cikin huhu.
A yawancin lokuta, marasa lafiya suna da cutar huhu, da kuma cutar huhu da ake kira acute respiratory distress syndrome (ADRS).
Idan akwai RASD, rashin kula da kumburi, tarin ruwa, da kuma ci gaba da ciwon fibrosis suna da lahani sosai ga musayar gas.
Rashin aiki na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na mai mai mai mai mai mai mai mai mai mai mai mai mai mai mai mai mai mai
Saboda haka, sakamakon da ya fi tsanani a kan radiography na ƙirjinmu ya fi tsanani a yanayin da ya fi tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna cewa an cire huhu, an samu membrane hyaline, an samu shigar da lymphocytes da sincyte a cikin huhu na mai haƙuri da ya mutu daga cutar, wanda ya dace da cutar kamuwa da cuta ta kwayar cuta da SDRA, kuma ya yi kama da cutar marasa lafiya da SARS da MERS.
An yi amfani da gano RNA na SARS-CoV-2 ta hanyar polymerase  reverse transcriptase (RT-PCR) sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sarkar sar
Duk da haka, saboda yawan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigardigar ƙididdigarƙaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddadd
Wani abu mai kama da haka ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da kuma sakamakon radiology yana da muhimmanci kuma yana da muhimmanci wajen yin bincike mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniya ta amfani da fasaha ta SHERLOCK, wanda ya dogara da CRISPR, don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a cikin 20 x 10-18 mol/L zuwa 200 x 10-18 mol/L (10 zuwa 100 kwafi a kowace microlitre shigarwa) ta amfani da sandar a cikin ƙasa da awa ɗaya, ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan wannan sabuwar fasaha za ta iya ƙara yawan saurin ji da kuma dacewa idan aka gwada ta a cikin gwajin asibiti.
Saboda rashin gogewa da sabon COVID, likitoci na iya samarwa da mafi kyawun ikon su, maganin warkarwa ga marasa lafiya na COVID-19, yayin da suke ƙoƙarin gwada nau'ikan magunguna da aka yi amfani da su ko kuma aka gabatar a baya don magance sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table2).2).
Waɗannan hanyoyin sun haɗa da maganin riga-kafi da na yanzu da kuma na gaba da maganin rigakafi, magungunan rigakafi, steroids, plasma na marasa lafiya da aka warkar, magani na kasar Sin, da kuma taimakon tunani.
An kuma ba da shawarar yin amfani da jini na marasa lafiya da suka warke.
Kamfanonin magani suna gudana a kan lokaci don samar da rigakafi da alluran rigakafin cutar.
SARS-CoV-2 ya fara kai hari ga huhu a farkon, kuma yana iya kai hari, a wani mataki, ga sauran gabobin da ke nuna ECA2, kamar su tsarin gastrointestinal da koda.
Amma, rashin numfashi da kuma rashin ƙarfi na gabobin jiki sune manyan barazanar marasa lafiya da kuma manyan abubuwan da ke sa mutane mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da kuma ceton rayuka, kuma ya haɗa da maganin oxygenation na gaba ɗaya, oxygenation mai girma, iska mai ba da izini, da kuma iska mai ba da izini, dangane da tsanani na cutar.
Marasa lafiya da ke fama da cututtukan numfashi masu tsanani suna bukatar su yi amfani da ECMO, wani fasaha na karyar zuciya da na huhu da aka gyara da ake amfani da shi wajen magance ciwon zuciya ko kuma shan numfashi mai tsanani.
Bugu da ƙari, kula da daidaiton electrolyte, hanawa da kuma magance cututtukan cututtuka na biyu da kuma bugun jini, da kuma kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya da SARS-CoV-2.
An san cewa cutar cytokine ta haifar da mummunan sakamako na tsarin rigakafi a cikin marasa lafiya da ke fama da SARS da MERS.
Cytokine cascade wani nau'i ne na tsarin inflammatory response, wanda aka nuna ta hanyar saki jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan ƙwayoyin suna sa ƙwayoyin jikin mutum su saki ƙwayoyin da ke da yawa, wato, waɗanda suke sa ɓarayi da kuma ɓarayi da yawa.
Maganin rigakafi yana da muhimmanci wajen magance cutar cytokine, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da corticosteroids da tocilizumab, wanda yake maganin IL6 wanda ya fi ƙarfin mutum, don magance cutar cytokine.
Sauran hanyoyin da za a iya hana rigakafin rigakafi don maganin cytokine sun hada da daidaitaccen amsawar rigakafin T; toshe IFN-y, IL-1 da TNF; hana JAKs, blinatumomab; suppressor na siginar cytokine 4; da kuma masu hana HDAC.
Ana amfani da steroids a matsayin masu hana rigakafi a maganin SARS don rage yawan cutar ta kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga mummunan rauni a huhu a cikin marasa lafiya da SARS da COVID-19.
Suna iya haifar da mummunan sakamako masu illa, musamman osteonecrosis avascular, wanda ke shafar hangen nesa.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na ƙananan zuwa matsakaiciyar sashi na maganin corticosteroid don amfani da hankali a cikin marasa lafiya masu cutar COVID-19.
A lokacin da aka rubuta wannan talifin, ba a tabbatar da wani maganin riga-kafi mai kyau ba.
Duk da haka, an gano cewa shan remdesivir a cikin jini, wani abu mai kama da nucleotide, ya yi tasiri a cikin wani mai haƙuri na Amurka da COVID-19.
Remdesivir sabon magani ne na rigakafin cutar da Gilead ta haɓaka, wanda aka fara amfani da shi wajen magance cututtukan da Ebola da Marburg suka jawo.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin RNA na faifai guda biyu, ciki har da MERS da SARS.
A bisa wannan, Gilead ta ba da wannan fili ga kasar Sin don gudanar da wasu gwaje-gwaje a kan mutane da suka kamu da SARS-CoV-2, kuma sakamakon yana jiran dogon lokaci.
Bugu da ƙari, an ba da shawarar baricitinib, interferon-α, lopinavir/ ritonavir, da ribavirin a matsayin yiwuwar magani ga marasa lafiya da ke fama da cututtukan numfashi.
Ana iya samun ciwon hanci, nausy, vomiting, cutar hanta da sauran sakamako masu illa bayan an yi maganin lopinavir/ ritonavir.
Dole ne a lura da yadda waɗannan magunguna suke shafar wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma na marasa lafiya da aka warkar da su da kuma samar da rigakafi
Ana tattara jinin marasa lafiya da suka warke daga wata cuta mai yaduwa don kula da wasu marasa lafiya da ke fama da wannan cuta, ko kuma don kare mutane masu lafiya daga kamuwa da cutar.
A gaskiya ma, marasa lafiya da aka warkar suna da ƙwayoyin rigakafi masu yawa a cikin jini don cutar.
Magungunan rigakafi sune immunoglobulin (lg) da kwayoyin cutar B ke samarwa don yaki da cututtuka da sauran kwayoyin halitta, kuma suna gane kwayoyin da ba su da alaƙa da cututtuka kuma suna hana su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wasu marasa lafiya da suka warke daga COVID-19, kuma an yi musu allura a cikin marasa lafiya 10 da ke cikin matsanancin yanayi.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, saboda ƙanƙarar kumburi da ƙwayar cuta da kuma ingantaccen oxygen a cikin jini.
Duk da haka, ana bukatar bincike da kuma bayani don a yi tunanin yin amfani da hanyar a kan babban sikelin kafin a ci gaba da yin takamaiman magunguna.
Bugu da ƙari, saboda maganin da ake yi, ya kamata a yi la'akari da wasu rashin amfani da ke tattare da jini.
Alal misali, ƙwayoyin ƙwayoyin cuta suna iya saurin karfafa maganin rigakafi kuma su haifar da cututtukan cytokine wanda ke da haɗari mai haɗari.
Yawan rigakafin jini a jini yawanci ba shi da yawa, kuma ana bukatar jini sosai don magance marasa lafiya da ke da ciwon daji.
Yana da wuya a ci gaba da samar da takamaiman rigakafi da sauri don magance annoba mai girma a duniya.
Saboda haka, yana da muhimmanci sosai kuma ya fi dacewa a ware ƙwayoyin B daga marasa lafiya da aka warkar kuma a gano lambobin kwayoyin da ke ba da lambar rigakafi masu tasiri ko kuma a gwada su don rigakafi masu tasiri a kan ƙwayoyin ƙwayoyin cuta masu mahimmanci.
Ta haka ne za mu iya ƙara yawan kwayoyin rigakafi cikin sauri.
An yi amfani da maganin gargajiya na kasar Sin, wato, maganin gargajiya na gargajiya, shekaru dubbai da suka shige don magance cututtuka da dama a kasar Sin.
Amma, tasirinsa ya dogara ne sosai da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da gano cutar bisa ka'idodin TCM.
Yawancin abubuwan da ke da tasiri ba a san su ba, ko kuma ba su da tabbas, saboda yana da wuya a cire su kuma a tabbatar da waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin takamaiman magunguna masu tasiri ga COVID-19, MTC ya zama ɗayan manyan magunguna na madadin ga marasa lafiya masu sauƙi ko matsakaici, ko marasa lafiya waɗanda suka dawo daga matakan cutar mai tsanani.
Alal misali, an gano cewa Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri wajen magance COVID-19.
An lura da mafi kyawun murmurewar marasa lafiya na COVID-19 a larduna da yawa a China waɗanda suka yi amfani da MTC a cikin kashi 87% na marasa lafiya, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da MTC a cikin kusan 30% na marasa lafiya na COVID-19, ya sami mafi ƙarancin murmurewa (13%).
Amma wannan kwatanci ne mai wuya, domin ana bukatar a yi la'akari da abubuwa da yawa da za su iya shafar mutum, kamar yawan marasa lafiya da kuma yadda za a yi la'akari da cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike na kwatanta tsakanin maganin gargajiya na yammacin duniya da maganin gargajiya na yammacin duniya.
An gano cewa lokutan da ake bukata don dawo da zafin jiki, bayyanar cututtuka, da kuma asibiti sun kasance ƙasa da yawa a cikin rukunin da likitancin yamma da na gargajiya suka bi fiye da na likitancin yamma.
Yawan rashin lafiyar (na asali zuwa na tsanani) ya kasance ƙasa da yawa ga mutanen da aka yi wa magani ta yamma da kuma maganin gargajiya fiye da na mutanen da aka yi wa magani ta yamma da kawai (7.4% da 46.2%), kuma mutuwar ta kasance ƙasa da na mutanen da aka yi wa magani ta yamma da maganin gargajiya fiye da na mutanen da aka yi wa magani ta yamma da kawai (8.8% da 39%).
Duk da haka, ana jiran ƙarin gwaji da aka yi da kyau a kan manyan sikelin da kuma cibiyoyin da za a yi amfani da shi don tabbatar da inganci da aminci na TCM.
Zai kuma yi kyau a bayyana hanyoyin da za a yi aiki da kuma bayyana abubuwan da ke cikin maganin MTC ko kuma haɗuwa da su, idan zai yiwu.
Marasa lafiya da aka tabbatar da COVID-19 ko kuma waɗanda ake zargin suna da cutar suna jin tsoron cutar mai saurin kamuwa da ita kuma tana iya zama mai mutuwa, kuma mutanen da ke cikin killacewa suna jin dadi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi, da kuma tari, da kuma sakamako masu illa na magani kamar rashin barci da ake samu daga maganin corticosteroid, na iya ƙara damuwa da kuma baƙin ciki na tunani.
A farkon annobar SARS, an ruwaito cututtukan psychiatric da dama, ciki har da ciwon ciki, damuwa, tashin hankali, tashin hankali, alamun psychosis, hauka, har ma da nuna son kai.
Kula da lambobin sadarwa da kuma killacewa na wajibi, a matsayin wani ɓangare na ayyukan tsarin kiwon lafiya na jama'a na yaki da annobar COVID-19, na iya sa mutane su zama masu damuwa, kuma suna iya jin laifi game da tasirin kamuwa da cuta, killacewa, da kuma lalata da aka ɗora wa iyalansu da abokansu.
Saboda haka, dole ne a ba da kulawar lafiyar hankali ga marasa lafiya da COVID-19, ga mutanen da ake zargin suna da cutar da kuma mutanen da suka tuntube su, da kuma ga yawan jama'a da ke bukatar hakan.
Taimakon tunani ya kamata ya haɗa da kafa ƙungiyoyin kula da lafiyar hankali na al'ada, sadarwa mai kyau tare da daidaitaccen sabuntawa game da cutar SARS-CoV-2 da shirye-shiryen magani, da kuma amfani da na'urori masu amfani da lantarki da aikace-aikace don hana kai tsaye tsakanin mutane.
Yin allurar rigakafi mai tasiri yana da muhimmanci wajen kawo ƙarshen hanyar watsawa daga dabba da kuma mutane masu kamuwa da cutar zuwa masu karɓa, kuma yana da mahimmanci ga maganin rigakafi na riga-kafi a cikin sarrafa cututtukan da ke fitowa daga ƙwayoyin cuta.
An dauki matakan samar da alluran rigakafi na S-protein don samar da karfi da kuma tsayayyen antibodies na hanawa da/ko kariya ga SARS-CoV.
An gwada alluran rigakafi a kan samfurin dabba don SARS.
Duk da haka, ingancin in vivo na waɗannan masu neman rigakafi a cikin tsofaffi da kuma ƙalubalen kisa da kariya daga kamuwa da cutar zoonotic virus har yanzu suna buƙatar a ƙayyade kafin a fara nazarin asibiti.
Wannan ya faru ne saboda an shafe shekaru 17 ana kashe cutar SARS kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
A wani bangare kuma, ana ci gaba da samun wasu cututtuka da kuma cutar MERS a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda ci gaba da samun magungunan dabbobi a wuraren da ake cutar.
An kirkiro dabarun yin allurar rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, masu ɗaukar hoto, ƙwayoyin cuta, ƙwayoyin cuta masu kama da ƙwayoyin cuta da kuma ƙananan ƙwayoyin ƙwayoyin cuta, kuma an gwada wasu a cikin samfurin dabba.
Ci gaban wani magani mai lafiya da inganci na SARS-CoV-2 ga mutanen da ba su da kariya ga cutar yana da gaggawa kuma yana da muhimmanci ga sarrafa cutar a yanzu.
Amma, yana da wuya a shawo kan matsalar saboda tsawon lokaci (watau watanni 18) da ake bukata don samar da allurar rigakafi da kuma canji a cikin karfin CoVs.
A matsayin sabuwar cuta, COVID-19 ta fara bayyana cikakkiyar ci gabanta na asibiti, ta kai dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna warkewa a hankali ba tare da wani sakamako ba.
Duk da haka, kamar SARS da MERS, COVID-19 yana da alaƙa da rashin lafiya da mutuwa mai yawa a cikin marasa lafiya masu tsanani.
Saboda haka, gina tsarin hasashen cutar yana da muhimmanci ga hukumomin kiwon lafiya su ba da fifiko ga ayyukan su, musamman a yankunan da ke da karancin albarkatu.
Bisa ga binciken asibiti da aka ruwaito zuwa yanzu, waɗannan dalilai na iya shafar ko kuma suna da alaƙa da yanayin yanayin marasa lafiya na COVID-19 (Table (Table33):
Shekara: Shekara ita ce mafi muhimmanci wajen gano cutar SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya fi rinjayar mutane tsakanin shekaru 30 zuwa 65, tare da kashi 47.7% na marasa lafiya da suka wuce shekaru 50 a cikin binciken da aka yi na mutane 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa mai tsanani sun fi fuskantar ciwon ciki da rikitarwa, kuma sun fi tsofaffi fiye da marasa lafiya da ba su bukatar kulawa mai tsanani ba (mafi yawan shekarunsu 66 zuwa 51), yana nuna cewa shekaru suna da tasiri ga sakamakon lafiyar marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 maza da 0.27/100,000 mata), kamar yadda aka bayyana a sama.
Cutar zuciya da rikitarwa: marasa lafiya da ke fama da cutar COVID-19 da ke bukatar kulawa mai tsanani suna da mafi yawan haɗarin samun rauni na zuciya ko rashin ƙarfi.
Rikicin zuciya ne ya fi haifar da mutuwa a cikin marasa lafiya da ke fama da SARS.
An ruwaito cewa SARS-CoV-2 na iya haɗuwa da ECA2 mai kyau colangiocytes, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya da COVID-19.
Yana da muhimmanci a lura cewa shekaru da cututtuka suna da nasaba sosai kuma suna iya shafan juna.
Sakamakon gwaji na yau da kullum: matakin C-reactive protein (CRP) a cikin jini yana nuna yadda za a yi tsanani daga ciwo ko rauni a cikin nama kuma an nuna shi a matsayin wani dalili na cutar, amsa ga magani, da kuma farfadowa.
An kuma yi nuni da alaƙar matakin CRP da tsanani da kuma hasashen COVID-19.
Bugu da ƙari, lactate hydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine quinase (CK) masu girma suna iya taimakawa wajen hango sakamakon.
Waɗannan enzymes suna cikin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gab
Saboda haka, alamomin gargajiya ne na rashin aikin zuciya ko hanta.
Babban alamun asibiti: dole ne a yi la'akari da radiography na kirji da kuma ci gaban lokaci na alamun asibiti tare da sauran al'amura don hango ko hasashen sakamakon COVID-19.
Amfani da Steroids: Kamar yadda aka bayyana a sama, steroids suna da kariya daga rigakafi da ake amfani da su a matsayin ƙarin magani don cututtuka masu kamuwa da cuta don rage yawan cutar.
Tun da an yi amfani da kwayoyin corticosteroid a yawancin marasa lafiya da ke fama da cutar SARS mai tsanani, mutane da yawa da suka tsira sun kamu da osteonecrosis avascular, da rashin iya aiki na dindindin da kuma rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya da ke fama da COVID-19.
Matsalolin tunani: Kamar yadda aka bayyana a sama, a lokacin annobar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa, saboda suna cikin dogon lokaci na keɓewa da rashin tabbas, kuma suna ganin mutuwar ƙaunatattun danginsu da sauran marasa lafiya.
Yana da muhimmanci a ba da shawara ta tunani da kuma goyon baya na dindindin don taimaka wa waɗannan marasa lafiya su warke daga damuwa kuma su koma ga rayuwarsu ta yau da kullum.
Bisa ga nazarin alƙaluma zuwa yanzu, COVID-19 na nuna cewa yana da halaye na annoba daban-daban daga halaye na SARS.
Baya ga yin kwayar cutar a cikin ƙananan numfashi, SARS-CoV-2 na iya yin kwayar cutar a cikin ƙananan numfashi kuma ba ya haifar da alamun bayyanar cututtuka a farkon lokacin kamuwa da cuta (ko kuma yana haifar da bayyanar cututtuka kawai), kamar sauran CoVs da ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin da suke yin kamuwa da cutar za su iya samar da ƙwayoyin cuta da yawa a yayin aikinsu na yau da kullum, wanda zai sa ya yi wuya a sarrafa cutar.
Duk da haka, an yi la'akari da cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya ke da rashin lafiya mai tsanani, tare da yawancin watsawa ba a farkon lokaci ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi tsanani da kuma wahalar sarrafawa fiye da annobar SARS.
Ana yin manyan ƙoƙari a halin yanzu a China, gami da kulle Wuhan da garuruwan da ke kusa da ita, da kuma ci gaba da killace kusan dukkanin jama'a, a cikin fatan dakatar da watsa SARS-CoV-2.
Duk da cewa waɗannan ayyukan sun shafi tattalin arzikin kasar da sauran bangarorin, adadin sababbin marasa lafiya yana raguwa, yana nuna cewa annobar ta ragu.
Mafi kyawun kimantawa shine cutar za ta ƙare a watan Maris, kuma lokacin jinkirta zai ɗauki watanni uku zuwa hudu.
Amma, wasu masana ba su da irin wannan begen.
Paul Hunter, da sauransu, sun kiyasta cewa COVID-19, wanda ya zama mafi kamuwa da cutar fiye da SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun kafa wani tsari don hango ko hasashen sakamakon annobar kuma sun nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin mazugi da kuma tsakiya na ƙuƙwalwar ƙuƙwalwa na marasa lafiya waɗanda suka warke kuma suka bar asibiti a cikin makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama wani yanayi na yau da kullun kamar mura.
Duk da haka, akwai alamun da suka nuna cewa akwai yiwuwar a yi amfani da dabarun da ake amfani da su a yanzu a kasar Sin, bisa ga raguwar yawan sababbin cututtuka.
An yi hasashen cewa cutar Ebola za ta iya haddasa mutum miliyan ɗaya da kuma mutuwar mutane miliyan rabin.
Amma, da aka yi musu tsauraran yanayi da kuma warewa, sai suka sami ikon sarrafa cutar.
Zai yiwu SARS-CoV-2, kamar SARS-CoV, ya zama mai rauni game da kamuwa da cutar kuma a wani lokaci ya zama ƙarancin cutar da ke rayuwa tare da mutane.
Ana kwatanta annobar COVID-19 da ta SARS da ta MERS a ƙasa (Fig.
SARS-CoV-2 yana da matukar iya yaduwa ta hanyar tari da kuma ta hanyar yin tawaye, kuma yana iya kasancewa ta hanyar kai tsaye zuwa kayan da ke dauke da cutar.
An kuma gano cutar a cikin fitsari, wanda ya haifar da wata sabuwar dama: na watsawa ta bakin-fatsar.
Wani bincike na kwanan nan na shari'o'i 138 ya nuna cewa kashi 41 cikin 100 na shari'o'in da aka yi amfani da su sun kasance sakamakon kamuwa da cuta a asibiti, ciki har da marasa lafiya 17 da ke fama da cututtuka da kuma masu aikin kiwon lafiya 40.
Saboda haka, ya kamata a yi karin tsaro don kare mutane, musamman ma masu aikin kiwon lafiya, masu aikin agaji, 'yan uwa, abokan aiki da kuma mutanen da ke da kai tsaye da masu cutar ko kuma mutane.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce yin amfani da abin rufe fuska; yin amfani da abin rufe fuska na tiyata da kuma abin rufe fuska na numfashi na N95 (series na 1860s) yana taimakawa wajen hana yaduwar cutar.
Masks na tiyata suna hana saukad da ruwa daga mutum mai cutar da za a iya ɗauka zuwa iska ko kuma su manne wa farfajiyar abubuwa inda za su iya kamuwa da wasu mutane.
Duk da haka, N95 masks (series 1860s) ne kawai ke karewa daga inhalation na ƙwayoyin cuta masu girma daga 10 nm zuwa 80 nm, tare da kashi 5% na ƙwayoyin cuta kawai da ke iya shiga cikin su gaba ɗaya; SARS-CoV-2 yana kama da SARS-CoV a girma, kuma duka suna da kimanin 85 nm.
Tun da ƙwayoyin cuta suna iya shiga cikin masks na tiyata har zuwa biyar a lokaci guda, dole ne masu aikin kiwon lafiya da ke hulɗa da marasa lafiya su yi amfani da masks na N95 (series 1860s), amma ba masks na tiyata ba.
Baya ga abin rufe fuska, dole ne ma'aikatan kiwon lafiya su saka tufafin ware don rage haɗuwa da cutar.
Hakanan ƙwayoyin cuta suna kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2, duk da cewa yana amfani da abin rufe fuska na N95; cutar na iya shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu aikin kiwon lafiya suna bukatar su saka kayan kāre fuska ko tabarau masu kariya a lokacin da suke kula da marasa lafiya.
Ga jama'a a yankunan da aka yi wa cuta ko kuma waɗanda za su iya cutar, ana ba da shawarar sosai cewa kowa ya wanke hannuwansa da sabulu mai tsabta fiye da yadda ya kamata, ya yi ƙoƙari ya zauna a gida a cikin keɓewa, kuma ya ƙuntata tuntuɓar waɗanda za su iya kamuwa da cutar.
Ana ganin mita ɗaya ne ya dace don kasancewa nesa da mai haƙuri.
Waɗannan ayyuka suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya fito ne a matsayin sabon kwayar cutar ga mutane, babban jituwa da shi zuwa SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya haifar da babban faɗakarwa ga China, bisa ga tarihin kwanan nan tare da cutar SARS a 2003.
Sai dai a ranar 19 ga Janairu 2020 ne dai darektan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin jama'a, yana cewa sabon kwayar cutar tana da ƙarancin kamuwa da cutar da kuma iyakancewar haifuwa tsakanin mutane, kuma ba shi da wuya a hana da kuma hana cutar.
Wannan sakon ya sa mutane suka fi shakatawa, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara, kuma an rasa lokacin da ya dace don hana cutar a Wuhan a ƙaramin sikelin.
Hukumomin da ke kula da cututtuka a kasar Sin za su iya amfana daga wannan ƙwazo kuma su yi gagarumin ci gaba a nan gaba.
Alal misali, waɗannan hukumomi suna bukatar: (1) su kasance masu hankali wajen yin jawabi a fili, tun da duk abin da suke faɗa yana shafar 'yan ƙasa kuma zai iya rinjayar halayensu da shawarwarin su; (2) su kasance masu saurin fahimta da kuma amsawa ga bayanai marasa kyau daga asibitoci, maimakon su jira sanarwar hukuma da na likita; (3) su kasance masu ƙuntatawa wajen hana wata cuta mai yuwuwa a farkon matakin, maimakon ƙoƙarin ƙarfafa jama'a; da kuma (4) su fi sau da yawa yin amfani da na'urori masu kyau da za su iya yin amfani da su wajen wayar da kan jama'a game da cututtukan cututtuka da kuma gwadawa da kuma inganta tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba na 2019.
A cikin ƙasa da watanni biyu, an yi amfani da shi a duk ƙasar Sin da kuma kusan ƙasashe 50 a faɗin duniya a lokacin da aka rubuta wannan rubutun.
Tun da cutar ta yi kama da SARS-CoV, kuma alamun cutar sun yi kama da COVID-19 da SARS, annobar COVID-19 ta haifar da jin kamar SARS ta dawo.
Duk da haka, akwai bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci wajen hana cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa, maza fiye da mata, kuma nauyi da yawan mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS na da yawan mutuwa fiye da COVID-19 (10.91% da 1.44%).
Marasa lafiya da COVID-19 suna watsa kwayar cutar lokacin da ba su da alamun bayyanar cututtuka, yayin da marasa lafiya da SARS yawanci ke watsa ta lokacin da suke cikin rashin lafiya mai tsanani, wanda ke haifar da wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana, a wani ɓangare, dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri kuma yana shafar yankuna da yawa fiye da SARS-CoV.
Gwajin RNA na yau da kullum don SARS-CoV-2 na iya zama mummunan a wasu marasa lafiya da COVID-19.
A wani bangare kuma, marasa lafiya da aka warkar za su iya sake samun gwajin cutar.
Waɗannan sakamakon sun ƙara haɗarin yaduwar cutar sosai.
Ganin ci gaban bincike kan COVID-19, har yanzu akwai wasu muhimman batutuwa da za a warware, kamar haka:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an sami wani ɗan layi na 96% tsakanin SARS-CoV-2 da CoVs guda biyu na bats masu kama da SARS, har yanzu ba za mu iya kammala cewa SARS-CoV-2 ya samo asali ne daga bats ba.
Wane dabba ne ya ba da cutar daga mahaifarsa, wato, ƙanƙara, zuwa ga mutane?
Idan ba mu san amsoshin tambayoyi na 1 da 2 ba, ba za mu iya dakatar da watsa shirye-shiryen ba, kuma annoba za ta iya sake faruwa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da gwaje-gwajen sinadarai sun nuna cewa SARS-CoV-2 yana haɗuwa da ECA2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na cutar?
Shin kwayar cutar tana haɗa kai da kwayoyin ECA2 a wasu gabobin?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar take juyawa ta hanyar kwayoyin halitta yayin da ake watsa ta tsakanin mutane?
Shin zai zama annoba ta duniya, ko kuwa zai ɓace kamar SARS ko kuma zai sake faruwa a lokutan yanayi kamar mura?
Yana da muhimmanci, amma yana iya ɗaukar lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu.
Duk da haka, ko da wane irin ƙoƙari ne ake bukata, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullum.
Tushen halittu na kwayar cutar korona ta mutum
Cutar da kuma daidaitawa sun yi ci gaba da haɓaka coronavirus (CoVs) da masu masaukin su, gami da mutane, har tsawon dubban shekaru.
Kafin 2003, an san cewa mutum biyu masu cutar sankara (HCoVs) suna haifar da rashin lafiya mai laushi, kamar sanyi na yau da kullun.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake nuna COVID-19 kuma ya ba kowa mamaki da babban yaduwar sa da kuma rage cutarwa idan aka kwatanta da ɗan'uwansa SARS-CoV.
Cutar HCoV na da cutar dabbobi, kuma fahimtar asalin HCoVs na da amfani sosai.
Yawancin HCoVs sun fito ne daga bats, wanda ba su da cutar.
An kuma san masu karɓar bakunan matsakaici na wasu HCoVs.
Gano dabbobi masu baƙi yana da tasiri kai tsaye a rigakafin cututtuka a cikin mutane.
Binciken yadda mai karɓar COVID ke hulɗa da dabbobi na iya samar da muhimman bayanai game da cutar ta COVID a cikin mutane.
A cikin wannan binciken, mun gabatar da cikakken bayani game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su, da asalin su na zoonotic da watsa tsakanin jinsuna.
Wani muhimmin bincike shi ne wanda muke yi na kwatanta da bambanci tsakanin HCoVs daban-daban daga hangen nesa na juyin halittar kwayar cutar da kuma sake hada kwayoyin halitta.
Ana tattauna cutar COVID-19 a cikin wannan mahallin.
Bugu da ƙari, an kuma nuna bukatun don ingantaccen canji tsakanin masu ba da izini da kuma tasirin ci gaban cutar a cikin mummunan cutar.
Coronaviruses (CoVs) suna cikin iyalin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙunshe da ƙwayoyin cuta masu kyau da RNA mai sauƙi.
Waɗannan ƙwayoyin cuta da suka fi girma, tsakanin kilobase 26 zuwa 32 a tsakanin ƙwayoyin RNA, an kira su "CoVs" saboda yanayin kirjinsu lokacin da aka lura da su a cikin wutan lantarki.
A tsarin, CoVs suna da ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
Kimanin kashi biyu bisa uku na genom din sun ƙunshi tsarin karantawa biyu (ORF1a da ORF1b) da aka rufe, wanda aka fassara zuwa pp1a da pp1ab replicase polyproteins.
Ana sake sarrafa poloprotein kuma suna samar da furotin 16 da ba na tsarin halitta ba, wanda ake kira nsp1 zuwa nsp16.
Ragowar ƙwayar halitta tana dauke da ORFs don furotin na tsarin, ciki har da spike (S), envelope (E), membrane (M), da nucleoprotein (N).
Wasu furotin masu amfani da ke cikin wani nau'i na musamman suna kuma ƙunshe da wasu nau'i na CoVs.
Bisa ga bambancin a cikin jerin sunadarai, ana rarraba CoVs zuwa nau'i hudu (alfaCoV, betaCoV, gamaCoV, da deltaCoV), daga cikinsu nau'in betaCoV yana dauke da yawancin HCoVs kuma an raba shi zuwa zuriya huɗu (A, B, C, da D).
Shaidar ilimin halittu ta nuna cewa bats da rodents suna aiki ne na tushen kwayoyin halitta ga yawancin alphaCoVs da betaCoVs, yayin da tsuntsaye sune babban adanawa na gammaCoVs da deltaCoVs.
A cikin dubban shekaru, CoVs sun ci gaba da ƙetare ƙuntatawa na jinsuna, kuma wasu sun zama masu cutarwa masu dacewa ga mutane.
A halin yanzu, an san mutum bakwai na cutar sankara (HCoVs).
Daga cikinsu, HCoV-229E da HCoV-NL63 alphaCoVs ne.
Sauran betaCoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, coronavirus na cututtukan numfashi mai tsanani (SARS-CoV), coronavirus na cututtukan numfashi na Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63 suna haifar da bayyanar cututtuka masu sauƙi, kamar sanyi na yau da kullum da/ko fitsari.
A gefe guda, SARS-CoV, MERS-CoV da sabon gano SARS-CoV-2 suna da cututtukan cututtuka masu yawa kuma suna haifar da mummunan kamuwa da cutar ta hanyar numfashi a cikin yawan marasa lafiya, tare da babban damar ci gaba da cutar ta numfashi mai tsanani (SDRA) da bayyanar cututtukan huhu.
An ware nau'in HCoV-229E na farko, B814, daga masu fama da sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin zurfin HCoV-229E da HCoV-OC43, duka biyu suna haifar da alamun kai-kai.
A gaskiya ma, ana karban ra'ayin cewa kamuwa da cutar HCoVs ba ta da lahani har zuwa annobar SARS.
Cutar SARS da ta auku a shekara ta 2003 ita ce mafi muni a yau kuma ta shafi mutane fiye da 8,000, inda yawan mutuwar da aka samu a cikin mutane kusan kashi 10 cikin ɗari.
Shekaru goma bayan haka, annobar cutar ta Rashin numfashi ta Gabas ta Tsakiya (MERS) ta haifar da annobar da ta ci gaba a yankin Larabawa, da kuma bazuwar ta bazu zuwa sauran duniya.
Sabon HCoV na 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine mai haifar da cutar ta cutar coronavirus ta 2019 (COVID-19), wanda ya kashe rayuka sama da 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ana faɗakar da mutane, kuma dole ne duniya ta shirya don annobar SARS-CoV-2 da ke zuwa.
Dukkanin HCoVs bakwai na zoonotic ne a cikin bats, beraye ko dabbobi.
Bayanai da yawa sun tabbatar da asalin juyin halitta na duk HCoVs daga bats, inda ƙwayoyin cuta suka dace sosai kuma ba su da cutarwa amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo manyan kalubalen kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga kasar Sin da sauran duniya.
Binciken asalin HCoVs na zoonotic yana ba da tsarin fahimtar tarihin halitta, ƙarfin motsawa, da kuma abubuwan da ke hana ƙaurawar cutar zuwa wasu jinsuna.
Wannan kuma na iya jagorantar da sauƙaƙe bincike na masu masaukin baki na SARS-CoV-2, mai matsakaici, da mai haɓaka, tare da mahimman tasirin rigakafin cutar ta gaba tsakanin jinsuna.
A cikin wannan labarin, mun gabatar da cikakken bayani game da asalin halittu, watsa tsakanin jinsuna, da kuma cutar cutar HCoVs.
Musamman, mun nuna kuma mun tattauna batun da kowa yake cewa kwayoyin cutar HCoVs na asali ba su da cutar a cikin gidajen ajiyarsu na halitta, amma sun zama masu cutarwa bayan watsa tsakanin jinsuna zuwa sabon mai masaukin.
Mun kuma lura da yanayin juyin halittar cutar HCoV, inda yawanci karuwar kamuwa da cutar ta zo tare da rage yawan kamuwa da cutar.
Ana kuma tattauna sakamakon annobar SARS-CoV-2 a wannan mahallin.
An san dabbobi masu cutar ta CoV tun daga ƙarshen shekarun 1930.
Kafin a fara ware nau'in HCoV-229E B814 daga cikin masu cutar sanyi na yau da kullun, an ware nau'ikan CoVs daban-daban a cikin dabbobi da yawa da suka kamu da cutar, gami da turkey, beraye, shanu, alade, cats, da karnuka.
A cikin shekaru goma da suka gabata, an gano HCoVs bakwai.
A takaice, taƙaitaccen tarihin gano HCoV a cikin tsari na lokaci (Table 1) zai zama mai bayani da kuma bayani.
An ware nau'in HCoV-229E na farko daga cikin masu shan numfashi na marasa lafiya da ke da cutar ta sama a shekara ta 1966, kuma an daidaita shi daga baya don girma a cikin WI-38 cell lineages.
Marasa lafiya da ke dauke da cutar HCoV-229E sun nuna alamun sanyi na kowa, ciki har da ciwon kai, zubar da jini, rashin jin daɗi da ciwon wuya, tare da zazzabi da tari a cikin kashi 10 zuwa 20% na lokuta.
Daga baya, a 1967, an ware HCoV-OC43 daga al'adun kwayoyin halitta da kuma wucewa ta hanyar kwayoyin halitta a cikin kwakwalwar beraye a lokacin lactation.
Halin da ake samu daga kamuwa da cutar HCoV-OC43 ya yi kama da wanda HCoV-229E ya haifar, wanda ba a iya ganewa daga cutar ta sauran cututtukan numfashi ba, kamar su cutar influenza A da rhinoviruses.
HCoV-229E da HCoV-OC43 suna rarraba a duniya, kuma suna da ƙwarewa a lokacin hunturu a cikin yanayi mai laushi.
A yawancin lokaci, lokacin da waɗannan ƙwayoyin cuta biyu suka yi girma ya fi mako ɗaya, kuma cutar ta yi mako biyu.
A cewar wani bincike da aka yi da masu aikin sa kai na mutum, mutane masu lafiya da suka kamu da cutar HCoV-229E sun kamu da sanyi mai laushi.
Wasu marasa lafiya da ke fama da rashin lafiya ne kawai suka kamu da cutar ta kasa.
SARS, wanda aka fi sani da "sanyen huhu na yau da kullum", shi ne cutar ta farko da aka rubuta ta HCoV a tarihin ɗan adam, kuma wakili na asali shi ne SARS-CoV, HCoV na uku da aka gano.
An fara samun cutar SARS a shekara ta 2002 a lardin Guangdong a kasar Sin.
Cutar SARS ta haifar da mutum 8,096 da aka ruwaito sun mutu, 774 sun mutu, suna yadawa zuwa ƙasashe da nahiyoyi da yawa.
Ban da masu "sake yadawa", an kiyasta cewa kowane mutum da ya kamu da cutar zai iya kamuwa da wasu biyu, tare da lokacin yin amfani da kwanaki 4 zuwa 7, da kuma lokacin da cutar ta kamu da cutar ta kai sama a rana ta goma.
Masu cutar SARS-CoV suna da farko suna da myalgia, ciwon kai, zazzabi, rashin jin daɗi da sanyi, sannan a bi su da bayyanar cututtuka na rashin jin daɗi, tari da rashin numfashi.
Lymphopenia, rashin aikin hanta, da kuma yawan creatine kinase sune cututtukan SARS na yau da kullum a gwaje-gwajen dakin gwaje-gwaje.
Ana kuma lura da cutar alveolar da ta bazu, da kuma karuwar kwayoyin epithelial da kuma karuwar macrophage a cikin marasa lafiya da ke fama da SARS.
Kimanin kashi 20 zuwa 30 cikin 100 na marasa lafiya suna bukatar magani mai tsanani da kuma iska mai iska a wani lokaci.
Baya ga ƙananan numfashi, gabobin da dama, ciki har da gastrointestinal tract, hanta da koda, na iya shafar waɗannan cututtukan, yawanci tare da fitowar cytokine, wanda zai iya zama mai mutuwa, musamman a cikin marasa lafiya masu rashin lafiya.
An fara gano cutar ne a wani binciken huhu na dangin mai cutar da ba shi da lafiya da ke tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi ƙoƙari sosai wajen bincike game da cutar HCoV.
An killace HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara gano cewa cutar tana da yawa a cikin yara ƙanana da tsofaffi da kuma marasa lafiya da ke fama da cututtukan numfashi.
Alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Wani bincike na dabam ya bayyana yadda aka ware wannan kwayar daga hanci na jariri mai wata takwas da ke fama da cutar huhu a ƙasar Holland.
Ko da yake an gano shi a Netherlands, amma an tarwatsa shi a ko'ina cikin duniya.
An kiyasta cewa HCoV-NL63 ya yi daidai da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yawan cutar yana ƙaruwa a lokacin hunturu, bazara da farkon bazara.
HCoV-NL63 yana da alaƙa da laryngitis na hanawa, wanda aka fi sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da ke asibiti da ciwon huhu da bronchiolitis a Hong Kong.
Baya ga cutar pneumonia da bronchiolitis da aka samu a cikin al'umma, an ruwaito HCoV-HKU1 yana da alaƙa da karuwar asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, an gano HCoV-HKU1 a duniya, yana haifar da cututtukan numfashi masu laushi.
Dukkanin waɗannan HCoVs huɗu da aka samo a cikin al'umma sun dace da mutane sosai kuma suna da ƙananan damar yin maye gurbi da haifar da cututtuka masu cutarwa, kodayake haɗari sun faru don dalilai da ba a sani ba a cikin wani ƙaramin hali na HCoV-NL63 mai cutarwa, wanda aka ruwaito kwanan nan a matsayin mai haifar da kamuwa da cutar ta hanyar numfashi a cikin China.
A gabaɗaya, idan waɗannan HCoVs suka sami ikon watsa su yadda ya kamata kuma su ci gaba da kasancewa a cikin mutane, za su zama marasa ƙarfi kuma marasa cutarwa.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da haihuwa da ya kamu da cutar huhu da kuma rashin lafiyar koda a Saudiyya.
Duk da yake yawancin lokuta da aka tabbatar da su daga dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ruwaito wasu lokuta da aka shigo da su daga ƙasashen Turai da Tunisia tare da yaduwar lokaci zuwa ga masu kusanci.
Wani annobar ta biyu ta faru a Koriya ta Kudu a shekarar 2015 inda aka samu mutane 186 da suka kamu da cutar.
Maganin asibiti na MERS yana kama da na SARS wanda ke nuna ci gaba da cutar huhu.
Ba kamar SARS ba, marasa lafiya da yawa da ke fama da cutar MERS suna fama da rashin lafiyar koda, wanda hakan ya sa MERS ta zama sananne ga cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun gastrointestinal kamar su diarrhea da kumburi.
A ranar 14 ga Fabrairu, 2020, an samu karin mutum 2,500 da aka tabbatar da su a dakin gwaje-gwaje, kuma an samu karin mutum 34.4% da suka mutu, wanda ya sa cutar ta zama daya daga cikin cututtukan da suka fi kowa mutuwa.
Daga tsakiyar zuwa ƙarshen Disamba na 2019, an gano ƙungiyoyin marasa lafiya da ke fama da cutar huhu, wanda a baya aka sani yana da alaƙa da kamuwa da cutar SARS-CoV-2, a Wuhan, Hubei Province, China.
Hukumar Lafiya ta Duniya ta bayyana ci gaba da barkewar cutar ta hanyar cutar ta kasa da ta kasa ta SARS-CoV-2 a matsayin gaggawa na Lafiya ta Jama'a na Muhimmanci a Duniya kuma ta kuma sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da yawan mutuwar da aka tabbatar da 3,4%.
An lura cewa mutuwar da aka yi a Hubei, China, ya kai kashi 4,2 cikin dari, yayin da mutuwar da aka yi a wajen birnin ta kai kashi 1,2 cikin dari.
SARS-CoV-2 yana haifar da kamuwa da cutar ta numfashi mai tsanani, kamar SARS-CoV da MERS-CoV, tare da zazzabi, tari da kuma rashin numfashi.
Wasu marasa lafiya ma suna fama da cutar.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya saurin zama cuta mai tsanani ta numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda yawan homologous na 82% a cikin jerin nucleotides, suna haɗuwa a cikin rassan daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 a fili ba shi da cutar, amma ya fi watsawa idan aka kwatanta da SARS-CoV da MERS-CoV.
An ruwaito cewa mutane marasa alamar sun kamu da SARS-CoV-2, kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, za a iya gano kamanceceniya da bambance-bambance masu mahimmanci.
Na farko, lokacin da cutar HCoV ke kamuwa da ita da tsawon lokacin da ta ke ci gaba suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin yanayin sauran HCoVs shida.
Na biyu, tsanani na bayyanar cututtuka na COVID-19 ya kasance tsakanin tsanani na SARS-CoV da tsanani na HCoVs hudu da aka samu a cikin al'umma (HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 na da halaye da aka fi lura da su yayin kamuwa da cutar ta HCoVs da aka samu a cikin al'umma, ciki har da bayyanar cututtuka marasa mahimmanci, masu sauƙi ko ma rashin bayyanar cututtuka.
A gefe guda kuma, ana iya lura da ƙananan ƙananan ƙananan COVID-19 kamar yadda ake yi da kamuwa da cutar SARS-CoV, kodayake adadin ya ɗan ragu.
Na uku, watsa SARS-CoV-2 na nuna wasu abubuwa masu ban sha'awa a cikin HCoVs da aka samo a cikin al'umma da kuma SARS-CoV.
A gefe guda, kamuwa da cutar SARS-CoV-2 tana da sama da HCoVs da aka samu a cikin al'umma.
A wani ɓangare kuma, dole ne a tabbatar da ko za a iya samun karuwar SARS-CoV-2 bayan ya wuce ga mutane, kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurori na ƙwayoyin cuta.
Har yanzu ana buƙatar bayyanawa a cikin nazarin gaba ko watsawar zinariya ta SARS-CoV-2 tana taka muhimmiyar rawa, kamar yadda yake a cikin SARS-CoV, aƙalla a wasu yanayi.
Yana da ban sha'awa sosai a gano ko SARS-CoV-2 na iya nuna yanayi, kamar yadda yake a cikin HCoVs da aka samo a cikin al'umma.
Ko ta yaya, halaye na SARS-CoV-2, gami da watsawa, kamuwa da cuta, da kuma ci gaba da yaduwa bayan ya shiga cikin mutane, za su rinjayi sakamakon cutar COVID-19 ta yanzu.
Dukkanin HCoVs da aka samu a cikin al'umma da ke haifar da bayyanar cututtuka masu sauƙi sun dace da mutane sosai.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun daidaita da HCoVs guda hudu.
A wasu kalmomi, su biyun na iya tsira daga annobar cutar HCoV ta dā.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutanen da ke fama da cututtuka masu tsanani na HCoVs.
Don haka, HCoVs suna bukatar su yi kwafi a cikin mutane a wani wuri mai yawa don su ba da damar samun gyare-gyare masu dacewa da ke hana ƙuntatawa.
A wannan ma'anar, idan cutar ta SARS-CoV-2 ta daɗe, mutane da yawa za su kamu da cutar, kuma za a iya samun damar kamuwa da cutar ga mutane.
Idan an daidaita shi yadda ya kamata, zai yi wuya a sarrafa watsawa ga mutane ta hanyar killacewa ko wasu matakan sarrafa kamuwa da cuta.
Shekaru da yawa da suka shige, waɗannan CoVs huɗu da aka samu a cikin al'ummar mutane suna yawo a cikin mutane, suna haifar da sanyi a cikin mutane masu ƙwarewa.
Waɗannan ƙwayoyin ba sa bukatar wani tanadin dabbobi.
A akasin haka, SARS-CoV da MERS-CoV, masu cutar da ke haifar da cutar, ba su dace da mutane ba, kuma ba za a iya ci gaba da watsa su tsakanin mutane ba.
Suna bukatar su ci gaba da yadawa a cikin wuraren da suke ajiye su na dabbobi kuma su yi amfani da damar da za su iya zuwa ga mutane masu iya kamuwa da cutar, wataƙila ta hanyar ɗaya ko fiye na masu ba da baƙi na tsakiya da masu ƙarfafawa.
SARS-CoV-2 yana da halaye irin na SARS-CoV, MERS-CoV da HCoVs huɗu da aka samo a cikin al'umma.
Yana da matukar iya yaduwa, kamar HCoVs da aka samu a cikin al'umma, aƙalla har yanzu.
Duk da haka, yana da cutar fiye da HCoVs da aka samo a cikin al'umma kuma ba shi da cutar fiye da SARS-CoV da MERS-CoV.
Har yanzu ya kamata a gano ko zai dace da 'yan Adam gaba ɗaya kuma ya yi yawo a tsakaninmu ba tare da wani dabba mai masaukin baki ko matsakaici ba.
Kafin tattauna asalin dabbobi na HCoVs, zai taimaka wajen tattauna ma'anoni da halaye na masu haɓaka, masu ba da gudummawa, masu riƙewa, masu matsakaici, da masu haɓaka HCoVs.
Dabba tana aiki a matsayin mai ba da gudummawa na HCoV idan tana da zuriyar da ke da dangantaka ta kai tsaye, ta hanyar raba babban homology a matakin nucleotide.
A yawancin lokaci, ƙwayar cuta ta asali tana da kyau kuma ba ta da cutar a wannan mahaifar.
Hakazalika, mai masaukin baki yana riƙe da HCoV a kai a kai kuma yana riƙe da shi.
A lokuta biyu, masu karɓar baƙi suna kamuwa da cutar ta halitta kuma su ne masu karɓar HCoV ko kuma ƙwayar cutar.
A wani ɓangare kuma, idan an gabatar da HCoV zuwa wani matsakaici mai ba da labari kafin ko kusa da gabatarwarsa ga mutane, ba zai dace da sabon baƙo ba, kuma yana da cututtuka.
Wannan matsakaiciyar mai watsa shiri na iya zama tushen zoonotic na kamuwa da cutar mutum kuma ya yi aiki kamar mai karfafawa, yana ba da damar kwayar cutar ta sake juyawa ta ɗan lokaci sannan kuma ya watsa ta zuwa mutane kuma ya ƙara girman kamuwa da cutar mutum.
HCoV na iya samun kamuwa da cutar ta dakatar idan ba zai iya ci gaba da watsawa a cikin mai watsa shiri ba.
A wani ɓangare kuma, HCoVs na iya daidaitawa zuwa ga mai masaukin baki kuma su kafa endemics na dogon lokaci.
A wannan yanayin, mai masaukin baki ya zama mai masaukin ajiyar halitta.
Bayanai na cututtuka sun nuna cewa mai cutar SARS ba shi da tarihin da ya shafi dabbobi masu farauta.
Bayan haka, an gano cewa ana samun cutar a cikin dabbobi da ke da ƙwayar cuta ta hanyar cutar.
An gano masked palm civets (Paguma larvata) da kuma wani kare-watshinka a cikin kasuwannin dabbobi masu rai a farkon matsayin masu dauke da kwayar cutar SARS-CoV.
An tabbatar da ganowa ta hanyar rashin gaskiya ta hanyar cewa ba a sanar da wani SARS ba bayan an kashe dukkan 'yan kasuwa a kasuwa.
Duk da haka, an ruwaito cewa dabbobi masu cin nama masu cin nama na daji ko na gonaki ba tare da haɗuwa da kasuwannin dabbobi masu rai ba suna da mummunan sakamako ga SARS-CoV, yana ba da shawarar cewa dabbobi masu cin nama masu cin nama na iya zama kawai matsakaiciyar mai karfafawa amma ba mai adanawa na halitta na SARS-CoV ba.
An lura cewa kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da antibodies na SARS-CoV; ba za a iya ƙyale yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu karɓar bakuncin SARS-CoV ba.
Duk wadannan dabbobi sun bayyana a matsayin masu karbar bakuncin SARS-CoV.
Binciken da aka yi a baya na dabba mai gida na SARS-CoV ya nuna cewa akwai wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Wadannan kwayoyin sun tabbatar da cutar antibody ta SARS-CoV da kuma tsarin genomic na SARSr-Rh-BatCoV HKU3.
Wannan da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa bats ne masu karɓar bakunan mutum masu tasowa.
An gano wasu CoVs masu kama da SARS (SL-CoVs) a cikin bats, amma babu wani CoV, ban da wanda aka kira WIV1, wanda za a iya ware shi a matsayin kwayar cutar mai rai.
An san cewa an dauki cutar ta SARS-CoV ne daga wani abu mai kama da angiotensin 2 (ECA2).
WIV1 da aka samo daga kwayoyin halittar kwayoyin halittar kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta.
Abin ban sha'awa shi ne cewa kwayoyin cutar SARS na marasa lafiya sun iya hana cutar ta WIV1.
Har zuwa yanzu, WIV1 yana wakiltar mafi kusa da SARS-CoV a cikin bats, yana da kashi 95% na homology a cikin nucleotide.
Duk da irin wannan jituwa tsakanin waɗannan ƙwayoyin cuta biyu, an yi imani da shi gaba ɗaya cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba, kuma cewa bats ba su da makomar makomar SARS-CoV.
Binciken filogenetic ya sanya MERS-CoV cikin rukuni guda da CoV-HKU4 a cikin bats da CoV-HKU5 a cikin bats.
CoV-HKU4 na bats da MERS-CoV suna amfani da mai karɓar mai karɓar guda, dipeptidyl-peptidase 4 (DPP4), don shigar da kwayar.
MERS-CoV RNA-dogon RNA polymerase sequences suna da kusancin phylogenetically zuwa homologs a betaCoVs na bats da aka gano a Turai da Afirka.
Har yanzu ba a samu wani MERS-CoV mai rai a cikin bats na daji ba.
MERS-CoV da kuma danginsa mafi kusa, CoV-HKU25 na bats, sun raba kashi 87% na homology a cikin nucleotide.
Saboda haka, ƙwayoyin cuta ba su da wuri a cikin MERS-CoV.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa dromedaries suna da cutar HIV a kan rigakafin cutar MERS-CoV, kamar yadda raƙuman Gabas ta Tsakiya suke a ƙasashen Afirka da dama.
An ware MERS-CoV mai rai, wanda ya yi kama da wanda aka samu a cikin mutane daga nasal swabs na dromedaries, wanda ya ƙara da hujja cewa raƙuma suna aiki a matsayin mai ba da izinin MERS-CoV.
Ya kamata kuma a lura cewa an lura da bayyanar cututtuka masu sauƙi amma tare da watsa ƙwayar cuta mai yawa a cikin raƙuma da aka kamu da cutar ta MERS-CoV.
Yana da muhimmanci a lura cewa raƙuman da suka kamu da cutar ba ta hanyar numfashi kawai ba, har ma ta hanyar ƙuƙwalwa da kuma bakin ciki, wanda kuma shi ne babbar hanyar watsa kwayar cutar a cikin bats.
Duk da haka, har yanzu babu amsoshi, saboda yawancin mutane da aka tabbatar da cutar MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, wanda za a iya danganta shi da yiwuwar watsa tsakanin mutane ko hanyoyin watsawa da ke tattare da jinsunan dabbobi marasa sani waɗanda ke ɗaukar MERS-CoV.
SARS-CoV-2 ya raba 96,2% na homology na nucleotide tare da CoV RaTG13 na bats, wanda aka ware daga bats Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin bi da bi tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don a danganta shi da dangantaka ta iyaye.
Wannan yana nufin cewa bats bazai iya zama masu karɓar bakuncin SARS-CoV-2 ba, sai dai idan an gano CoVs kusan iri ɗaya daga bats a nan gaba.
Ana tsammanin cewa za a kafa masu karɓar dabbobi na SARS-CoV-2 a cikin jinsunan daji da aka sayar da su da aka kashe a kasuwar 'ya'yan itacen teku ta Huanan, wanda yawancin farkon shari'o'in COVID-19 suka danganta da shi, yana nuna yiwuwar watsa dabbobi ga mutane.
Wasu bincike na kwanan nan da aka yi dangane da tsarin halittu sun nuna cewa wani rukuni na ƙananan dabbobi masu haɗari da ke cikin haɗari da za a iya kira pangolins (Manis javanica) na iya zama gida ga tsoffin betaCoVs da suka shafi SARS-CoV-2.
Waɗannan sababbin kwayoyin cuta na CVD na pangolin suna da kashi 85% zuwa 92% na kama da nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa kai tsaye da RaTG13 kuma suna da kusan 90% na ainihi a cikin nucleotide.
Suna tattara su a cikin ƙananan ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin itacen phylogenetic, ɗayan wanda ke raba yankin haɗin mai karɓa (DLR) tare da SARS-CoV-2, tare da 97,4% na ainihi a cikin amino acid sequence.
A bambanci mai girma, DLRs na SARS-CoV-2 da RaTG13 sun fi bambanta, ko da yake suna da babban digiri na homology a cikin dukkanin kwayoyin halitta.
Wani binciken da aka yi kwanan nan a kan 'yan kwari masu rashin lafiya ya kuma ba da rahoton gano jituwa na kwayar cutar daga samfurori na huhu, wanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tsarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta na ɓangare, wanda ya kai kashi 86.3% na yawan kwayoyin halitta na kwayar cutar.
Ba za mu iya ƙyale yiwuwar pangolim ya kasance ɗaya daga cikin dabbobi masu tsakiya na SARS-CoV-2 ba.
A halin yanzu, babu wata hujja da ta tabbatar da asalin SARS-CoV-2 na Pangolin saboda bambancin bi da bi tsakanin SARS-CoV-2 da betaCoVs da suka shafi SARS-CoV-2 na Pangolin.
Bugu da ƙari, nisan tsakanin SARS-CoV-2 da RaTG13 ya fi nisan tsakanin SARS-CoV-2 da betaCoVs da suka shafi SARS-CoV-2 na pangolin.
Har yanzu ana bukatar a bayyana hanyar juyin halitta na SARS-CoV-2 a cikin bats, pangolins da sauran dabbobi masu shayarwa.
Duk da yake an sami mafi girma a cikin DLRs tsakanin SARS-CoV-2 da pangolin, betaCoVs da suka shafi SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girma a cikin tsarin genomic na gaba.
Yana da matukar zato cewa babban kamanceceniya tsakanin DLRs na betaCoVs na pangolin da suka shafi SARS-CoV-2 da SARS-CoV-2 ya samo asali ne daga juyin halitta mai juyawa wanda ke tattare da zaɓaɓɓu.
Wani batu na daban yana goyon bayan sake haɗuwa tsakanin betaCoV na pangolin da suka shafi SARS-CoV-2 da RaTG13 a cikin nau'in dabba na uku.
A matsayin mai motsa juyin halitta, sake haɗuwa yana da yawa a cikin betaCoVs.
Ana ci gaba da bincike kan asalin zoonotic na SARS-CoV-2.
Ban da HCoVs masu cutarwa, an kuma yi nazarin asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin lissafi ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoVs na bats, yayin da aka gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ruwaito cewa wani cutar kwayar cutar da ake kira ARCoV.2 (Apalachian RidgeCoV) da aka gano a cikin kwayar cutar Tricolor ta Amurka tana da alaƙa kai tsaye da HCoV-NL63.
A gefe guda kuma, HCoV-229E ya danganci wani nau'in cutar kwayar cutar da ake kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana zargin cewa chameleons ne masu ba da masaukin baki.
Don ƙarin bayani, an taƙaita ilimin da ake samu game da asalin dabbobi na HCoVs da aka sani a cikin Hoton 1 da Table 2.
Nazarin ilimin lissafi ya samar da hujja game da abubuwan da suka faru na watsa HCoVs tsakanin jinsuna a tarihi.
Lokacin da HCoV-OC43 ya haye jinsuna kuma ya kamu da mutane daga dabbobi a cikin 1890s, an yi rikodin annobar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano alpha-CoVs na bats da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai alphaCoV na alpacas.
Akwai shaidu da yawa da suka nuna cewa cutar ta kai tsaye daga bats zuwa mutane.
Na farko, mutane, amma ba alpacas ba, suna iya tuntuɓar bats a cikin wani yanki na muhalli.
Amma, mutane suna da dangantaka ta kai tsaye da alpacas.
Na biyu, alphaCoVs na bats da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a bats, yayin da alphaCoV na alpacas ya haifar da cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a samu alphaCoV na alpacas a cikin dabbobi masu daji ba.
Saboda haka, ba za a iya ware yiwuwar alpacas su sami alphaCoV da ke da alaƙa da HCoV-229E daga mutane ba.
A gaskiya, bats sune tushen kai tsaye na ƙwayoyin cuta masu cutarwa ga mutane, ciki har da ƙwayar fushi, ƙwayar Ebola, ƙwayar Nipah, da ƙwayar Hendra.
Saboda haka, ba abin mamaki ba ne cewa bats suna watsa HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, yayin da alphaCoVs ke aiki a matsayin tushen HCoV-229E, alpacas da dromedaries na iya aiki a matsayin masu watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen zuwa mutane, kamar yadda yake a cikin MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bats zuwa dromedaries da dromedaries zuwa mutane.
An san asalin MERS-CoV daga kwayoyin halittar kwayoyin halittar halittu a farkon gano su kuma an tabbatar da su daga baya.
Babu shakka, bats suna ba da wadataccen adadin kwayoyin cutar don musayar kwayoyin halitta tsakanin jinsuna da kuma watsa su tsakanin jinsuna.
Tsawon rayuwa, yawan mutane da yawa da ke zama a cikin gida, da kuma kusanci da mutane da yawa da kuma iyawar tashi suna da kyau sosai don bats su zama "masu yada kwayar cutar".
A wani bangare kuma, gabatarwar MERS-CoV zuwa dromedaries ya koma shekarun baya.
Ya dace da waɗannan raƙuma sosai, kuma ya ƙaura daga matsakaiciyar mai masaukin zuwa mai masaukin tanki na halitta da kwanciyar hankali.
MERS-CoV yana haifar da rashin lafiya mai laushi kuma yana da ƙananan ƙananan canji a cikin waɗannan dabbobi.
Yaduwar sa zuwa mutane shine haɗari, kuma mutane suna zama masu karɓar MERS-CoV na ƙarshe, saboda ba za a iya ci gaba da watsa shi ba.
Ba kamar yadda raƙuma ke yi wajen watsa MERS-CoV ba, bangolin suna yin wani abu dabam wajen watsa SARS-CoV-2.
A cikin takamaiman bayani, betaCoVs na pangolin suna da matukar cutarwa a pangolin.
Suna iya zama masu baƙon beta-CoVs masu alaƙa da SARS-CoV-2 kamar yadda suke da civets a cikin SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane da yawa da za a tabbatar ko a watsar da su a cikin nazarin gaba.
Da farko, bats na iya zama mai karɓar bakuncin wani kwayar cutar da ta shafi SARS-CoV-2, kusan iri ɗaya da SARS-CoV-2.
Mutane za su iya raba yanayin da ke cikin sararin samaniya da bats ta hanyar yanka ko kuma hakar ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin masu karɓar baƙi na matsakaici, wanda aka gabatar da cutar da ke da alaƙa da SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar yanka da cin nama.
Ana iya samun masu shayarwa da yawa, ciki har da dabbobi masu gida, masu saurin kamuwa da SARS-CoV-2.
Ana bukatar bincike kan maganin rigakafi da aka samar daga dabbobi na gida da na daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ya yi hulɗa da bats da pangolins.
Ana ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Baya ga nau'ikan dabbobi masu ba da izini, manyan abubuwa uku a cikin kwayar suna da muhimmanci wajen taimaka wa CoVs su ƙetare shingen jinsuna.
Na farko, yawan canjin da suke yi a RNA.
Idan aka kwatanta da sauran kwayoyin RNA masu laushi, ana iya ganin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙarin ƙididdigar ƙididdigar ƙididdigarƙarin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
CoVs suna da exorribonuclease tare da tsarin sake dubawa, wanda cirewa ya haifar da wuce gona da iri da kuma ragewa, ko ma rashin yiwuwar.
Abin sha'awa shi ne, analog na remdesivir na kawar da kwayar cutar ta CoV ta hanyar hana wannan exorribonuclease da RNA polymerase.
Remdesivir yana daya daga cikin masu bada shawara na cutar SARS-CoV-2 da aka gwada a cikin gwaji na asibiti.
Amma, yawan mutations na CoVs ya kusan ninka na masu karbarsu sau miliyan.
Bugu da ƙari, yawanci yawan canjin ya fi girma idan masu cutar ba su dace da mai ba su ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin canji, yawan canjin SARS-CoV-2 yana da ƙananan, wanda ya nuna cewa ya fi dacewa da mutane.
Wataƙila ya riga ya daidaita da wani mai masaukin da yake tuntuɓar mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da dromedaries.
A ka'idar, ba zai yiwu a yi canjin kwayoyin halitta ba da sauri ya sa alluran rigakafi da maganin rigakafi na SARS-CoV-2 ba su da tasiri.
Na biyu, babban RNA a cikin CoVs yana da ƙarin plasticity a cikin gyaran genome don mutations da recombinations, don haka ƙara yiwuwar coevolution tsakanin jinsuna, wanda ke da amfani ga fitowar sabon CoVs lokacin da yanayi ya zama dace.
Wannan ya tabbatar da cewa akwai wasu takardun karatu da kuma ayyukan furotin da aka yi amfani da su wajen yin amfani da inci uku na ƙarshe na ƙasan kwayoyin halitta.
Na uku, CoVs suna sauya samfurori a bazuwar kuma sau da yawa yayin sake fasalin RNA ta hanyar tsarin 'zabar kwafi' na musamman.
A cikin wani mai masaukin da ke aiki a matsayin mai haɗuwa, sau da yawa ana musayar tef a lokacin da ake fassara RNA na CoV.
Ana iya haɗa RNA mai tsawo da kuma na asali don samar da sabon CoV.
An gano alamun halitta na halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma a cikin CoVs na dabbobi kamar SL-CoV na bats da batCoV-HKU9.
Hadin gwiwar ƙwayar cuta da mai watsawa
Baya ga abubuwan da aka ambata a sama, haɗuwa da ƙwayar cuta da mai karɓa na mai karɓa wani muhimmin abu ne da ke shafar watsa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓi mai kyau yayin abubuwan watsawa tsakanin nau'ikan.
Bisa ga bincike na kwatancen tsakanin SARS-CoVs na mutum da na ɗan adam, an yi imanin cewa SARS-CoV yana samun saurin daidaitawa a cikin masu masauki daban-daban, musamman tare da mutations a cikin S-protein DLR.
A kullum, DLR a cikin furotin S na CoV yana hulɗa da mai karɓar ƙwayoyin halitta kuma ana zaɓa shi sosai ta hanyar amsawar antibody na mai masaukin baki.
A cikin SARS-CoV, DLR yana cikin amino acid 318 zuwa 510 a cikin sashin S1, wanda ke ɗaure da ECA2 na mutum, da kuma masu karɓar sa don shigar da kwayar cutar.
DLR na SARS-CoV na iya gane masu karɓar ECA2 daga dabbobi da yawa, ciki har da bats, civets, mice, da kuma kare-kare, yana ba da damar watsa cutar tsakanin jinsuna.
A gaskiya ma, an lura cewa amino acid shida ne kawai suka bambanta da na mutum da na civet a cikin DLR, kuma hudu daga cikinsu suna cikin hanyar ɗaurewa zuwa mai karɓa don hulɗa da mai karɓar ECA2.
SARS-CoV na civets yana da K479N da S487T mutations a cikin DLR, wanda zai iya ƙara haɗuwa da hulɗar ƙwayoyin cuta tare da mai karɓar ECA2 na mutum.
A wasu kalmomi, maye gurbin amino acid guda biyu na iya zama da muhimmanci wajen daidaitawa da kwayar cutar a cikin mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nufin cewa an iya canza alaƙar S-protein da ECA2 na mutum.
A gaskiya ma, wani binciken da aka yi da lantarki na nuna cewa wannan haɗin yana da dangantaka da sau 10 zuwa 20 fiye da na ECA2 na mutum da kuma SARS-CoV S.
Hakanan zai taimaka wajen sanin ko wani correceptor na iya zama dole don watsa SARS-CoV-2.
Abin ban sha'awa shi ne cewa HCoV-NL63 ma yana ɗaure da ECA2, amma tare da wani ɓangare na furotin S.
Akwai wasu masu karɓar HCoV kamar aminopeptidase N don HCoV-229E da 9-O-acetyl siallic acid don HCoV-OC43.
Za su iya amsawa ta hanyar daidaita waɗannan CoVs a cikin mutane bayan watsa su tsakanin jinsunan dabbobi masu masaukin su.
Baya ga masu karɓar salula, sakamakon watsa HCoVs tsakanin jinsuna kuma yana ƙarƙashin wasu abubuwan ƙuntatawa da dogaro da mai masaukin.
Wannan bambancin sunadarai na wannan mai masaukin tsakanin mutane da kuma masu masaukin HCoVs na halitta kamar su bats, dromedaries, da rodents na iya zama shinge ga watsa tsakanin jinsuna.
HCoVs suna bukatar su yi amfani da abubuwan da ke nuna cewa suna dogara da mai karɓar baƙi kuma su kawar da abubuwan da ke hana karɓar baƙi don ingantaccen watsa tsakanin jinsuna.
A wannan yanayin, ana bukatar a gano kuma a gano ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ana iya samun sakamako mai kyau ta hanyar yin amfani da fasahar CRISPR ta zamani don gano ko wane irin mutum ne ya kamu da cutar SARS-CoV-2.
Fitowar sabbin HCoVs: Komawa zuwa matakin sifili
Bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin
A wannan yanayin, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Bugu da ƙari, saurin maye gurbin kwayoyin halitta da kuma sake haɗuwa suna haɓaka juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko kuma rasa sababbin kwayoyin gina jiki na iya canja yanayin kwayar cutar sosai.
Daga cikin furotin na SARS-CoV, ana ganin ORF8 yana da mahimmanci a cikin daidaita shi zuwa mutane, tunda an ware kwayar cutar linzamin kwamfuta da ke da alaƙa da SARS-CoV, amma an gano cewa suna ba da furotin ORF8 daban-daban.
An gano wani abu na ware nucleotide 29 daga SARS-CoVs a cikin nau'ikan da aka keɓe a farkon annobar ɗan adam.
Wannan ƙuntatawa ya raba ORF8 zuwa ORF8a da ORF8b, kuma an yi imanin cewa shi ne maye gurbin da ke inganta maye gurbin masu masaukin baki.
Bugu da ƙari, SARS-CoV yana da yiwuwar rikodin rikodin tare da alphaCoVs da gammaCoVs, inda aka gano ƙananan ƙananan yankuna a cikin RNA-dogara RNA polymerase.
An kuma gano wuraren da za a sake yin amfani da su a nsp9, a mafi yawan nsp10 da kuma sassan nsp14.
Hakazalika, an nuna cewa cutar ta MERS-CoV ta wuce ta hanyar abubuwan sake haɗuwa tsakanin zuriya daban-daban, wanda ya faru a cikin dromedaries a Saudi Arabia.
Bayan SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin sauran HCoVs, inda HCoVs suka sake haɗuwa da sauran CoVs na dabbobi a cikin kwayoyin halitta marasa tsari.
Ya kamata kuma a lura cewa zaɓa na wucin gadi na iya taimakawa wajen haifar da canje-canje marasa kyau a cikin kwayoyin halitta na kwayar cuta, wanda zai iya haifar da sauƙaƙe matsin lamba na zaɓa akan ƙwayoyin cuta, kamar matsin lamba na tsarin rigakafi na mai masaukin baki.
Misali na irin wannan tasirin shine rasa ORF4 mai tsawo a cikin samfurin HCoV-229E, saboda cire nucleotides biyu.
Duk da yake ana iya ganin ORF4 mai kyau a cikin kwayoyin cutar da ke tattare da HCoV-229E a cikin kwayoyin halittun da ke tattare da linzamin kwamfuta da raƙuma, alphaCoV na alpaca yana nuna shigar da nucleotide mai sauƙi wanda ke haifar da canji a cikin zane.
A ƙarshe, amma ba mafi mahimmanci ba, juyin halitta na sababbin HCoVs kuma yana motsawa ta hanyar matsin lamba a cikin wuraren ajiyarsu.
Babu alamun bayyanar cututtuka ko kuma bayyanar cututtuka ne kawai da aka gano a cikin bats lokacin da suka kamu da CoVs, yana nuna daidaitawar juna tsakanin CoVs da bats.
Ana iya ganin cewa bats sun dace da CoVs sosai a fannin jikinsu da na jiki.
Alal misali, rashin ƙarfi a cikin kunna amsa mai ci a cikin bats yana rage cututtukan da CoVs ke haifarwa.
Bugu da ƙari, an kawar da ayyukan kwayoyin halitta a cikin bats saboda daidaitawar mai karɓar kwayoyin halitta NKG2/CD94 mai hanawa, da kuma ƙananan ƙarancin ƙwayoyin halittar aji na farko na babban tsarin haɗin gwiwar.
Bugu da ƙari, yawan kwayoyin oxygen (ERO) da aka samo daga kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na kwayoyin halitta na iya kawar da kwayar cutar ta CoV da kuma rinjayar sake duba exorribonuclease, don haka samar da matsin lamba don samar da kwayoyin cutar masu cutarwa sosai lokacin da aka gabatar da su a cikin sabon mai masaukin baki.
Ƙari ga haka, wasu cututtuka masu cutar CoV za su iya samo asali ta hanyar sake haɗuwa, kuma hakan zai iya haifar da samun sababbin furotin ko kuma sababbin halaye na furotin don daidaitawar mai masaukin.
Saboda haka, ba zato ba tsammani ne cewa HCoVs uku sun fito a cikin shekaru 20 da suka gabata.
CVD ba su da cututtuka, ko kuma suna haddasa alamun rashin ƙarfi a cikin masu ba su gida, kamar su bats da raƙuma.
Suna yin yawa ba tare da sun sa baƙi su yi fama da cutar ba.
Wannan takarda ta bayyana dalilin da ya sa aka gano masu dauke da cutar da ba su da alamun cutar da kuma dalilin da ya sa mutane suke kamuwa da cutar.
Abubuwan da ke damun su sun fi yawaita ne saboda yawan ƙwayar cuta da kuma maganin cytokine, wanda ya fi ƙarfin ƙwayar cuta, kuma ya fi muni a cutar da aka yi wa huhu.
Amma a cikin marasa alamar cutar, an kashe maganin rigakafi daga kwayar cutar.
Wannan dabarar kashe amsa ta rigakafi na iya samun sakamako mai kyau a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin bats.
Saboda haka, gudanar da interferon nau'in I a farkon matakin kamuwa da SARS-CoV-2 a cikin mutane ya kamata ya zama mai amfani.
Bugu da ƙari, ƙwayar NLRP3 mai ƙonewa a cikin bats ba ta da kyau.
Bisa ga wannan tunani, hana NLRP3 mai kumburi tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Tashin SARS-CoV-2 ya bi ka'idojin da suka haifar da SARS-CoV da MERS-CoV.
Duk da yake an gano cewa betaCoV na bats yana da kashi 95% na nucleotide homology tare da SARS-CoV, akwai wani CoV na bats wanda ke da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Ko da yake an gano cewa ciyawa da sauran dabbobi a cikin kasuwanni suna da kwayoyin da suka yi kama da SARS-CoV, ba a gano masu ba da baki ga SARS-CoV-2 ba.
An gano betaCoVs na pangolin, tare da babban kama da SARS-CoV-2, yana nuna cewa pangolin na iya zama ɗaya daga cikin masu ba da sabis na tsakiya, ko kuma pangolin betaCoVs na iya ba da gudummawa da ɓangarorin kwayoyin halitta don ƙarshen SARS-CoV-2.
Ko da yake tambayoyi sun kasance, babu wata hujja cewa SARS-CoV-2 mutum ne ya yi ta hanyar haɗari ko gangan.
An sake samun sanarwa game da cutar ta COVID-19 a duniya saboda annobar SARS-CoV-2 da ta barke kwanan nan.
Nazarin CoVs a cikin bats da sauran dabbobi ya canza tunaninmu sosai game da mahimmancin asalin dabbobi da wuraren ajiye dabbobi na HCoVs a watsa tsakanin mutane.
Bayanai masu yawa sun nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun fito ne daga bats kuma ana watsa su ga mutane ta hanyar masu ba da baki.
Tun da cutar SARS-CoV ta fito ne daga tuntuɓar mutane da fararen fata a kasuwanni, rufe kasuwanni masu ruwa da kuma kashe fararen fata a cikin waɗannan kasuwanni na iya kawo ƙarshen annobar SARS.
A cikin wannan tunanin, dole ne a cire pangolin daga kasuwannin ruwa don hana watsa cutar zoonotic, yayin da aka gano wasu layin betaCoVs na pangolin da ke da alaƙa da SARS-CoV-2.
Duk da haka, ana buƙatar bayyana a cikin nazarin gaba ko SARS-CoV-2 yana watsawa ga mutane ta hanyar pangolins da sauran masu shayarwa, da kuma yadda za a watsa shi.
A wani bangare kuma, cutar ta MERS-CoV ta daɗe tana cikin dromedaries.
Waɗannan raƙuman suna da muhimmanci a sufuri kuma suna da muhimmanci wajen samun nama, da madara, da fata da kuma ulu ga al'ummar yankin.
Ana rarraba su a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yi hadaya da dukan raƙuman don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana yaduwar cutar MERS, ya kamata a bi hanyar da ta dace don samar da ingantattun alluran rigakafin MERS-CoV ga raƙuma, tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin ba, za a iya samun sababbin kwayoyin halitta da za su iya haifar da annoba.
Akwai nau'o'in cututtukan CoV da ke yawo a cikin yanayi.
Musamman, cututtukan cututtuka na bats da ke da yiwuwar cutar zoonotic sun bambanta sosai.
Akwai yiwuwar cewa waɗannan CoVs na zoonotic za su iya tasowa kuma su sake haɗuwa, wanda zai haifar da sababbin CoVs waɗanda za su iya zama masu yaduwa da/ko kisa ga mutane a nan gaba.
Dole ne a daina cin dabbobi a wasu wurare a kasar Sin don rage rashin bukatar dabbobi da mutane.
Da ake fama da cutar SARS, MERS da COVID-19, ya kamata a yi shiri da kuma tsara yadda za a magance ta.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniya tun da daɗewa.
Suna zama a cikin wuraren da suke ajiye su har sai sun sami damar ƙaura zuwa wani jinsin.
Ko da yake bats suna da halaye da yawa da ke taimaka wa kamuwa da cutar, za a iya rage yawan mutanen da za su iya yin cuta da su da kuma wasu dabbobin daji idan aka koya musu su guje musu.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don samun kyakkyawar fahimtar yanayin halittu na CoVs da masu masaukin su na halitta, wanda zai taimaka wajen hana watsa dabbobi zuwa mutane da cututtuka a nan gaba.
A ƙarshe, hanya mafi inganci ta hana cutar ta kwayar cuta ita ce ta hana mutane kasancewa a cikin wuraren da ake ajiye kwayoyin halitta don cutar ta kwayar cuta.
Wasu sassan jigon asalin SARS-CoV-2 har yanzu ba su bayyana ba.
Da farko, idan bats sun watsa wani kwayar cutar SARS-CoV-2 zuwa pangolins, yana da muhimmanci a gano a wace yanayi ne bats da pangolins za su iya raba wuri na muhalli iri ɗaya.
Na biyu, idan bats suna taka rawa kai tsaye wajen watsawa ga mutane, ya kamata a tantance yadda mutane ke hulɗa da bats.
Na uku, idan dabba ce ta uku da take hidima a matsayin mai ba da masaukin baki, dole ne a bayyana yadda take hulɗa da jinsuna dabam-dabam, har da mutane da bats da pangolins.
A ƙarshe, tun da yake dabbobi masu shayarwa da dama, ciki har da dabbobi masu gida, na iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a yi saka idanu da kuma gwajin kamuwa da cutar.
Idan wani dan gizo-gizo ne, ko wani mamba, ko wani dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma kwayoyin cutar da suka yi kama da juna za a gano su a cikin mahalarta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman abubuwan da ke tattare da rigakafi da kula da COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin bincike na "masu zargin" da "masu tabbatar da" COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar jagora mai sauri don ganewa da kula da kamuwa da cutar coronavirus ta 2019 (2019-nCoV). Wannan jagorar tana ba da kwarewarmu kuma yana da kyakkyawan tushe don magance wannan annobar ta duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabon abu ne. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ƙwarewa a cikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani akai-akai.
A cikin wannan wasiƙar, mun amsa wani bayani game da jagorarmu kuma mun samar da sabbin ƙa'idodin bincike na "abubuwan da ake zargi" da "abubuwan da aka tabbatar" bisa ga sabon Jagorar Bincike da Kula da COVID-19 (sarrafa ta bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya buga.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ana kiranta cutar coronavirus ta 2019 (COVID-19), kuma an kira cutar coronavirus 2 na cututtukan numfashi mai tsanani (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta lasafta COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta kirkiro jagorar jagora mai sauri da aka buga a kan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Ya jawo hankalin mutane sosai tun lokacin da aka wallafa shi.
Duk da haka, lura cewa COVID-19 sabon cuta ne. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da gwaje-gwaje na yau da kullun a cikin aikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani akai-akai.
Alal misali, Jagorancin Bincike da Kula da COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya wallafa tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020 sun yi fitowa guda bakwai tare da canje-canje masu yawa a mahallin wasu.
Yanzu, jagorarmu ta karɓi tsokaci daga Zhou et al., wanda ya gabatar da wata shawara mai sauƙi game da sakamakon sakamakon sakamakon gwajinsa.
Wannan aikin ya kara sabbin hujjoji ga jagorarmu kuma yana ba da muhimman bayanai game da wannan annoba ta duniya.
Muna goyon bayan aikinku mai muhimmanci kuma muna nuna godiyarmu.
Duk da haka, aikinsa yana bukatar sabuntawa kuma bisa ga sabuwar Jagorancin Bincike da Kula da COVID-19 (sarrafa gwaji ta bakwai) da kuma binciken da aka yi kwanan nan.
A cikin littafin nan na bakwai (Maris 3, 2020), don tabbatar da wani abu mai ban sha'awa, dole ne a hada wani abu daga cikin abubuwan tarihin cututtuka tare da abubuwa biyu na bayyanar cututtuka don yin cikakken bincike, ko kuma dole ne a cika abubuwa uku na bayyanar cututtuka idan babu bayyanar cututtuka:
Tarihin cututtukan cututtuka: (1) tarihin tafiya ko zama a cikin birnin Wuhan da yankunan da ke kusa da shi ko kuma a wasu al'ummomi inda aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin tuntuɓar cututtuka masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko alamun numfashi daga birnin Wuhan da yankunan da ke kusa da shi ko kuma daga wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin tuntuɓar rukuni na tabbataccen shari'o'i (mafi girma ko daidai da shari'o'i biyu da zazzabi da/ko alamun numfashi na mako 2 da suka faru a cikin kananan wurare kamar gida, ofis, dakunan karatu, da sauransu).
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da kayan aikin gano hoto na kamuwa da cutar COVID-19; (3) ƙididdigar ƙwayoyin fari na jini na gaba ɗaya da ke nuna yawan ƙwayoyin lymphocytes na yau da kullun, raguwa ko raguwa a farkon matakin bayyanar cututtuka.
Dole ne a tabbatar da cewa an tabbatar da cutar ta hanyar yin amfani da kwayoyin halitta don gano ko gano wani abu daga cikin kwayoyin halitta na SARS-CoV-2 ko kuma cutarwa: (1) PCR gwajin da ya dace da SARS-CoV-2; (2) cikakken kwayar cutar ta nuna babban daidaituwa ga sabon coronavirus da aka sani; (3) tabbatacce ga magungunan IgM da IgG na musamman ga SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko kuma wani canji na IgG na musamman ga SARS-CoV-2 daga tabbatacce zuwa tabbatacce ko karuwa zuwa sau hudu a cikin matakin dawowa sama da na gaggawa.
Za mu iya lura cewa an ƙara gwajin PCR na ainihin lokaci don nucleic acid a cikin jini ko kuma hanyoyin numfashi zuwa bugu na biyu da na uku (Janairu 18 da 22, 2020).
An ƙara gano cutarwa ta samfurin jini a bugu na huɗu da na biyar (na 27 ga Janairu, 2020 da na 8 ga Fabrairu, 2020), kuma an ƙara hujjojin sorological a bugu na bakwai.
Waɗannan canje-canjen sun dogara ne akan ci gaba da aikin masu bincike don neman samfurin gano nucleic acid mai kyau don ganewa da sauri da kuma samfurori na numfashi, ciki har da samfurin jini, wanda ya kara samun samfurori daban-daban kuma ya taimaka wajen kawo sakamako mai kyau na takamaiman antibodies ga ingantattun ka'idoji.
Bugu da ƙari, akwai ƙarin tabbaci da ke tuna mana mu kula da marasa lafiya marasa bayyanar cututtuka da marasa bayyanar cututtuka.
Saboda haka, ya kamata a sabunta tsarin Zhou et al. domin ya ƙayyade cewa mutumin da ba shi da alamun cututtuka yana da "kashi".
Ana bukatar a duba tsarin a wasu bincike da kuma ayyukan asibiti.
A ƙarshe, muna sa ran ƙarin hujjoji na kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don gano "abubuwan da ake zargi" da kuma "abubuwan da aka tabbatar", muna ba da shawarar ku duba kuma ku bi sababbin jagororin ƙasashenku.
Ƙungiyarmu za ta sabunta jagorarmu a kan kari don ta ba da taimako.
Bangladesh ta samu karin mutum biyar da suka mutu sakamakon COVID-19, wanda ya fi hakan a kowace rana
A jiya, Bangladesh ta tabbatar da wasu mutane biyar da suka mutu sakamakon COVID-19 a ranar.
Wannan shi ne adadin mutuwar da aka yi a rana daya sakamakon cutar.
A jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ruwaito cewa adadin wadanda aka tabbatar da cewa sun kamu da cutar sun hada da mutane 114 da suka kamu da cutar da kuma mutane 33 da suka warke da cutar da suka samu a gida.
An yi rahoton mutuwar mutane 17.
A wani labari na kan layi, darektan IEDCR, Dokta Meerjady Sabrina Flora, ta ce mutuwar ta hada da maza hudu da mace guda.
A cewar Dr. Meerjady, mutane biyu sun fi shekara 60, biyu sun kai shekaru 51 zuwa 60, ɗayan kuma ya kai shekaru 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda suka mutu sun fito ne daga Dhaka.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a matsayin annobar cutar a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa Anadolu Agency, wata hukumar yada labarai ta kasar, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda aka kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani sakon da aka wallafa ta hanyar bidiyo, ministan sufuri da gadaje na Bengal Obaidul Quader ya ce, za a dakatar da sufuri na jama'a fiye da yadda aka shirya a baya, har zuwa ranar Asabar mai zuwa.
Wannan dakatarwar ta fara ne a ranar 26 ga Maris kuma an shirya ta ta ƙare a ranar Asabar, 4 ga Afrilu.
Ana kuma ba da izinin jigilar kayayyakin da ake bukata (kayan magani, man fetur da abinci).
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗaya daga cikinsu.
A ranar 19 ga Maris, dukansu uku sun warke.
SARS-CoV-2 ya wuce kamuwa da cuta miliyan a duniya
A ranar Alhamis, jimlar adadin mutanen da suka kamu da cutar SARS-CoV-2 a duniya ta wuce miliyan daya, kamar yadda bayanan Jami'ar Johns Hopkins suka nuna.
Akalla mutuwar dubu 52 na da alaƙa da COVID-19, cutar da coronavirus ke haifarwa.
Wannan ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona da kuma Zambiya ta fara mutuwa sakamakon cutar.
Koriya ta Arewa ta ce har zuwa ranar Alhamis tana daya daga cikin kasashe kalilan da suka rage ba tare da kamuwa da cutar coronavirus ba.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, ciki har da mutane 79,332 a cikin sa'o'i 24 kafin 10 na yamma na Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar korona, wanda ya shafi mutuwar mutane 5,900.
Labarin CBS News ya ruwaito, yana ambaton bayanan Jami'ar Johns Hopkins, cewa an yi mutuwar sama da 1,000 a Amurka sakamakon kamuwa da cutar coronavirus a ranar Laraba.
A faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow Sergei Sobyanin ya tsawaita cikakken toshewar birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya ce za a ci gaba da biyan 'yan Rasha albashi idan ba su zo aiki ba har zuwa ranar 30 ga Afrilu.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kasa har tsawon kwanaki 15, kuma ta amince da shi da kuri'u 215 a madadin, 10 a madadin, da kuma 1 a madadin.
Saudiyya ta tsawaita tsawon lokacin da ake gudanar da aikin tattara mutane a cikin biranen Makka da Madina don dukan yini, tun da farko daga karfe 3 zuwa 6 na yamma.
Thailand na shirin yin aikin tarawa daga karfe 10 na safe zuwa 4 na safe
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun rage yawan kayayyakin da ake amfani da su a duk wata ma'amala
A daren Asabar da Lahadi, cibiyoyin sayar da kayayyaki na Australiya Woolworths da Coles sun rage ƙuntatawa na sayen takardar wanka zuwa fakiti biyu da fakiti ɗaya a kowace ma'aikatar a duk faɗin ƙasar.
A ranar Litinin, ALDI ta kuma kafa wata iyaka ta fakitin.
An sanar da wannan ta hanyar saƙonnin da aka saka a cikin akwatunan da kuma shafukan Facebook na cibiyoyin sadarwa.
Saboda tsoron COVID-19, ana zargin masu sayen suna ajiyewa idan akwai bukatar su keɓe kansu.
A ranar Laraba, kamfanin Woolworths ya kuma iyakance sayen takardar bayan gida zuwa kunshin da aka ba da umarni.
Waɗannan canje-canjen sun zo ne bayan da aka yi amfani da su a kan 4 da 5 ga Maris, Woolworths da Coles.
Coles a cikin sanarwar ta na 8 ga Maris, ta ruwaito cewa, ko da an hana fakitin hudu, "manyan shagunan har yanzu suna kashe kaya a kasa da awa daya bayan bayarwa" kuma ta kira bukatar "marasa-ƙari", yayin da ALDI ta kira ta "ba zato ba tsammani" a cikin wani sakon Facebook a ranar Talata.
A makon da ya gabata, tallace-tallace sun yi "ƙaruwa sosai", in ji wani mai magana da yawun kamfanin Woolworths.
Costco ta sayar da kayayyaki a Camberra kuma ta rage adadin da za a iya biya zuwa fakiti biyu a makon da ya gabata.
Don ƙara rage ƙarancin, Coles ta ba da umarni daga manyan masu samar da kaya da kuma ƙara yawan isar da sako, Woolworths ta ba da umarni na ƙarin kaya, yayin da ALDI ta ba da kyauta a gaba don ingantawa da aka shirya a ranar Laraba.
Russell Zimmerman, shugaban hukumar masu sayar da kaya ta Australiya, ya ce masu sayar da kayayyaki suna ƙoƙari su ƙara yawan kayayyaki, amma ƙuntatawa na hukumar a cikin yawan aikawa da motoci yana hana hakan.
Yana sa ran samun tsada sosai domin masu samar da kayayyaki suna ƙoƙarin biyan bukatar, kuma ba a ba da tallafi sosai ba.
A ranar Talata, ALDI ta sanar da cewa bayan an saki kayayyakin da wuri, wasu shagunan ba za su iya yin tallata ranar Laraba ba.
A wani rahoto da aka wallafa a News.com.au, Dokta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce, shaguna suna sake tattara kayayyaki a kowace dare.
Ya nuna cewa takardar bayan gida abu ne mai yawa da ba shi da yawa, kuma idan ya ƙare, yana barin sarari a kan ɗakunan ajiya, yana ƙara jin ƙarancin.
Coles da Woolworths sun yi imani cewa idan akwai yalwa a kan ɗakunan ajiya, idan ana iya sayen kayayyaki kamar takarda mai tsabta da kuma maganin antiseptic kuma suna nan a yalwace, za ka rage tsoro, in ji Russell Zimmerman ga ABC News.
Kamfanin kera takardar bayan gida mai suna Who Gives the Crap ya ce a ranar Laraba ta gabata za su rasa kayayyakin.
Kamfanin Kimberly-Clark, wanda ke samar da takardar gida Kleenex, da Solaris Paper, wanda ke samar da Sorbent, sun jaddada cewa suna aiki awanni 24 a rana 7 a mako don ci gaba da samarwa, a cewar rahoton News.com.au.
Shafin yanar gizon gidajen ƙasa domain.com ya ruwaito cewa wasu masu sayar da gidaje suna ba da takardar wanka kyauta ga masu ba da gwaninta na farko a Melbourne, lokacin da ake yin ƙananan gwanjo tare da masu siye suna shiga hutu a ƙarshen ranar aiki.
Labarin ranar Alhamis na jaridar NT News, jaridar Darwin, ya haɗa da shafi takwas da aka saka don a yanke shi kuma a yi amfani da shi a matsayin takardar wanka.
Da farko, shagunan sun yi jinkirin sanya takunkumi, a cewar wani rahoto na ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin aiwatar da takunkumi kan sayayya.
Russell Zimmerman ya ƙara da cewa akwai wasu kayayyaki da ake bukatarsu sosai, kamar su masks, maganin kashe cututtuka, kayayyakin bushewa, sabulu na hannu da gari.
Kamar yadda a Ostiraliya, a daren Lahadi, kantin sayar da kayayyaki na kan layi na Ocado na Burtaniya ya ƙuntata sayen takardar bayan gida ta Andres zuwa fakitin 12 na kunshe.
Hukumar Lafiya ta Duniya ta ayyana cutar COVID-19 a matsayin annobar annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa barkewar cutar COVID-19  cutar da coronavirus SARS-CoV-2  ta haifar ita ce annoba.
Ko da yake kalmar "zazzabin cuta" tana nuna kawai yadda cutar ta yadu, ba yadda hatsarin da ake samu a wasu lokuta ba, WHO ta nanata bukatar ƙarfafa gwamnatoci su yi aiki:
Dukkanin kasashe na iya canza yanayin annobar.
Idan kasashen duniya za su iya ganowa, gwadawa, bi da su, ware su, su bi su, kuma su tura mutane su yi aiki, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa da matakan yadawa da kuma nauyi da kuma rashin aiki.
A cewar Dr. Tom Frieden, tsohon darektan Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amirka, annobar ta "ba a taɓa gani ba".
A cikin wani bayani da CNN ta wallafa a watan Fabrairu, ya ce "ban da mura, ba a lura da wani kwayar cutar numfashi ba tun lokacin da ta taso har zuwa ci gaba da yaduwar duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana mai cewa "ba mu taɓa ganin annobar da coronavirus ya fara ba".
Ya ci gaba da cewa, "kuma ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba".
Sabuwar annobar ta biyo bayan shawarar WHO ta watan Janairu na bayyana barkewar cutar a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya.
Shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasar Amirka, Dokta Anthony Fauci, ya ce, cutar "za ta ƙara muni".
A ranar Alhamis, jaridar Associated Press ta ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, inda fiye da mutane 4,600 suka mutu.
Cutar coronavirus ta 201920 annobar cutar ce ta ci gaba da kamuwa da cutar coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus ta cutar ta 2 ta cutar ta numfashi mai tsanani (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disambar 2019, an bayyana ta a matsayin gagarumin matsalar lafiyar jama'a ta duniya a ranar 30 ga Janairu, 2020 kuma an amince da ita a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, inda aka samu kusan mutane 97,000 da suka mutu.
Mutane 364,000 ne suka warke.
An kiyasta cewa yawan mutuwa a kasar Sin ya kai kashi 4 cikin 100, yayin da a duniya ya kai kashi 13.04 cikin 100 a Algeria zuwa kashi 0.08 cikin 100 a New Zealand.
Alamomin da aka fi sani sun haɗa da zazzabi, tari da kuma rashin numfashi.
Abubuwan da za su iya jawo musu matsaloli sun haɗa da ciwon huhu da kuma rashin jin daɗin numfashi.
Lokaci daga bayyanar har zuwa bayyanar cututtuka yana da kimanin kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko maganin rigakafi da aka sani.
Maganin farko shi ne maganin bayyanar cututtuka da kuma tallafi. Abubuwan da ake ba da shawara na rigakafi sun haɗa da wanke hannu, rufe bakinka yayin tari, nisantar mutane da kuma saka idanu da keɓe mutane da ake zargin suna da kamuwa da cuta.
Hukumomi a faɗin duniya sun amsa da aiwatar da takunkumin tafiye-tafiye, killacewa, rufewa, kula da haɗari a wurin aiki, da kuma rufe wuraren aiki.
Cutar ta haifar da mummunan katsewar tattalin arzikin duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu da kuma rashin wadatar wadata da aka kara ta hanyar cinikin da ke haifar da firgici.
Makarantu da jami'o'i sun rufe a kasa ko kuma a gida a kasashe 193, suna shafar kusan kashi 99.4% na yawan ɗaliban duniya.
Bayanai marasa kyau game da cutar sun bazu a kan layi kuma akwai wasu abubuwan da suka faru na rashin jin daɗin jama'a da nuna bambanci ga Sinawa, mutanen da suka fito daga gabashin Asiya da kudu maso gabashin Asiya da kuma wasu mutane daga yankunan da cutar ta kamu da su.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antu masu nauyi, an rage yawan gurɓataccen iska da kuma iskar carbon.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei) sun ruwaito wani rukuni na cututtukan cutar pneumonia da ba a san dalilinsa ba a ranar 31 ga Disamba, 2019 kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta suna da alaƙa da kasuwar kayan amfanin gona na Huanan kuma saboda haka an yi imanin cewa cutar tana da asalin dabbobi.
An gano cutar da ta haifar da barkewar cutar a matsayin SARS-CoV-2, wanda aka gano kwanan nan kuma yana da alaƙa da kwayar cutar coronavirus na bat, pangolin, da SARS-CoV. Mutumin farko da ke da alamun sanarwa ya kamu da cutar a ranar 1 ga Disamba, 2019 kuma bai nuna alaƙa da gungun 'yan kasuwa na' ya'yan itace ba.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoton da ba a tabbatar ba na South China Morning Post ya nuna cewa wani hali ya nuna 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, wanda zai iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabbin shari'o'in da aka ruwaito suka ragu a China amma suka karu a Italiya, Iran da Koriya ta Kudu, adadin sabbin shari'o'in da ke waje da China ya zarce adadin sabbin shari'o'in da ke China a karon farko.
Akwai yiwuwar rashin sanarwa mai yawa, musamman a cikin mutanen da ke da ƙananan alamun.
A ranar 26 ga Fabrairu, an samu ƙarancin adadin cututtuka a tsakanin matasa masu shekaru 19 da ƙasa da haka, wato kashi 2.4 cikin 100 na cututtuka a duniya. Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60 cikin 100 na mutanen Birtaniya za su bukaci kamuwa da cutar kafin a samu rigakafin da ya dace.
Abubuwan da aka yi magana a kansu sun shafi yawan mutanen da aka gwada su don COVID-19 kuma waɗanda aka tabbatar da gwajin su tabbatacce bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawanta, kuma wasu ƙasashe sun ɗauki manufofin hukuma na kada a gwada mutane kawai da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga Maris ya gano cewa a kasar Sin, a ranar 23 ga Janairu, an kiyasta cewa kashi 86 cikin 100 na kamuwa da COVID-19 ba a gano su ba kuma wadannan kamuwa da cutar da ba a rubuta su ba ne suka zama tushen kamuwa da cutar ga kashi 79 cikin 100 na kamuwa da cutar da aka rubuta.
Wani bincike na kididdiga da aka wallafa a ranar 30 ga Maris ya nuna cewa yawan mutanen da suka kamu da cutar a Italiya ya fi yawan wadanda aka ruwaito.
An kiyasta cewa adadin haihuwa na asali (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 suna warkewa.
Ga waɗanda ba su warke ba, tsawon lokaci daga bayyanar cututtuka zuwa mutuwa ya kai kwanaki 6 zuwa 41, kwanaki 14 ne suka fi kowa.
A ranar 10 ga Afrilu, 2020, an yi rahoton mutuwar kusan 97,000 da COVID-19.
A kasar Sin, har zuwa 5 ga Fabrairu, kimanin kashi 80% na mutuwar sun faru ne a cikin mutanen da suka wuce shekaru 60 da haihuwa, kuma kashi 75% suna da yanayin kiwon lafiya na farko, gami da cututtukan zuciya da ciwon sukari.
Yawan mutanen da suka mutu daga COVID-19 na iya zama mafi girma, tun da ba za su iya haɗa da mutanen da suka mutu ba tare da sun yi gwajin ba, misali, waɗanda suka mutu a gida, a gidajen marasa lafiya, da dai sauransu.
Bayanai na Italiya sun nuna cewa adadin mutuwar da aka samu a lokacin annobar ya wuce adadin mutuwar COVID ta hanyar kashi 4-5x.
Wata kakakin cibiyar kula da cututtuka da rigakafin cututtuka ta Amurka (CDC) ta amince cewa "mun san cewa [adadin mutuwar hukuma] an yi kasawa", sanarwa da rahoton rahoton rahoton da aka samu a Amurka. Wannan kasawa yana faruwa a cikin annobar cutar kamar cutar sankarar alade ta H1N1 a shekarar 2009.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a Iran da Koriya ta Kudu da kuma Italiya.
A ranar 13 ga Maris, fiye da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar a duk nahiyoyi sai dai Antarctica.
Wadannan lambobi sun bambanta bisa ga yankin da kuma tsawon lokaci kuma suna rinjayar yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokaci tun farkon barkewar cutar da halayen yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu, 2020.
Yawan ya bambanta bisa ga yankin.
A kasar Sin, ƙididdigar yawan mutuwar ta ragu daga kashi 17.3 cikin dari (a cikin mutanen da suka fara bayyanar cututtuka tsakanin 1-10 ga Janairu na 2020) zuwa kashi 0.7 cikin dari (ga mutanen da suka fara bayyanar cututtuka bayan 1 ga Fabrairu na 2020). Sauran matakan sun haɗa da CFR, wanda ke wakiltar yawan mutanen da aka gano da ke mutuwa saboda cutar, da kuma cutar kamuwa da cuta (IFR), wanda ke wakiltar yawan waɗanda suka kamu da cutar (masu gano da marasa gano) da ke mutuwa saboda cutar.
Waɗannan kididdigar ba su da tsayayye a kan lokaci kuma suna bin wani yawan mutane na musamman na kamuwa da cuta ta hanyar warware matsalar.
Wasu masana sun yi ƙoƙarin yin lissafin waɗannan lambobin don wasu al'ummomi.
Cibiyar Nazarin Kimiyya ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar ta cutar ta kasance tsakanin kashi 0.1 zuwa 0.39%.
Wannan ƙididdigar ta sama ta wannan zangon ta dace da sakamakon gwajin farko na COVID-19 a Jamus da kuma nazarin kididdiga wanda ya bincika tasirin gwajin akan ƙididdigar CFR.
Hukumar ta WHO ta ce za a iya sarrafa annobar.
Ba a san lokacin da za a yi annobar ba kuma za a iya canja wurin da ya dace.
Maciej Boni, daga Jami'ar Jihar Pennsylvania, ya ce: "Ba tare da a kula da su ba, cututtuka masu kamuwa da cuta sukan kai ga ƙaruwa kuma su koma baya sa'ad da babu masu kula da cutar.
Amma ba zai yiwu a yi wani hasashen da ya dace a yanzu game da lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhong Nanshan, ya ce "za a iya kammala shi a watan Yuni" idan dukan ƙasashe suka yi aiki don bin shawarwarin WHO game da matakan hana yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski, na Makarantar Lafiya da Lafiya ta Tropical a London, ya bayyana cewa SARS-CoV-2 "mai yiwuwa zai ci gaba da yawo har shekara guda ko biyu".
A cewar wani bincike na Imperial College, wanda Neil Ferguson ya ja-goranci, ana bukatar nisantar jiki da kuma wasu matakai "har sai an samu allurar (mai yiwuwa a cikin watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa wannan coronavirus ya ɓace gaba ɗaya, tun da yake yana da matukar yaduwa" kuma "yana iya zama cuta ta yanayi, yana sake bayyana a kowace shekara".
Idan ya sake faruwa, zai dogara ne da rigakafin rukuni da kuma tsawon lokacin da ya faru.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma waɗanda suka kamu da cutar na iya zama marasa bayyanar cututtuka.
Abubuwan da suka fi kowa a cikin cututtuka biyu sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, fitowar numfashi (sneak), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da naƙasa, ciwon wuya, ciwon kai, sanyi, zagi, haemoptysis, diarrhea ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka sun lissafa alamun gaggawa su ne wahalar numfashi, ciwo ko matsa lamba a kirji, rikicewar kwatsam, wahalar tafiya da fuska ko lebe masu launin shuɗi. Ana ba da shawarar neman taimakon likita idan waɗannan alamun sun kasance. Ci gaban cutar na iya haifar da mummunan huhu, cutar rashin jin daɗin numfashi mai tsanani, sepsis, mummunan rauni, da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa alamar bayyanar cututtuka, amma sakamakon gwajin da ya tabbatar da kamuwa da cutar ya nuna cewa sun kamu da cutar, saboda haka masu bincike sun ba da shawarar cewa a saka idanu da kuma duba waɗanda suka yi kusa da wanda ke da kamuwa da cutar don a kawar da kamuwa da cutar.
Ƙididdigar kasar Sin na yawan marasa lafiya sun bambanta daga kashi 44 zuwa kashi 100.
Lokacin da ake amfani da shi na yau da kullum (lokacin da ke tsakanin fara kamuwa da cuta da bayyanar cututtuka) ya bambanta daga kwana ɗaya zuwa 14, amma yawanci kwana biyar ne. A matsayin misali na rashin tabbas, kimantawar adadin mutanen da ke da COVID-19 da suka rasa ƙanshi da farko ya kasance 30% kuma daga baya ya ragu zuwa 15%.
Har yanzu ana gano wasu bayanai game da yadda cutar take yaduwa.
An yi imanin cewa wannan cuta tana yadawa ne ta hanyar tuntuɓar kusa da ƙananan saukad da aka yi yayin yin tari, numfashi ko magana, kuma ana ɗaukar kusanci daga mita 1-2 (3 zuwa 6 feet).
Nazarin ya nuna cewa yin tari ba tare da rufe bakinka ba zai iya sa ka ji kamar ka yi tsatsa daga mita 15 zuwa mita 27.
Wasu mutane sun ce za a iya watsa kwayar cutar ta hanyar saukad da da ke cikin iska na tsawon lokaci, wanda za a iya samarwa yayin tattaunawa. Hakanan za a iya samar da saukad da numfashi yayin numfashi, gami da magana, kodayake cutar ba ta tsayawa a tsaye ba.
Sa'ad da aka yi amfani da maganin, za a iya samun saɓo a bakin da hanci na mutanen da ke kusa da su ko kuma a yi musu iska.
Wasu hanyoyin likita kamar su allura da kuma karyar zuciya da huhu (CPR) na iya haifar da kumburi na numfashi wanda ke haifar da yaduwar iska.
Ƙari ga haka, za a iya samun yaduwar idan mutum ya taɓa wani gurɓataccen wuri, har da fata, sa'an nan kuma ya taɓa idanunsa ko hanci ko bakinsa.
Ko da yake akwai damuwa cewa zai iya yaduwa ta cikin fitsari, an yi imanin cewa haɗarin hakan ba shi da yawa.
Gwamnatin kasar Sin ta musanta yiwuwar watsa SARS-CoV-2 daga zinare zuwa cikin jini. Kwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake watsawa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
An gwada cutar a kwanaki uku kafin bayyanar cututtuka, wanda ya nuna cewa za a iya watsa ta kafin bayyanar cututtuka.
Akwai wasu rahotanni na asymptomatic da aka tabbatar da su a cikin dakin gwaje-gwaje, amma an gano rashin alamar cutar a wasu ƙasashe a lokacin bincike na tuntuɓar.
Cibiyar Tsare-tsaren Cutar ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku.
Musamman, an gano cewa cutar tana iya ganowa har zuwa kwanaki uku a cikin filastik (polypropylene) da karfe 304, kwana ɗaya a cikin kwali da har zuwa sa'o'i huɗu a cikin tagulla.
Amma, wannan ya bambanta bisa ga yanayin zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun riga sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya canja wurin cutar zuwa mutane, amma hukumomin Birtaniya sun ba da shawarar wanke hannuwanku bayan kun taɓa dabbobi ko kuma bayan kun taɓa wani yanki da mutane suka taɓa.
Coronavirus 2 na cutar ta numfashi mai tsanani (SARS-CoV-2) sabon kwayar cuta ne, wanda aka fara ware daga mutane uku da ke fama da cutar huhu da ke da alaƙa da wasu cututtukan cutar numfashi mai tsanani a Wuhan.
Dukkanin halayen sabon SARS-CoV-2 suna kama da na coronavirus da ke da alaƙa da su a cikin yanayin su. A waje da jikin mutum, kwayar cutar tana mutuwa ta sabulu na gida, wanda ke narkar da ɓoye mai kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa yana da asali na dabbobi.
Binciken kwayoyin halitta ya nuna cewa coronavirus yana da alaƙa ta hanyar kwayoyin halitta da jinsin Betacoronavirus, subgenus Sarbecovirus (layin B).
Yana da kama da kashi 96 cikin dari, a matakin genomic, da sauran samfurori na coronavirus daga bats (BatCoV RaTG13).
A watan Fabrairun shekarar 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai tsakanin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin
A cikin kwatancen da aka yi na dukan genomes, zuwa yanzu, an sami kashi 92% na raba kwayoyin halitta tsakanin cutar korona ta pangolin da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolin ne mai matsakaici ba.
Ana iya gano kamuwa da cutar ta hanyar bayyanar cututtuka a wani lokaci, amma za a iya tabbatar da shi ta hanyar yin kwafin da aka bi ta hanyar yin amfani da polymerase chain reaction (rRT-PCR) na ɓarkewar da aka kamu da ita ko kuma ta hanyar daukar hoto na kwamfuta (CT).
Wani bincike da aka yi a Wuhan, inda aka kwatanta rRT-PCR da CT ya nuna cewa CT yana da muhimmanci sosai, ko da yake ba shi da ƙayyadaddun bayanai, tare da yawancin halayen hotonsa da suka yi daidai da sauran cututtukan huhu da cututtukan cututtuka.
Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ba da shawarar cewa "ba a yi amfani da CT don tantancewa ko a matsayin gwajin gaba don gano COVID-19 ba".
WHO ta wallafa wasu takardun shaida na RNA don SARS-CoV-2, na farko daga cikinsu an buga shi a ranar 17 ga Janairu.
Wannan gwajin yana amfani da reverse transcription followed by polymerase chain reaction (rRT-PCR) a cikin lokaci na ainihi.
Ana iya gwada shi a cikin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin
Ana samun sakamako a cikin 'yan sa'o'i ko kwanaki.
Yawancin lokaci ana yin wannan gwajin ta hanyar nasopharyngeal rubbing, ko da yake ana amfani da garkuwar garkuwar.
A ranar 6 ga Afrilu, 2020, babu wani daga cikin waɗannan da ya tabbatar da cewa ya isa ya zama daidai don a amince da shi don amfani da shi.
An amince da gwajin magani da kamfanin Cellex a Amirka don amfani da shi a cikin gaggawa ne kawai ga masu bincike da suka yi aiki.
Abubuwan da ke cikin hotunan radiographs da CT na mutane masu cutar sun hada da rashin haske a cikin asymmetrical peripheral dark glass da kuma rashin zubar da jini.
Ƙungiyar Radiology ta Italiya tana tattara bayanai na duniya a kan layi na sakamakon hotunan da aka tabbatar.
Saboda yawan kamuwa da cutar ta adenovirus, hotunan da ba a tabbatar da PCR ba suna da iyakantaccen ƙayyadaddun bayanai game da gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da na PCR kuma ya nuna cewa ko da yake hoton bai kai ga kamuwa da cuta ba, amma ya fi sauri kuma ya fi saurin fahimta, wanda ya nuna cewa ana amfani da shi a matsayin kayan bincike a wuraren annobar.
An yi amfani da hanyoyin sadarwa na kwakwalwa na kwakwalwa don gano siffofin hoto na cutar ta hanyar daukar hoto da kuma CT.
Hanyoyi don hana yaduwar cutar sun haɗa da kiyaye tsabtace mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba, tari ko numfashi a cikin takarda mai takarda da kuma saka wannan takarda kai tsaye a cikin kwandon shara.
Idan ka riga ka kamu da cutar, kana bukatar ka saka abin rufe fuska a wurin jama'a.
Ana kuma ba da shawarar yin nesa da mutane don hana yaduwar cutar. Gwamnatoci da yawa sun ƙuntata ko kuma sun hana yin balaguro ba na asali zuwa ko daga ƙasashe da yankunan da cutar ta shafa.
Amma cutar ta kai matakin da ya shafi al'umma a yankuna da yawa a duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi kuma wasu 'yan al'umma ba su san inda ko yadda aka kamu da cutar ba. Ana ba da shawarar cewa masu aikin kiwon lafiya da ke kula da mutanen da za su iya kamuwa da cutar su yi amfani da matakan tsaro na yau da kullun, matakan tuntuɓar ido da kariya. Binciken tuntuɓar wata hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano tushen kamuwa da cuta da hana watsawa daga baya.
Gwamnatocin da ke amfani da bayanan wuri daga wayoyin salula don wannan dalili sun tayar da tambayoyi game da tsare sirri, tare da Amnesty International da fiye da kungiyoyi 100 da ke ba da sanarwar neman iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an gabatar da su don amfani na son rai. A ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyin masana goma sha biyu suna aiki a kan hanyoyin da ke da alaƙa da sirri, kamar amfani da Bluetooth don yin rikodin kusanci ga mai amfani da sauran wayoyin hannu.
Masu amfani za su sami saƙo idan sun yi hulɗa da wani da ya tabbatar da cewa yana da cutar COVID-19. Wasu ra'ayoyin da ba daidai ba game da yadda za a hana kamuwa da cutar sun bazu, kamar, don misali, wanke hanci da kuma yin gargadi da kayan lambu, wanda ya riga ya tabbatar da rashin tasiri.
Babu allurar rigakafin COVID-19. Duk da haka, ƙungiyoyi da dama suna aiki don haɓaka ɗaya.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Hukumar kula da cututtuka ta bada shawarar cewa mutane su wanke hannayensu da ruwa da sabulu a kai a kai na akalla na biyu, musamman bayan amfani da bayan gida ko kuma idan hannayensu sun kasance da ƙazanta sosai. Ya kamata kuma a wanke hannayensu kafin cin abinci da kuma bayan sun yi ta wanke hanci, tari ko tsotsa.
Wannan shi ne saboda a waje da jikin mutum, ana kashe kwayar ta da sabulu na gida, wanda ke karya murfinta.
Hukumar ta kuma ba da shawarar yin amfani da kayan tsabtace hannu da aka yi amfani da giya da ke da ƙaramar kashi 60 cikin ɗari na giya, idan babu sabulu da ruwa da za a iya samunsu a wuri.
Hukumar lafiya ta duniya ta ba da shawara cewa kada ku taɓa idanunku, hanci ko bakinku ba tare da wanke hannu ba.
Za a iya tsabtace farfajiyar da yawa (a cikin minti daya na bayyanar da maganin kashe cuta ga farfajiyar bakin karfe), ciki har da ethanol a 6271%, isopropyl alcohol a 50100%, sodium hypochlorite a 0,1%, hydrogen peroxide a 0,5% da iodopovidone a 0,27,5%.
Sauran hanyoyin, kamar benzalkonium chloride da chloride gluconate, ba su da tasiri sosai.
Hukumar ta bayar da shawarar cewa idan an yi zargin ko an tabbatar da COVID-19 a wani wuri kamar ofishi ko makarantar yara, duk wuraren kamar ofisoshin, dakunan wanka, wuraren jama'a, kayan lantarki da aka raba kamar kwamfutar hannu, allon tabawa, keyboard, na'urorin sarrafawa, da akwatunan lantarki da marasa lafiya ke amfani da su, ya kamata a yi musu maganin rigakafi.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa a rufe baki da hanci da ɗamara ko kuma takarda a lokacin da kake tari ko kuma yin numfashi, kuma a yi watsi da duk wani takarda nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, domin yin amfani da abin rufe fuska zai iya iyakance yawan da kuma nisan da za a yi saukowa daga saukad da numfashi yayin magana, numfashi ko tari.
Hukumar lafiya ta duniya ta wallafa umarni game da lokacin da za a yi amfani da abin rufe fuska da kuma yadda za a yi amfani da shi.
Wani masanin cututtuka na cutar daga jami'ar Leeds, Stephen Griffin ya ce, "sawon masks zai iya rage yawan mutane su taɓa fuskokinsu, wanda shi ne babban tushen kamuwa da cuta ba tare da tsabtace hannu ba".
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska ga mutane masu lafiya kawai lokacin da suke cikin haɗari mai yawa, kamar masu kula da mutanen da ke da COVID-19, duk da cewa sun kuma yarda cewa yin amfani da abin rufe fuska na iya taimaka wa mutane su guji taɓa kansu.
A ƙasashe da dama, an soma ƙarfafa jama'a su yi amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likita ba don fuskar da aka yi da masana'anta. China ta ba da shawarar musamman ga yin amfani da abin rufe fuska na likita da za a iya amfani da shi ta hanyar mutane masu lafiya a gaba ɗaya, musamman idan sun kusanci wani mutum (tsayawa mita 1 ko ƙasa da nesa).
A Hong Kong, ana ba da shawarar yin amfani da abin rufe fuska na tiyata a lokacin da kake amfani da sufuri ko kuma lokacin da kake zama a wurare masu yawa.
Hukumomin kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska na masana'anta a gida kuma su wanke su kullum.
A Jamhuriyar Czech da Slovakia, an hana su fita a fili ba tare da sun saka abin rufe fuska ba ko kuma sun rufe hanci da bakinsu.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska a lokacin da ya fita a wuraren jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta bukaci duk wanda ya shiga manyan kantuna ya saka abin rufe fuska.
A Isra'ila, an umurci dukan mazauna su saka abin rufe fuska a fili.
Taiwan, wadda ta samar da masks miliyan 10 a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas na gari-gidanka su saka masks a fuskarsu daga ranar 1 ga Afrilu.
A Panama, ana bukatar a yi amfani da abin rufe fuska a lokacin da kake fita a titi. A lokaci guda, an bada shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya saya ba.
An kuma yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da nesa na jiki) ya ƙunshi ayyukan sarrafa kamuwa da cuta don rage yawan kamuwa da cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da killacewa, ƙuntatawa a kan tafiya da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Ana iya yin amfani da hanyoyin nisantawa ta zamantakewa ta wajen kasancewa a gida, ta wajen iyakance tafiye-tafiye, ta wajen guje wa wuraren da mutane suke ɗungum, ta wajen yin gaisuwa ba tare da yin magana da kowa ba, da kuma ta wajen nisanta mutane.
A halin yanzu, gwamnatoci da yawa suna tilasta ko kuma ba da shawarar yin nesa da jama'a a yankunan da cutar ta shafa.
Matsakaicin adadin mutane da aka ba da shawarar ta hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya an rage su da sauri daga mutane 250 (idan babu ilimin watsa COVID-19 a wani yanki) zuwa mutane 50 sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a na mutane sama da biyu. Manya tsofaffi da waɗanda ke da cututtukan da ke tattare da su kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma tsarin rigakafi masu rauni suna fuskantar haɗarin kamuwa da cututtuka masu tsanani da rikitarwa, kuma CDC ta ba da shawarar kasancewa a gida gwargwadon iko a yankunan annobar al'umma. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "nesa ta zamantakewa" da "nesa ta jiki", don bayyana cewa makasudin shine rage hulɗa ta jiki ta hanyar kiyaye alaƙar zamantakewa, ko dai ta zahiri ko ta nesa.
Amfani da kalmar "tsayawa ta zamantakewa" ya haifar da ma'anar cewa ana buƙatar warewar zamantakewa gaba ɗaya maimakon ƙarfafa tuntuɓar ta wasu hanyoyin. Wasu hukumomi sun buga jagororin kiwon lafiya na jima'i a lokacin annobar.
Waɗannan shawarwarin sun haɗa da yin jima'i da wanda kake zama da shi kawai, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar yin zaman kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda suka yi zaton sun kamu da cutar.
Hukumomin lafiya sun ba da cikakken umarni game da yadda za a yi zaman kai-kai. Gwamnatoci da yawa sun bukaci ko kuma sun ba da shawarar yin zaman kai-kai ga dukan mutanen da ke zaune a yankunan da aka shafa.
An ba da umurni mafi tsauri na keɓe kai ga waɗanda suke cikin rukunin haɗari.
An shawarci mutane da za su iya kasancewa a cikin haɗari da wasu da COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki da ke da yaduwar yaduwar yaduwar su yi kwanaki 14 na keɓe kansu daga lokacin da aka fara nuna su.
Dabarun da za a iya amfani da su wajen hana barkewar cutar su ne hana ta ko kuma kawar da ita da kuma rage ta.
Ana yin hanawa a farkon fasalin barkewar cutar kuma ana nufin ganowa da ware masu kamuwa da cutar, da kuma gabatar da wasu matakan sarrafa kamuwa da cuta da alluran rigakafin da za su hana yaduwar cutar zuwa ga sauran jama'a.
Idan ba za a iya hana yaduwar cutar ba, ana yin ƙoƙari don rage ta: matakan da ake ɗauka yanzu suna rage saurin yaduwar da kuma rage tasirinsa a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan hanawa da kuma ragewa a lokaci guda, a hade.
Dakatar da cutar tana bukatar tsauraran matakai don juyar da annobar zuwa matakin haihuwa na asali wanda ya kasa 1. Gudanar da barkewar cutar kamuwa da cuta, wani bangare na shi ne ƙoƙarin rage ƙaruwar annobar. Wannan abin da muke kira "ƙaddamar da cutar ta annoba".
Hakan yana rage haɗarin yin amfani da ayyukan kiwon lafiya a kan wani abu, yana ba da ƙarin lokaci don a samu alluran rigakafi da kuma hanyoyin magani.
Ayyukan da ba na magani ba ne da za su iya magance cutar sun haɗa da matakan kariya na mutum kamar tsabtace hannu, yin amfani da masks na fuska da kuma keɓe kai; matakan da ke tattare da nesa na jiki kamar rufe makarantu da soke abubuwan da ke haifar da taro; shigar da al'umma don ƙarfafa yarda da shiga cikin waɗannan ayyukan; da matakan muhalli kamar tsabtace wuraren tuntuɓar. An ɗauki matakan da suka fi tsauri don hana cutar a China lokacin da cutar ta bayyana.
Wasu ƙasashe sun ɗauki matakai dabam-dabam don su rage yaduwar cutar.
Alal misali, Koriya ta Kudu ta gabatar da bincike mai zurfi da kuma sanya mutane a cikin gida.
A Singapore, an tallafa wa waɗanda suka kamu da cutar kudi a lokacin da suke yin keɓe kansu, kuma an yi wa waɗanda ba su yi hakan ba tsabar kudi mai tsanani.
A Taiwan, an samu karuwar samar da abin rufe fuska kuma an hukunta waɗanda ke adana kayan kiwon lafiya. A cikin gwaji da aka yi a Birtaniya da Amurka, an nuna cewa ragewa (ƙanƙasawar saurin kamuwa da cuta ba tare da dakatar da yaduwar cutar ba) da kuma kawar da cutar (watau juyawa ci gaban cutar) suna da manyan kalubale.
Manufofin ragewa na iya rage yawan bukatar kiwon lafiya da kashi biyu bisa uku, kuma mutuwar ta kashi biyu cikin uku. Duk da haka, hakan zai haifar da mutuwar dubbai da yawa, kuma a lokaci guda, zai yi wa tsarin kiwon lafiya nauyi.
Dakatar da cutar na iya zama mafi kyawun madadin, amma dole ne a ci gaba da shi har sai an sami yaduwar cutar ta cikin mutanen ko kuma har sai an sami allurar rigakafi idan hakan ya faru kafin. In ba haka ba, watsawar za ta sake faruwa da zarar an sassauta matakan.
Yin aiki na dogon lokaci don kawar da cutar yana kawo farashi na zamantakewa da tattalin arziki.
Babu wani magani na riga-kafi da aka amince da shi wanda ke da alaƙa da COVID-19. Duk da haka, akwai ƙoƙari wajen haɓaka magunguna, wanda ya haɗa da gwajin magunguna na yanzu.
Yin amfani da magani don sanyi da ba a rubuta ba, shan ruwa mai yawa, da kuma yin hutu zai iya taimaka wajen rage alamun.
Dangane da yadda yanayin yake, ana iya bukatar yin amfani da oxygen, yin amfani da ruwa a cikin jini, ko kuma taimakon numfashi.
Yin amfani da kwayoyi na iya sa yanayin ya yi muni.
Abubuwan da aka amince da su a baya don magance wasu cututtukan kwayar cuta suna cikin bincike don amfani da su wajen magance COVID-19.
Hukumar lafiya ta duniya ta kuma bayyana cewa wasu magungunan "gida da na gargajiya" na iya rage alamun cutar SARS-CoV-19.
WHO ta bayyana karuwa da kuma daidaitawa da kulawar lafiya ga bukatun da COVID-19 ta kawo a matsayin muhimman matakan yaki da barkewar cutar.
Cibiyar Tallafawa da Kula da Cututtuka ta Turai, ECDC, da ofishin WHO a Turai sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko don motsa albarkatun su a matakai daban-daban, gami da haɓaka ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin da ba dole ba, da keɓewa da keɓe marasa lafiya da suka gwada COVID-19 da kyau, da haɓaka ƙarfin kulawa mai tsanani ta hanyar horar da ma'aikata da haɓaka yawan gadaje da masu iska.
Akwai ra'ayoyi da yawa game da yadda aka haifi mutum na farko (wanda ake kira marasa lafiya).
An fara samun sanadiyar cutar korona a ranar 1 ga watan Disamba na shekarar 2019 a birnin Wuhan da ke lardin Hubei, kasar Sin.
A cikin wata daya, yawan masu dauke da cutar korona a yankin ya karu a hankali.
A ranar 26 ga watan Disamba, wani rukuni na marasa lafiya ne Dr. Zhang Jixian ya lura da su kuma ya kula da su a asibitin lardin Hubei.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan sun yi wa abokan aikinsa gargadi game da "Coronavirus na SARS".
Likitoci takwas daga cikin likitocin, ciki har da Li Wenliang, sun fuskanci tsautawa daga 'yan sanda don yada labaran karya. Wani likitan, Ai Fen, ya fuskanci tsautawa daga ma'aikatansa don ya ba da sanarwar.
Hukumar kula da lafiya ta birnin Wuhan a ranar 31 ga watan Disamba ta ba da sanarwar ga jama'a kuma ta sanar da WHO.
An riga an ba da rahoton isasshen cututtukan huhu na asali da ba a sani ba ga hukumomin kiwon lafiya na Wuhan don samar da bincike a farkon watan Janairu. A farkon matakan barkewar cutar, adadin cututtukan ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta yada zuwa wasu lardunan kasar Sin, wanda aka sauƙaƙe ta hanyar ƙaurawar Sabuwar Shekarar Sin da kuma gaskiyar cewa Wuhan cibiyar sufuri ce, ban da babban tashar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton wasu mutane 140 da suka kamu da cutar a rana guda, ciki har da mutane biyu a Beijing da kuma daya a Shenzen.
Bayanai na hukuma na baya sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar har zuwa 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin waɗanda aka tabbatar da cutar a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 1.61 na cutar a duk duniya; sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Kimanin ƙasashe da yankuna 200 sun riga sun sami akalla ɗaya.
Saboda annobar a Turai, ƙasashe da yawa da ke cikin Yarjejeniyar Schengen sun ƙuntata motsi da kuma kafa ƙuntatawa a kan iyaka.
Sakamakon haka ya hada da matakan hanawa, kamar su killace gida (wanda aka fi sani da dokar hana fita, dokar hana fita ko kuma dokar kulle) da kuma hanawa. A ranar 2 ga Afrilu, kimanin mutane miliyan 300 (kusan kashi 90 cikin 100 na yawan jama'a) suna cikin wani hali a Amurka, fiye da mutane miliyan 50 suna cikin Philippines, kimanin mutane miliyan 59 suna cikin Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun riga sun shiga wani nau'in kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 kwana biyu bayan haka, kusan kashi ɗaya bisa uku na yawan duniya.
An samu mutum na farko da aka tabbatar da cutar COVID-19 a Wuhan a ranar 1 ga watan Disamba na shekarar 2019. Wani rahoto da ba a tabbatar da shi ba ya nuna wani mutum da ya kamu da cutar a ranar 17 ga watan Nuwamba.
Dokta Zhang Jixian ta lura da wasu marasa lafiya da ke fama da cutar huhu daga wasu dalilai da ba a san su ba a ranar 26 ga watan Disamba.
Gwaje-gwajen farko na kwayoyin halitta, a ranar 27 ga watan Disamba na 2019, a cikin samfurin da aka cire daga marasa lafiya sun nuna kasancewar coronavirus na SARS.
Hukumar kula da lafiyar birnin Wuhan ta ba da sanarwar ga jama'a a ranar 31 ga watan Disamba.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
A lokacin da aka sanar da hakan, 'yan sanda sun gargadi likitocin Wuhan don " yada jita-jita" game da annobar.
Hukumar Lafiya ta kasar Sin da farko ta ce babu "bayani mai kyau" na yaduwar cutar tsakanin mutane.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri, wanda daga baya sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya bayyana shi a matsayin "yaƙin jama'a" don dakile yaduwar cutar.
A cikin abin da aka kwatanta da "babban kulle-kulle a tarihin 'yan adam", an sanar da dokar hana fita a ranar 23 ga Janairu don dakatar da tafiye-tafiye zuwa Wuhan, wanda aka shimfida zuwa birane 15 na Hubei, yana kaiwa kusan mutane miliyan 57 a duka.
An haramta amfani da motocin sirri a cikin birnin.
An soke bikin sabuwar shekara ta kasar Sin a wasu wurare a ranar 25 ga watan Janairu.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti kuma, wato, Leishenshan, don kula da ƙarin marasa lafiya.
Tare da sabbin asibitocin da aka gina, kasar Sin ta mayar da wasu cibiyoyin Wuhan 14 zuwa asibitoci na wucin gadi, kamar cibiyoyin taro da filayen wasa. A ranar 26 ga Janairu, gwamnati ta ƙaddamar da ƙarin matakan dakile barkewar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da faɗaɗa hutun bikin bazara.
An rufe jami'o'i da makarantu a duk faɗin ƙasar.
Manyan yankunan Hong Kong da Macau sun ɗauki matakai da yawa, musamman ma game da makarantu da jami'o'i.
An yi amfani da matakan da za a bi don yin aiki a nesa a yankuna da yawa a ƙasar.
An yi wa'azin da ya shafi tafiye-tafiye a Hubei da wajenta.
An sauya zirga-zirgar jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An sanya ido kan motsi na jama'a a birane da dama, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga wani nau'in ƙuntatawa na fita. Bayan barkewar cutar ta shiga matakin ta duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana " shigo da " cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar killace-kwana ta kwanaki 14 ga duk matafiya na duniya da suka isa birnin. A ranar 23 ga Maris, babban yankin China yana da shari'ar watsa labarai guda ɗaya a cikin kwanaki biyar, a wannan yanayin, ta hanyar matafiyi wanda ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ruwaito cewa an dakatar da yaduwar cututtukan watsa labarai na cikin gida kuma an sarrafa cutar a kasar Sin.
A wannan ranar, an rage takunkumin tafiye-tafiye a Hubei, sai dai a Wuhan, watanni biyu bayan an sanya dokar kulle. Ministan harkokin wajen kasar Sin ya sanar a ranar 26 ga Maris, 2020, cewa za a dakatar da shigar da mutane da takardar visa ko izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani game da lokacin da za a dakatar da wannan manufar ba.
Duk wanda yake so ya shiga kasar Sin zai buƙaci yin takardar izinin shiga a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu su sake budewa a ranar 30 ga watan Maris, ta ba da tanadi na karfafawa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki, ta fara da minti uku na shiru a duk fadin kasar, a ranar 4 ga Afrilu da karfe 10 na safe, daidai da bikin Qingming. Gwamnatin tsakiya, duk da haka, ta nemi iyalai su yi ta'aziyyarsu ta yanar gizo, suna kiyaye nesa da jiki don hana sabon barkewar COVID-19.
A ranar 20 ga Janairu, 2020, an tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu.
Hukumar kula da lafiyar kasar ta ruwaito wani gagarumin karuwa a cikin wadanda aka tabbatar da cutar a ranar 20 ga watan Fabrairu, wanda aka danganta shi ne da taron da aka yi a Daegu na wani sabon addini da ake kira Shincheonji Church of Jesus.
An yi zargin cewa masu bauta wa Shincheonji da suka ziyarci Daegu daga Wuhan ne suka haddasa barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin cocin 9,336, 1,261, ko kusan kashi 13 cikin ɗari, sun ba da rahoton samun alamun cutar. Koriya ta Kudu ta ba da sanarwar matakin faɗakarwa mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar, kuma a ranar 29 ga Fabrairu, adadin sun kai 3,150.
An sanya dukkan sansanonin sojin Koriya ta Kudu a cikin killace bayan an tabbatar da gwajin da ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jiragen sama kuma an canza su. Koriya ta Kudu ta gabatar da abin da aka ɗauka shine mafi girma da kuma mafi kyawun shirin duniya dangane da tantancewa ga cutar. Ƙasar ta kuma ware mutanen da suka kamu da cutar kuma ta gano da kuma killace duk wanda ya tuntube su.
Hanyoyin tantancewa sun haɗa da bayar da rahoton bayyanar cututtuka na mutum ga waɗanda suka dawo daga tafiye-tafiye na duniya ta hanyar aikace-aikacen hannu, gwajin kwayar ta drive-thru, tare da sakamakon da ke samuwa a rana mai zuwa, da kuma ƙara ƙarfin gwaji, wanda ya ba da damar gwada mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen sarrafa barkewar cutar, ko da yake bai sanya birane gaba ɗaya cikin killace ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon bisa zargin rashin kula da cutar ta gwamnati, ko kuma ƙara yawan amsarsa.
A ranar 23 ga Maris, an ruwaito cewa Koriya ta Kudu ta samu mafi karancin adadin mutane a cikin makonni hudu.
A ranar 29 ga Maris, an sanar da cewa daga 1 ga Afrilu, duk sababbin masu zuwa daga ƙasashen waje za su shiga killace na mako biyu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ruwaito cewa Koriya ta Kudu ta samu bukatar taimako wajen gwada cutar daga kasashe 121 daban-daban.
Iran ta tabbatar da farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu a wannan rana.
Matakan da gwamnatin ta sanar sun hada da sokewa na kide kide da sauran al'adu, wasanni, da kuma ayyukan addini a ranar Juma'a, rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 cewa ba shi da shirin yin kwarantina a yankunan da cutar ta shafa, kuma za a sanya mutane ne kawai a cikin kwarantina.
An sanar da tsare-tsaren rage tafiye-tafiye tsakanin biranen a watan Maris, ko da yake ana ci gaba da yin manyan zirga-zirga tsakanin biranen kafin Sabuwar Shekara ta Farisa.
Shaidu masu ibada a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin zargin rufewa da yaduwar cutar a Iran, fiye da kasashe goma sun biye da shari'o'in da suka shafi Iran a ranar 28 ga Fabrairu suna nuna cewa yaduwar cutar na iya zama mafi tsanani fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito zuwa wannan lokacin.
An rufe majalisar dokokin Iran, inda mambobi 23 daga cikin 290 suka tabbatar da cewa sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira da gaggawa ga hukumomin kurkuku na Iran da su saki 'yancin bil adama da ke fursuna saboda rashin amincewa da zaman lafiya, kuma su sake dukan fursunonin da suka cancanta.
Hukumar ta ce akwai babban haɗarin yaduwar cutar a cibiyoyin da aka rufe kamar cibiyoyin tsare, waɗanda kuma ke fama da rashin kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shi ne mafi yawan mutane tun lokacin da annobar ta fara a kasar.
Akalla 'yan siyasa 12 da suka yi aiki ko kuma sun yi ritaya da kuma jami'an gwamnati sun mutu sakamakon cutar har zuwa 17 ga Maris.
A ranar 23 ga watan Maris, Iran ta samu karin mutane 50 a kowace awa da kuma wani sabon mutuwa a kowane minti 10 sakamakon cutar korona.
Wani wakilin WHO ya ce, akwai yiwuwar samun karin mutane biyar a Iran fiye da yadda ake samun rahotanni.
An yi hasashen cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin tattalin arzikin kasar wajen magance cutar ta kwayar cutar.
Babban Kwamishinan 'Yancin Dan Adam ya nemi a sassauta takunkumin tattalin arziki ga al'umman da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar ta bazu zuwa Italiya a ranar 31 ga Janairu, lokacin da 'yan yawon bude ido biyu na kasar Sin suka tabbatar da cutar SARS-CoV-2 a Roma.
Yawan wadanda suka kamu da cutar ya karu sosai, wanda ya sa gwamnatin Italiya ta dakatar da dukkan jiragen sama zuwa da kuma daga kasar Sin kuma ta ayyana dokar ta baci.
An gano wani rukuni da ba shi da alaƙa da shari'o'in COVID-19 daga baya, farawa da shari'o'i 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar dokar doka don dakile barkewar cutar, gami da killace mutane sama da 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta barke, an hana mutane shiga da fita.
An riga an yanke shawarar dakatar da ayyukan aiki da wasanni a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta nemi a rufe dukan makarantu da jami'o'i a ƙasar lokacin da Italiya ta kai mutuwar 100.
Duk manyan abubuwan wasanni, gami da wasannin ƙwallon ƙafa na Serie A, dole ne a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk abubuwan wasanni gaba ɗaya na akalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya nemi rufe kusan dukkanin ayyukan kasuwanci, sai dai manyan kantuna da kantunan shan magani. A ranar 6 ga Maris, Kwalejin Italiyanci ta Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta wallafa shawarwari game da ɗabi'ar likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta wuce China a matsayin ƙasa da ta fi yawan mutuwar da ke tattare da cutar Coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 da ke tattare da annobar.
A ranar 22 ga Maris, an sanar da cewa Rasha ta tura jiragen saman soja tara da kayayyakin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da cewa akwai mutane 128,948 da suka kamu da cutar, 15,887 sun mutu kuma 21,815 sun warke a Italiya, yawancinsu a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da tsofaffin mutanen Italiya da rashin iya gwada duk wanda ya kamu da cutar a wannan lokacin na iya haifar da yawan mutuwar.
Amsar Burtaniya ga cutar ta fara fitowa a matsayin daya daga cikin mafi kyawun ƙasashe da aka shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin nisan jama'a ko matakan killace jama'a ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami zargi saboda rashin kulawa da kuma gagarumin amsa ga matsalolin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da wata sanarwa inda ya shawarci dakatar da duk ba dole ba tafiya da kuma zamantakewa lamba, yana ba da shawarar cewa mutane suyi aiki daga gida kamar yadda ya kamata kuma su guji wurare kamar sanduna, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa duk wuraren shakatawa kamar mashaya da dakunan karatu ya kamata a rufe su da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashi na ma'aikata har zuwa iyakar £ 2,500 a kowane wata don kauce wa rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da matakan nesa da zamantakewa, yana hana taron mutane fiye da biyu da kuma iyakance tafiya da ayyukan waje zuwa mafi ƙarancin da ake buƙata.
Ba kamar matakan da suka gabata ba, 'yan sanda sun ƙarfafa waɗannan ƙuntatawa ta hanyar ba da fines da kuma tarwatsa wuraren zama.
Yawancin kasuwancin da aka ba da umarni su rufe, sai dai ga kasuwancin da aka ɗauka "mafi mahimmanci", ciki har da manyan kantuna, kantuna, bankuna, shagunan kayan aiki, tashoshin gas da kuma dakunan aiki na mota.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da aka sani da cutar COVID-19 a jihar Washington ta Pacific a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An fara aiki da rundunar White House don yaki da cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta bayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumi ga shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka  babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka  ta sanar da cewa sun ci gaba da kera kayan gwajin kansu.
Duk da haka, Amurka ta yi jinkirin fara gwajin, wanda ya ɓoye ainihin yadda annobar ta yi a lokacin.
Ana yin gwaji da kayan gwaji marasa kyau da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewa da gwamnatin tarayya ga kayan gwaji na gwamnati (daga makarantu, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma takaddun shaida ga mutanen da za a gwada su har zuwa farkon Maris (an buƙaci neman likita a baya).
A ranar 27 ga Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwajin gwaji kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ruwaito cewa an yi gwajin da bai kai 14,000 ba.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da suke da alamun kuma suna da bukatar likita sun jira na sa'o'i ko kwanaki kafin a gwada su". Bayan an ruwaito mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da dokar ta baci, wani mataki da wasu jihohi suka bi ba da daɗewa ba.
Makarantun da ke yankin Seattle sun soke karatun a ranar 3 ga Maris, kuma a cikin rabi na biyu na Maris, makarantu a duk faɗin ƙasar suna rufewa. A ranar 6 ga Maris, 2020, an yi gargadin Amurka game da ƙididdigar tasirin sabon coronavirus a cikin ƙasar ta ƙungiyar masana cututtukan cututtuka daga Kwalejin Imperial na London.
A wannan rana, Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kuɗi don Shirya da Amsawa ga Coronavirus, wanda ya ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya a matsayin amsa ga barkewar cutar.
Ƙungiyoyin sun sa ma'aikata su yi tafiya ba tare da yin taro ba, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30, wanda ya fara aiki daga ranar 13 ga Maris.
A rana ta gaba, ya faɗaɗa takunkumin don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga Maris, ya bayyana dokar ta baci ta kasa, wanda ya sa kudade na tarayya suka kasance a shirye don magance matsalar.
Tun daga ranar 15 ga Maris, kamfanoni da yawa a fadin Amurka sun rufe ko rage lokutan aiki don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City tana da shari'o'in cutar Corona Virus 10,700, wanda ya fi yawan adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce, ana ganin cewa zaman nesa yana aiki, tun da aka rage yawan adadin mutane daga kwana biyu zuwa kwana hudu.
A ranar 28 ga Maris, an tabbatar da shari'o'i 32,308 a New York City, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton ƙarin kamuwa da cutar Corona fiye da kowace ƙasa a duniya, gami da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da shari'o'i 400,335 a Amurka, kuma mutane 12,841 sun mutu.
Rahotanni sun nuna cewa a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita ka'idodin nisantar zamantakewa har zuwa ranar 30 ga Afrilu.
A wannan rana, jirgin ruwa mai suna USNS Comfort, wato, asibiti mai ɗauke da gado dubu, ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 sakamakon cutar Corona a cikin sa'o'i 24.
A jihar New York, adadin mutane sun wuce 100,000 a ranar 3 ga Afrilu. An soki Fadar White House saboda ta raina barazanar da kuma sarrafa aika saƙonni ta hanyar umarci jami'an lafiya da masana kimiyya su daidaita wallafe-wallafen da sanarwa game da cutar a ofishin Mataimakin Shugaban Amurka Mike Pence.
An yi ta ta nuna goyon baya ga tsarin Trump na gudanar da rikicin a duk faɗin jam'iyyun.
Wasu jami'an Amurka da masu sharhi sun soki amincewar Amurka da shigo da kayayyakin da suka dace daga kasar Sin, ciki har da kayayyakin kiwon lafiya.
An yi amfani da nazarin tsarin tafiye-tafiye na iska don tsarawa da kuma hango ko hasashen yadda yaɗuwar yaɗuwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 na International Air Transport Association, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan fasinjoji da suka tashi daga Wuhan.
Dubai, Sydney da Melbourne sun kuma kasance sanannun wurare ga mutanen da suka tashi daga Wuhan.
An ruwaito cewa Bali ta kasance mafi ƙarancin iyawa a cikin shahararrun wurare 20 na shirye-shirye, yayin da aka ce birane a Ostiraliya sun fi iyawa. Ostiraliya ta ba da izinin shirin gaggawa na New Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ta bayyana cewa akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, an bayyana gaggawa na lafiyar dan Adam a Ostiraliya.
Saboda ingantaccen killacewar jigilar jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya janye 'yan ƙasarsu da jami'an diflomasiyya daga yankin, da farko ta hanyar jiragen haya na ƙasar asali, tare da sakin hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus da Thailand suna cikin waɗanda suka fara shirin janye 'yan ƙasarsu.
Pakistan ta ce ba za ta cire 'yan kasar da suka fito daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta janye 'yan Brazil 34 ko kuma 'yan uwa da suka fi su hudu' yan Poland, da na kasar Sin da na Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka a Poland, inda jirgin ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
'Yan kasar Brazil da suka tafi Wuhan sun kasance a cikin killace a wani sansanin soja kusa da Brasilia.
A wannan rana, an kwashe 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin biyu da gwamnatin Amurka ta haya) daga Wuhan kuma an tura su zuwa Tushen Sojan Sama na Trenton don a yi musu killace na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojojin Kanada na Trenton.
Hukumomin Ostiraliya sun kai 'yan kasar 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin cibiyar killace su, inda suka zauna har tsawon kwanaki 14.
Jirgin da ke janye 'yan ƙasar New Zealand ya sauka a Auckland a ranar 5 ga Fabrairu; fasinjojinsa (gami da wasu daga Australia da Pacific) an killace su a wani sansanin jiragen ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta janye Amurkawa daga jirgin ruwa na Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama da ke dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess, ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara janye 'yan kasar daga Iran. A ranar 14 ga Maris, wani jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta haya ya koma da 'yan kasar Afirka ta Kudu 112.
An yi bincike na likita kafin a kai jirgin, kuma an bar 'yan Afirka ta Kudu hudu da suka nuna alamun cutar coronavirus a baya don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka samu gwajin da bai dace ba ne aka mayar da su.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji waɗanda, a matsayin matakin rigakafi, suka kasance a cikin kallo da keɓewa na kwanaki 14 a Resort The Ranch.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki a wani ɓangare saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako ga wadanda cutar ta shafa a kasar Sin, tare da wata kungiya a yankin Greater Chicago da aka ce ta samu nasarar aika da masks N95 dubu 50 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da dala miliyan 100 ga WHO don tallafawa bincike kan alluran rigakafi da kuma kokarin magance su tare da kare "mutanen da ke cikin hatsari a Afirka da Kudancin Asiya".
Kamfanin Interaksyon ya ruwaito cewa gwamnatin kasar Sin ta ba da masks 200,000 ga Philippines a ranar 6 ga Fabrairu bayan da Sanata Richard Gordon ya tura masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan ɗaya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da fiye da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da bayar da kyautar safofin hannu na likita miliyan 18 ga China, Jamus ta ba da kayayyakin likita da yawa, gami da tufafi masu kariya 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a cikin taimakon kuɗi ga ƙasashen da cutar ta shafa. Bayan shari'o'in a China sun daidaita, ƙasar ta ci gaba da aika taimako ga ƙasashe da yawa da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kuma kwararrun masana don taimakawa Italiya wajen gudanar da barkewar cutar Coronavirus.
Jack Ma ya tura kayan gwaji miliyan 1.1 da masks miliyan 6 da kuma tufafi 60,000 zuwa Addis Ababa a Habasha don turawa ta Tarayyar Afirka.
Daga baya, ya tura kayan gwaji 5,000, da masks 100,000 da kuma masu iska 5 zuwa Panama.
Ma kuma ya ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks da kuma gwajin gwaji da aka yi a kasar Sin.
Alal misali, Spain ta tattara kayan gwajin Coronavirus 58,000 da kasar Sin ta yi da ƙimar daidaito na kashi 30 cikin ɗari, yayin da Netherlands ta dawo da masks na fuska 600,000 da suka lalace.
Belgium ta tattara masks 100,000 da ba za a iya amfani da su ba, wanda ake zargin daga kasar Sin ne amma a gaskiya daga Colombia ne.
A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafawa kasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da hukumomin kasar Sin ke yi na sarrafa cutar da kuma hana ta.
Hukumar ta lura da bambanci tsakanin barkewar cutar SARS ta 2002 zuwa 2004, inda aka zargi hukumomin kasar Sin da yin watsi da bayanai da suka sa hana rigakafi da kokarin dakile ta zama da wuya, da kuma rikicin da ke faruwa a yanzu, inda gwamnatin tsakiya ta "bayar da sabuntawa na yau da kullum don kauce wa firgita da ke tafe na bukukuwan sabuwar shekara ta wata".
A ranar 23 ga Janairu, a cikin martani ga shawarar manyan hukumomi na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya lura cewa "wannan ba shakka ba shawarar WHO ba ce" kuma kuma "yana da matukar mahimmin alamar ƙaddamar da cutar a yankin da ta fi mayar da hankali". A ranar 30 ga Janairu, bayan an tabbatar da watsawa tsakanin mutane daga wajen China da kuma karuwar adadin shari'o'i a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin Bala'in Kiwon Lafiya na Duniya (PHEIC), na shida na PHEIC tun lokacin da aka fara kiran matakin a lokacin annobar cutar sankarar 2009 ta naman alade.
Daraktan WHO, Tedros Adhanom, ya ce an yi kira ga PHEIC saboda "hadarin yaduwar duniya, musamman a ƙasashen da ke da ƙananan da matsakaitan albashi ba tare da tsarin kiwon lafiya mai ƙarfi ba.
A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu dalilin da zai sa a dauki matakan da ba su da mahimmanci a cikin tafiye-tafiye na duniya da kasuwanci" kuma cewa "WHO ba ta ba da shawarar rage cinikayya da tafiye-tafiye".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun a ƙasashen da ke da ƙananan da matsakaitan kuɗi, ta ambata gaggawa a taimaka wa waɗannan ƙasashen da "ba su da tsarin da ke aiki don gano mutanen da suka kamu da cutar, ko da ta taso".
Tedros ya yi wasu maganganu na baya yana nuna cewa "mu masu karfi ne kamar yadda mu masu rauni ne" kuma ya nemi al'ummar duniya "su zuba jari yanzu ko kuma su biya daga baya". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ya kafa COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince ya ba da "ikon dukan tsarin Majalisar Dinkin Duniya a matsayin amsa".
A sakamakon haka, an kunna tawagar gudanar da rikicin Majalisar Dinkin Duniya, ta ba da damar daidaita duk abin da Majalisar Dinkin Duniya ta amsa, wanda WHO ta ce zai ba su damar "daidaita kansu ga amsawar kiwon lafiya yayin da sauran hukumomi za su iya shiga cikin kwarewarsu a fannin zamantakewa, tattalin arziki da kuma ci gaban da ke tattare da barkewar cutar".
A ranar 14 ga Fabrairu, an baiwa WHO ta Joint Mission Team tare da China izinin samar da taimakon masana na duniya da na WHO a ƙasar Sin don gudanar da gida da kuma tantance "zafin cutar da kuma iyawar kamuwa da ita" ta hanyar bitar bita da tarurruka tare da manyan cibiyoyin matakin ƙasa da kuma yin ziyara ta filin don tantance " tasirin ayyukan amsawa a lardin da matakan birni, gami da birane da yankunan karkara". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya ya kamata ta yi ƙari don shirya don yiwuwar annobar Coronavirus", ta bayyana cewa duk da yake yana da wuri sosai don bayyana annobar, ƙasashe ya kamata su kafa "matakin shiri".
A cikin martani ga barkewar cutar a Iran, WHO ta aika da Ƙungiyar Gudanar da Ayyukan Hadin gwiwa don kimanta halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce kimantawar barazanar Coronavirus a duniya za ta tashi daga "babba" zuwa "mai girma", wanda shine mafi girman matakin gargadi da kimanta haɗari.
Mike Ryan, darektan shirin gaggawa na kiwon lafiya, ya yi kashedi a wata sanarwa cewa "Wannan sanarwa ce ta gaskiya ga kowace gwamnati a duniya: Ku tashi.
Wannan kwayar cutar na iya zuwa, kuma dole ne ku kasance a shirye", yana mai cewa matakan da suka dace na iya taimaka wa duniya ta kauce wa "mafi muni".
Ryan ya kuma ce bayanan da ake samu a yanzu ba su ba da izinin jami'an kiwon lafiya su bayyana cewa annobar ta duniya ce ba, yana mai cewa irin wannan sanarwa zai nuna cewa "mu a zahiri muna amincewa da cewa kowane ɗan adam a duniya zai kasance a cikin wannan cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta bayyana barkewar cutar Coronavirus a matsayin annoba.
Darakta Janar ya ce WHO tana "da matukar damuwa da matakan da ke damun yaduwar da kuma tsanani, da kuma matakan da ke damun rashin aiki". WHO ta fuskanci sukar da yawa saboda abin da aka gani a matsayin rashin dacewar gudanar da cutar, ciki har da jinkirin bayyana gaggawa na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annobar.
Wannan martani ya hada da wata takarda ga Darakta Janar na WHO, Tedros Adhanom, da ya yi murabus, wanda mutane 733,000 suka rattaba hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada girmama hakkin kowane mutum yayin annobar COVID-19.
Ƙungiyar ta ce kowa yana da hakkin ya yi amfani da shi don ya ceci rayuka kuma gwamnati ce ke da alhakin hakan.
Ƙungiyar ta nanata cewa rashin albarkatu ko shirin kiwon lafiya bai kamata ya zama hujja ga nuna bambanci ga wani rukuni ba.
Masana sun nuna cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, 'yan ƙasa, tsofaffi, marasa lafiya, marasa gida, waɗanda ke rayuwa cikin matsanancin talauci, waɗanda aka tsare, da 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba da suke bukatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Hukumar Tattalin Arziki da Ci gaban Tattalin Arziki ta kaddamar da dandamali don samar da cikakken bayani game da amsoshin siyasa a ƙasashe a duniya, da ra'ayoyi da shawarwari a kan lokaci.
Daga cikin manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin ƙuntatawa da ƙuntatawa kan tafiya, cibiyar dijital ta haɗa da Mai Sawun Manufofin Kasar, wanda ke taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen amsawa ta duniya ga ƙalubalen Coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, Ministan ofishin Burtaniya Michael Gove, da kuma dan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro saboda gudanar da annobar, wadda ta fara a lardin Hubei na kasar Sin.
An kori jami'an jam'iyyar kwaminis ta kasar Sin a matakin lardin kasar Sin saboda yadda suka bi da kokarin da ake yi na yin rigakafi a kasar Sin ta tsakiya, a wani hali na rashin jin dadin yadda jami'an siyasa suka amsa barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian sun yi watsi da ganewar cutar Coronavirus da ta fara a Wuhan, suna goyon bayan ka'idodin makirci game da COVID-19 da suka fito daga Amurka ko Italiya.
Gwamnatin Amurka ta Donald Trump ta kira Coronavirus "Cinese Virus" ko "Wuhan Virus" ta ce ƙuntatawa na China "ya wuce gona da iri ga wani cutar da ta zama annobar duniya", wanda wasu masu sukar suka yi la'akari da shi a matsayin wariyar launin fata da kuma "hanyar kawar da gazawar gwamnati don hana cutar".
Jaridar Daily Beast ta samu daga wata hanyar sadarwa ta gwamnatin Amurka da ke da tushe a Majalisar Tsaro ta Kasa, da kuma wata dabara da aka ambata kamar "Dukkanin wannan yana da alaƙa da China.
An shawarce mu da mu yi kokarin samun wadannan sakonni ta kowane hali, ciki har da taron manema labarai da kuma bayyanawa a talabijin. "Tashoshi kamar Politico, Foreign Policy da Bloomberg sun nuna cewa kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa wani bangare ne na tallata tasiri a duniya.
Shugaban harkokin wajen Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani ɓangaren siyasa na ƙasa wanda ya haɗa da gwagwarmayar tasiri ta hanyar ra'ayi mai nuna bambanci da 'yancin kai' siyasa.
Borrell ya kuma ce "Sin tana ba da sako ne da ƙarfi cewa ba kamar Amurka ba, ita ce abokiyar da za a iya dogara da ita".
China ta kuma nemi Amurka ta dakatar da takunkumin da ta dauka kan Syria da Venezuela da Iran, yayin da ake zargin ta tura tallafi ga kasashen nan.
Jack Ma ya ba da kyautar masks 100,000 ga Cuba a ranar 3 ga Afrilu, Amurka ta hana shi yin hakan.
An kuma zargi hukumomin Amirka da tura taimakon da aka ba wasu al'ummai zuwa ƙasarsu.
Kuma ka ji jayayya game da abin rufe fuska da aka ruwaito tsakanin wasu ƙasashe kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kama ɗaruruwan masu sanyaya iska da aka yi niyya don Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kai na Tarayyar Turai da waɗanda cutar ta shafa a Italiya.
Saƙon Italiya a Tarayyar Turai, Maurizio Massari, ya ce: "Kasin kasar Sin ce kawai ta amsa a bangare biyu.
Hakika, wannan ba kyakkyawan alamar haɗin kai na Turai ba ne".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Minista Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da likitocin soja, motocin kashe cututtuka na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a san shi ba cewa kashi 80 cikin 100 na kayayyakin da Rasha ta kawo "ba su da amfani ko kuma ba su da amfani ga Italiya".
Majiyar ta zargi Rasha da kai hari "na siyasa da diplomasiyya".
Shugaban yankin Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin saman sufuri da ke dauke da kayayyakin kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce, "ta wajen ba da taimako ga 'yan'uwansa na Amirka, [Putin] ya ɗauka cewa idan masana'antun Amurka na kayan aikin likita da kayan aikin likita suna cikin yanayi mai kyau, za su yi aiki da juna idan ya cancanta".
Aikin soja na NATO da aka shirya "Defender 2020" a Jamus, Poland da Baltic States, shi ne mafi girma a NATO soja motsa jiki tun karshen Cold War, za a ci gaba da a rage.
Sakatare Janar don Kamfen ɗin Rushewar Nukiliya Kate Hudson ta soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, wannan yana sanya rayuwar ba kawai sojojin Amurka da ƙasashen Turai da dama da ke shiga cikin haɗari ba, har ma da mazaunan ƙasashen da suke aiki". Gwamnatin Iran ta yi fama da cutar, tare da kusan 'yan majalisa goma sha biyu da aka kamu da ita, da kuma manyan siyasa goma sha biyar da ke aiki ko tsoffin' yan siyasa.
Shugaban Iran Hassan Rouhani ya rubuta wasikar jama'a ga shugabannin duniya, yana neman taimako a ranar 14 ga Maris, 2020, yana cewa kasarsa tana fama da fama da cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka akan Iran.
Masu nazarin siyasa sun yi hasashen cewa hakan zai iya shafar yiwuwar sake zaben Donald Trump a matsayin shugaban kasa a zaben 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
Koriya ta Kudu ta soki kokarin da kasar Japan ta yi na yin kwarantina, bayan da kasar Japan ta sanar da cewa za a sanya kowa da kowa daga Koriya ta Kudu a cikin killace na mako biyu a wuraren da gwamnati ta tsara.
An fara nuna rashin jituwa a al'ummar Koriya ta Kudu game da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan bukukuwa suna neman tsige Moon a kan abin da suka kira rashin kula da annobar, ko kuma suna yaba da martani.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisa ta amince da cewa Firayim Minista Viktor Orbán zai iya mulki ta hanyar doka har abada, dakatar da majalisa da kuma zaben, da kuma hukunta waɗanda ake ganin sun yada labaran karya game da cutar da kuma gwamnatin ta kula da rikicin.
An yi zargin cewa cutar ta Coronavirus ta jawo karancin kayayyaki da yawa, sakamakon karuwar amfani da kayan aiki a duniya don yaki da barkewar cutar, cin kasuwa da tsoro, da kuma katsewa a masana'antu da ayyukan kaya.
Hukumar Abinci da Kula da Abinci ta Amirka ta yi gargadi game da rashin magani da kuma kayan aikin likita saboda yawan amfani da shi da kuma katsewar mai ba da kayayyaki.
Wasu 'yan gida ma sun yi ta cin kasuwa domin tsoro, wanda ya sa kayayyakin da ake bukata kamar abinci, takardar wanka, ruwa mai kwalban, da kuma karancin kayayyaki suka kasance a kan ɗakunan ajiya.
Masana'antun fasaha sun yi gargadi game da jinkirin aikawa da kayayyakin lantarki.
A cewar Daraktan Dinkin Duniya Tedros Adhanom, bukatar kayan kariya ta mutum ta ƙaru sau 100.
Wannan bukatar ta kai ga karin farashin har sau ashirin na farashin al'ada kuma ta haifar da jinkirin samar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Hakan ya kuma jawo karancin kayan aikin kare kai a duniya, kuma WHO ta yi gargadin cewa hakan zai sa lafiyar ma'aikata cikin haɗari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen Sin, daigou, su sayar da kayayyakin Ostiraliya a kasar Sin.
Aikin ya haifar da karancin kayan abinci ga jarirai a wasu manyan kantuna kuma daga baya gwamnatin Ostiraliya ta dakatar da shi. Duk da yawan cututtukan COVID-19 a arewacin Italiya da yankin Wuhan, da kuma sakamakon babban buƙatar abinci, an ceci yankunan biyu daga karancin abinci.
Matakan da kasar Sin da Italiya suka dauka kan ajiya da kuma cinikin kayayyakin da ba a yarda da su ba sun yi nasara wajen kawar da matsalar rashin abinci mai tsanani da aka yi hasashen za ta auku a Turai da kuma Arewacin Amirka.
Arewacin Italiya da yawan aikin gona da ta yi ba ta samu raguwa mai yawa ba, amma farashin zai iya tashi bisa ga masana'antun masana'antu.
An gano shelves na abinci a kan wani lokaci, har ma a birnin Wuhan, kuma jami'an gwamnatin kasar Sin sun saki naman alade don tabbatar da isasshen abinci ga jama'a.
Akwai irin wannan dokar a Italiya, wadda ta bukaci masu samar da abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a kasar Sin: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma tallace-tallace a kantin sayar da kayayyaki sun ragu da kashi 20.5%.
Tun da kasar Sin tana da babbar tattalin arziki da cibiyar masana'antu, an ga barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demarais daga sashen leken asiri na The Economist ta yi hasashen cewa kasuwanni za su kasance masu karaya har sai an samu cikakken bayani game da sakamakon da za su samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar a kan ci gaban duniya zai iya wuce barkewar cutar SARS ta 2002-2004.
Wani masanin jami'ar Washington a St. Louis ya ce zai iya kaiwa dala biliyan 300 ga tasirin kayayyakin duniya har tsawon shekaru biyu.
An ce kungiyar kasashen da ke fitar da man fetur ta OPEC ta yi 'ruɗu' bayan da farashin man fetur ya ragu sosai saboda rashin bukatar kasar Sin.
Kasuwancin jari na duniya sun fadi a ranar 24 ga Fabrairu saboda ƙaruwa mai mahimmanci a cikin adadin shari'o'in COVID-19 a wajen Kudancin China.
A ranar 27 ga watan Fabrairu, saboda damuwa game da barkewar cutar Coronavirus, wasu alamun jari na Amurka ciki har da NASDAQ-100, S&P 500, da kuma Dow Jones masana'antu sun nuna mafi yawan raguwa tun daga 2008, tare da Dow ya fadi da maki 1,191, mafi girma a cikin rana daya tun lokacin rikicin kudi na 2007-08.
Duk sauran alamomi uku sun ƙare da mako tare da ƙasa da kashi 10.
A ranar 28 ga Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da matsayin mallakar mallaka na kasar Sin, amma ya ci gaba da yin mummunan ra'ayi.
Kasuwancin ya sake faɗuwa bisa ga damuwar cutar coronavirus, mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin tattalin arziki zai yi ta raguwa.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa da jihohi da kuma manyan bankuna suka dauka a kan lokaci.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin da aka yi ta rushewar kudi a 2008.
Yawon shakatawa na ɗaya daga cikin sassan da aka fi shafa saboda ƙuntatawa na tafiya, rufe wuraren jama'a ciki har da wuraren yawon buɗe ido, da kuma shawarar gwamnatoci game da duk wani tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen su saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin saman yankin na Burtaniya Flybe ya rushe.
Wannan tasiri a kan jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta yi daidai da Chunyun, babban tashar tafiya da ke hade da hutun Sabuwar Shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke taron da yawa da suka shafi manyan taron jama'a, gami da bukukuwa na Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da ke rufe shagunan su da wuraren yawon buɗe ido kamar Disneyland a Hong Kong da Shanghai.
An rufe abubuwan da suka faru na Sabuwar Shekara ta Watanni da wuraren yawon bude ido don kauce wa taro, ciki har da Taron Hauka a Beijing da kuma taron haikalin gargajiya.
A larduna 24 daga cikin 31 da ke kasar Sin, da kananan hukumomi da yankuna, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna umurtar yawancin wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin 100 na GDP na ƙasar kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta kara yawan yadda take magance cutar ta kamuwa da cuta zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin Sabuwar Shekara.
Ziyarar masu sayar da kayayyaki a Turai da Latin Amirka ta ragu da kashi 40%.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun yi kashi 50 zuwa 60 cikin ɗari.
Wannan kuma ya haifar da raguwar 33-43% a cikin zirga-zirgar ƙafa zuwa cibiyoyin kasuwanci a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cinikayya a duniya sun sanya ƙarin matakai kamar tsaftacewa, shigar da na'urorin bincike na zafi don bincika zafin jiki na masu siye, da soke taron. A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, an kiyasta cewa koma bayan tattalin arziki da annobar ta haifar zai iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda zai faru a cikin yanayi ba tare da annobar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi fice a birnin Wuhan, mutane miliyan biyar a kasar Sin sun rasa ayyukansu.
Yawancin 'yan gudun hijira miliyan 300 da ke kasar Sin sun bar gidajensu a lardunan cikin gida ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, fiye da Amirkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Fitowar Coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma ƙimar rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Federal Reserve Bank of St. Louis. Ragewa a Indiya ya bar dubban miliyoyin ma'aikatan Indiya masu ƙaura (wanda ake biya ta hanyar biyan kuɗi na yau da kullun) marasa aiki. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun sha wani nau'in rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da ƙasar ta ɗauki ragowa a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi taimakon rashin aikin yi, kuma ma'aikata miliyan 1 a Birtaniya sun nemi shirin ba da bashi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun sanya ma'aikatansu a cikin shirye-shiryen rage yawan aiki da gwamnati ke tallafawa da ake kira Kurzabeit.
Faransa da Birtaniya sun amince da tsarin biyan kuɗin da ake biyan ma'aikata a Jamus.
Masana'antun fasaha da al'adun gargajiya sun yi matukar tasiri ta hanyar annobar, ta shafi ayyukan ƙungiyoyi, da kuma mutane - duka masu aiki da masu zaman kansu - a duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (sau da yawa ana tallafa musu ta hanyar gwamnati) don samar da damar samun al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatan su da jama'a, da kuma taimaka wa masu fasaha a duk lokacin da zai yiwu.
A watan Maris na shekarar 2020, a duniya da kuma a matakai daban-daban, gidajen tarihi, kantunan littattafai, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu sun rufe har abada tare da baje kolin su, abubuwan da suka faru da wasan kwaikwayon da aka soke ko kuma aka jinkirta.
A sakamakon haka, an yi ƙoƙari sosai don samar da ayyuka na madadin ta hanyar dandamali na dijital. Wani sabon abu kuma da ke saurin saurin cutar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa kamar bukukuwa na kiɗa da kide kide, tarurruka na fasaha da abubuwan da ke faruwa.
A lokacin da aka yi bikin, an yi watsi da ayyukan da ake yi a lokacin da ake yin Idin Ƙetarewa a Roma.
Yawancin majami'u sun ba da shawarar dattawa su zauna a gida maimakon halartar misa a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta rediyo, streaming live online ko talabijin yayin da wasu ke ba da sabis na drive-in.
Da yake Roman Katolika ta rufe majami'u da kuma cocinta, kuma filin St. Peter ya zama babu Kiristoci masu bautar gumaka, wasu hukumomin addini sun soke ayyukan kuma sun ƙuntata taron jama'a a majami'u, masallatai, majami'u, haikali, da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma an rufe wuraren ibada daga baya, yayin da Saudiyya ta haramta shigar da baƙi baƙi da mazaunanta zuwa wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar katsewa a cikin kalandar wasanni na duniya tun lokacin yakin duniya na biyu.
Yawancin manyan abubuwan da suka faru an soke ko kuma an jinkirta su, ciki har da gasar zakarun Turai ta 2019-2020, Premier League ta 2019-2020, NBA ta 2019-2020, da kuma NHL ta 2019-2020.
Futar ta tsoma baki a cikin shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka tsara don farawa a ƙarshen Yuli; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a "sake shirya taron zuwa kwanan wata bayan 2020, amma ba bayan lokacin bazara na 2021 ba".
Wannan ya sa 'yan wasa da yawa su yi wasa ta yanar gizo, tare da shafukan yanar gizo da yawa na yanar gizo suna ba da rahoton ƙaruwar ƙimar sabon biyan kuɗi.
Gidajen wasan kwaikwayo masu yawa kamar na Broadway sun soke dukan wasan kwaikwayon.
Wasu masu fasaha sun binciko hanyoyin ci gaba da samarwa da raba ayyukansu ta yanar gizo a matsayin madadin ga gabatarwa ta rayuwa ta gargajiya, kamar yin wasan kwaikwayo tare da watsa shirye-shiryen kai tsaye ko ƙirƙirar "ƙungiyoyi" na kan layi don masu fasaha su gabatar da kansu, raba da kuma tallata ayyukansu.
A kan layi, ana yada wasu labarai game da cutar coronavirus a Intanet, yayin da mutane da yawa ke neman jin daɗi da nishaɗi a cikin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an lura da karuwar nuna wariya, ƙiyayya da wariyar launin fata ga mutanen da ke da asalin kasar Sin ko gabashin Asiya, da kuma mutanen da ke yankunan da ake magana a kai a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, rashin amincewa, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya Pacific.
Sakamakon watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke cikin China) ya nuna rashin jin daɗin wariyar launin fata da aka nuna a cikin kungiyoyi da yawa a duniya game da mutanen China sun cancanci cutar ko kuma suna karɓar hukunci mai kyau don abin da suka yi.
Wasu ƙasashen Afirka sun kuma lura da karuwar rashin amincewa da kasar Sin.
Mutane da yawa da ke birnin Wuhan da kuma Hubei sun ruwaito cewa an nuna musu wariya saboda asalin yankin da suka fito.
Wannan ya samu goyon baya daga kasar Sin, a kan layi da kuma wajen layi, kuma ana nufin wadanda ke yankunan da cutar ta shafa.
Bayan barkewar cutar a cikin sabbin kasashe masu fama da cutar, 'yan kasar Italiya, kasar farko a Turai da ta fara fuskantar mummunan barkewar cutar COVID-19, na iya kasancewa cikin rashin amincewa da kuma rashin jin daɗin al'umma. 'Yan ƙasa daga kasashe da suka hada da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun neman hana Sinawa shiga ƙasashensu, a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya shiga cikin Shafin Twitter na Trending Topics.
Mutanen China, da kuma wasu 'yan Asiya a Birtaniya da Amirka, sun ruwaito ƙaruwar ƙalubalen wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci zargi saboda ya kira coronavirus "Cinese virus", kalmar da masu sukar suka dauka ta kasance mai nuna wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zangar a Ukraine sun kai hari kan motocin da ke dauke da 'yan Ukraine da kuma 'yan kasashen waje da suka bar birnin Wuhan zuwa birnin Novi Sanzhary.
An ce an tsananta wa daliban da ke arewa maso gabashin Indiya da ke kan iyakar kasar Sin da kuma daliban da ke manyan biranen Indiya saboda barkewar cutar korona.
Shugaban jam'iyyar Bharatiya Janata Party a jihar West Bengal, Dilip Ghosh, ya ce, 'Sin sun lalata yanayi kuma wannan shi ne dalilin da ya sa Allah ya juya musu baya.'
Bayan haka, ofishin jakadancin kasar Sin a Kolkata ya yi tir da wannan furucin, inda suka ce "ba daidai ba ne". A kasar Sin, cutar ta yi sanadin nuna bambanci da wariyar launin fata ga mutanen da ba 'yan kasar Sin ba, inda aka kira 'yan kasashen waje "ƙazamar waje" da kuma "ƙazamarwa".
Yawancin jaridu masu biyan kuɗi sun cire su daga wasu ko duk labaran da suka shafi coronavirus.
Wasu jaridu sun wallafa labarai game da cutar a cikin littattafan da aka buɗe.
Wasu masana kimiyya sun zaɓi su raba binciken su a kan sabobin preprint kamar bioRxiv.
cututtukan cututtuka masu tasowa  cututtukan cututtuka masu tasowa, sau da yawa ba a taɓa gani ba game da yadda cutar ta yadu ko kuma yadda za a watsa ta
Duniya Duniya da cuta  Bayani na duniya da kuma yaduwar cutar
Jerin annoba da annoba  Jerin yawan mutuwar da ake samu daga kamuwa da cuta
Cinikin dabbobi masu daji da kuma cutar dabbobi  Hadarin kiwon lafiya da ke tattare da cinikin dabbobi masu daji
Nazarin dakin gwaje-gwaje na cutar coronavirus ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ta danganta da ita ya haɗa da hanyoyin gano kasancewar cutar da waɗanda ke gano rigakafin da aka samar don amsawa ga kamuwa da cuta.
Ana tabbatar da kasancewar cutar a cikin samfurori ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko na yanzu.
Ana iya amfani da gano rigakafi (sorology) don ganewar asali da kuma lura da al'umma.
Ana gwada mutane da yawa da suka kamu da cutar, har da waɗanda ba su da alamun bayyanar cututtuka sosai don a ba su rahoto ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin yawan mutuwar cutar da kuma matakin rigakafin garken a cikin jama'a daga sakamakon wannan gwajin.
Saboda ƙarancin gwaji, a watan Maris na shekarar 2020 babu wata ƙasa da ke da tabbacin bayanan cutar a cikin al'ummarta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambancin gaske a yawan gwaje-gwajen da aka yi a ƙasashe.
Wannan bambancin zai iya shafar yawan mutuwar da aka samu a wasu ƙasashe, wanda za a iya ƙididdigewa sosai.
Ta amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR), ana iya yin gwajin a kan samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharyngeal rubbing ko saliva samfur.
A yawancin lokaci, sakamakon zai kasance cikin sa'o'i ko kwanaki biyu.
Gwajin RT-PCR da aka yi da farjin farjin yana da tabbaci a mako na farko na rashin lafiya.
Daga baya, cutar za ta iya ɓacewa a cikin garkuwar yayin da take ci gaba da ƙaruwa a cikin huhu.
A matsayin madadin, ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, za a iya cire kayan samfurin daga cikin hanyar numfashi ta hanyar catheter mai tsotsewa ko kuma a yi amfani da kayan fitarwa ta hanyar fitarwa (sakewa).
An yi wani gwajin PCR na farko a Charité, Berlin, a watan Janairun 2020 ta amfani da polymerase chain reaction tare da ainihin lokacin rikodin rikodin (rRT-PCR), kuma yana zama tushen kayan aikin 250,000 don rarraba ta WHO.
Kasar Burtaniya ta kuma ci gaba da gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya ci gaba da wani nau'i na asibiti, kayan aikin gano SARS-CoV-2 dangane da PCR (PowerCheck Coronavirus) a ranar 28 ga Janairu, 2020.
Yana neman kwayar halitta "E" da dukkan beta coronavirus ke rabawa, da kuma kwayar halitta RdRp, ta SARS-CoV-2 ta musamman. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami amincewa don amfani da gaggawa daga Hukumar Kula da Kayan Aikin Kayan Aiki ta China don kit ɗin gano SARS-CoV-2 na PCR. A Amurka, Cibiyar Kula da Cututtuka da Rigakafi (CDC) tana rarraba sabon kwamiti na ganewar asali na RT-PCR na Coronavirus (2019-nCoV) a cikin ainihin lokacin ga dakunan gwaje-gwaje na lafiyar jama'a ta hanyar Reagent Resource ta Duniya.
Ɗaya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin sigar kayan gwajin ya haifar da gwaji mara kyau na masu aiki da ƙarancin ƙarfi, da kuma hana gwaji a CDC a Atlanta; wannan ya haifar da matsakaici na samfurori kasa da 100 a kowace rana da aka aiwatar da su cikin nasara a cikin watan Fabrairu na 2020.
Ba a amince da gwaje-gwajen da ke amfani da abubuwa biyu ba har zuwa 28 ga Fabrairu, 2020, kuma daga nan ne aka ba da izinin fara gwajin ga gida da kuma dakunan gwaje-gwaje na jihar.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin gaggawa.
Daga ranar 5 ga Maris, 2020, LabCorp ta sanar da kasancewar gwajin COVID-19 na ƙasa don RT-PCR.
Quest Diagnostics ta kuma sanya gwajin COVID-19 a cikin ƙasa daga 9 ga Maris, 2020.
Babu wani ƙuntatawa a kan adadi da aka sanar; ana buƙatar tattara da sarrafa samfurori bisa ga bukatun CDC.
A Rasha, cibiyar bincike ta jihar kan cututtukan cututtuka da fasahar halittu, VECTOR ce ta haɓaka da samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ce ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya gudanarwa a cikin awanni 3.5 a cikin sikelin, don haka ba da damar inji ɗaya don aiwatar da kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin Amfani da Gaggawa (USA) ga Labs Abbott don gwaji a cikin tsarin m2000 na Abbott; FDA ta ba da izini a baya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma samu takardar shaidar Amurka daga FDA don gwajin da zai ɗauki kimanin minti 45.
Hukumar ta amince da gwajin da ke amfani da fasahar isothermic nucleic acid amplification maimakon PCR.
Tun da yake ba ya bukatar a yi sau da yawa a kan yanayin zafi, wannan hanyar tana iya kawo sakamako mai kyau a cikin minti biyar kawai kuma sakamako mara kyau a cikin minti 13.
Akwai kimanin 18,000 na waɗannan injunan a halin yanzu a Amurka kuma Abbott na fatan haɓaka samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Gwaje-gwaje wanda ke amfani da antibody na monoclonal kuma yana ɗaure shi musamman zuwa furotin nucleocapsid (protein N) na sabon coronavirus ana haɓaka a Taiwan, tare da tsammanin samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin sauri na mura.
Wani bita na wallafe-wallafen a watan Maris na 2020 ya kammala cewa "rawanin X-ray na ƙirjin suna da ƙarancin ƙimar ganewar asali a farkon matakan, yayin da binciken CT, CT, na iya kasancewa a gaban bayyanar cututtuka".
Abubuwan da ke cikin TC sun haɗa da opacity na biyu-matsakaici a cikin gilashin duhu tare da rarraba baya, na gefe da kuma asymmetric.
Ƙarfi na ƙwayoyin cuta, da kuma ƙirar mosaic da kuma ƙarfafawa suna ci gaba da ci gaba da cutar.
Wani bincike da ya kwatanta PCR da CT a Wuhan a wurin da cutar ta barke a yanzu ya nuna cewa CT ya fi PCR muhimmanci, ko da yake ba shi da ƙayyadaddun bayanai, tare da yawancin abubuwan da ke cikin hotonsa da suka dace da sauran cututtukan huhu da cututtukan cututtuka.
Tun daga Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don tantancewa ko a matsayin gwajin farko don gano COVID-19". Tun daga Maris 2020, CDC ta ba da shawarar PCR don dubawa na farko.
Wani ɓangare na maganin rigakafi ga kamuwa da cuta shi ne samar da rigakafi ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane da suka fara kwanaki 7 ko kuma bayan bayyanar cututtuka, don sanin rigakafi, da kuma lura da yawan jama'a. Ana iya yin gwaje-gwaje a cikin cibiyar bincike (CLT) ko ta hanyar gwajin gwaji na nesa (PoCT).
Aikin sarrafa kansa mai ƙwarewa a cikin dakunan gwaje-gwaje da yawa zai iya yin waɗannan gwaje-gwajen, amma kasancewa a wurin zai dogara da yawan aikin da ake yi a kowace hanya.
A cikin CLT, ana amfani da jini guda ɗaya na jini, ko da yake ana iya amfani da samfurori da yawa don lura da amsawar rigakafi.
A cikin PoCT, ana samun jini guda ɗaya ta hanyar bugun jini.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin tattara kafin gwaji. A ranar 26 ga Maris, 2020, FDA ta nuna hukumomi 29 da suka sanar da hukumar kamar yadda aka buƙata, kuma daga yanzu sun dace su rarraba gwajin rigakafin su.
Tun daga ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai tare da izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies ga cutar a cikin samfurin jini.
Ana iya gwadawa da ɗaruruwan samfurori a cikin sa'o'i, kuma hakan yana da saurin gaske fiye da gwajin PCR na RNA na kwayar cuta.
A farkon watan Afrilu, Birtaniya ta ce babu wani daga cikin kayan gwajin rigakafin da aka samu da ya dace da amfani.
Hong Kong ta shirya tsarin da marasa lafiya masu tuhuma za su iya zama a gida, "sashen gaggawa zai ba da bututun samfurin ga mai haƙuri", dole ne su fitar da saliva a cikin bututun, su aika da shi baya, kuma su sami sakamako ba da daɗewa ba. NHS ta Burtaniya ta sanar da cewa tana daidaita tsarin don gwada abubuwan da ake zargi a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun je asibiti ko buƙatar yin maganin rigakafi idan an yi amfani da shi. A cikin gwajin drive-thru don COVID-19 a cikin abubuwan da ake zargi, ƙwararren likita na kiwon lafiya yana tattara samfurori da ɗaukar matakan da suka dace.
Cibiyoyin motsa jiki sun taimaka wa Koriya ta Kudu ta gudanar da wasu gwaje-gwaje mafi sauri da kuma zurfin bincike a cikin ƙasa. A Jamus, Ƙungiyar Likitoci na Ƙasar ta Sanarwar Lafiya ta Sanarwar ta ce a ranar 2 ga Maris cewa tana da damar yin gwajin kusan 12,000 a kowace rana a cikin kulawar asibiti, inda 10,700 aka gwada a makon da ya gabata.
Asusun inshorar lafiya ne zai biya kuɗin idan likita ya nemi a yi maka gwajin.
Shugaban Cibiyar Robert Koch ya ce Jamus tana da iyawar gwaji 160,000 a mako.
Tun daga ranar 19 ga Maris, an yi gwaji a manyan birane da dama.
Tun daga 26 ga Maris, 2020, adadin gwaje-gwajen da aka yi a Jamus ba a sani ba, saboda an rubuta gwaje-gwaje masu kyau kawai.
Labarin bincike na farko ya bayyana cewa tun daga makon 12 na shekarar 2020 an gwada samfurori aƙalla 483,295 zuwa makon 12 na shekarar 2020 kuma samfurori 33,491 (6.9%) sun tabbatar da cewa sun sami SARS-CoV-2. A Isra'ila, masu bincike daga asibitocin Technion da Rambam sun haɓaka kuma sun gwada wata hanya don gwada samfurori daga marasa lafiya 64 a lokaci guda, tattara samfurori da yin ƙarin gwaje-gwaje kawai idan an yi la'akari da samfurin da aka haɗa a matsayin mai kyau. A Wuhan, wani dakin gwaje-gwaje na 2000 m2 don gano gaggawa da ake kira "Huo-Yan" (Cina: 火眼, ko "Fire Eye" a Turanci) an buɗe shi a ranar 5 ga Fabrairu, 2020 ta BGI, wanda zai iya aiwatar da samfurori sama da 10,000 a kowace rana.
A lokacin da Wanda ya kafa BGI, Wang Jian, ya duba aikin, kuma ya ɗauki kwanaki 5, yin samfurin ya nuna cewa a Hubei, za a samu kashi 47 cikin ɗari na shari'o'in da suka fi girma kuma farashin da ya dace na yin amfani da rigakafin zai ninka idan ba a sami damar yin amfani da intanet ba.
Nan da nan sai Huo-Yan Labs da ke Shenzhen, Tianjin, Beijing, da Shanghai suka bi Wuhan Lab, a total birane 12 a duk faɗin China.
A ranar 4 ga Maris, 2020, jimlar yawan gwajin yau da kullun ya kai gwaje-gwaje 50,000 a rana. An ƙaddamar da samfuran buɗe tushen da aka saki ta Origami Assays don gwada samfurori 1,122 na marasa lafiya don COVID-19, ta amfani da gwaji 93 kawai. Ana iya gudanar da waɗannan samfuran daidaitawa a ƙananan dakunan gwaje-gwaje ba tare da buƙatar sarrafa robotic don ruwa ba.
A watan Maris, ƙarancin ko kuma rashin isasshen reagent ya zama cikas ga gwaji mai yawa a cikin Tarayyar Turai, Birtaniya da Amurka.
Wannan ya sa wasu marubuta su yi nazarin tsarin shirya samfurori wanda ya shafi dumama samfurori zuwa 98 °C (208 °F) na minti 5 don sakin genomes na RNA don ƙarin gwaje-gwaje. A ranar 31 ga Maris, an bayyana cewa UAE yanzu tana yin ƙarin gwaje-gwaje a cikin yawanta don Coronavirus fiye da sauran ƙasashe, kuma za su kasance kan hanyar haɓaka matakin gwaji da kaiwa ga yawancin jama'a.
Wannan ya faru ne ta hanyar haɗuwa da ƙarfin drive-thru, da kuma sayen dakin gwaje-gwaje na sarrafawa mai yawa na yawan jama'a na Group 42 da BGI (wanda ya samo asali daga dakin gwaje-gwajen gaggawa na Huo-Yan a China).
An gina shi a cikin kwanaki 14, kuma dakin gwaje-gwaje na iya gudanar da dubban gwaje-gwaje na RT-PCR a kowace rana kuma shi ne na farko a duniya a irin wannan sikelin da ke aiki a wajen kasar Sin.
An kirkiro hanyoyin gwaji daban-daban da suka shafi bangarori daban-daban na tsarin kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta yi amfani da hanyar Jamus wajen yin kayayyaki da aka aika zuwa ƙasashen da ba su da albarkatun da za su iya samar da nasu.
An bayyana hanyar ta Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta kasance ba har zuwa 28 ga Janairu, akwai jinkiri a cikin gwajin da aka samar ga Amurka da China, kuma Amurka ta fuskanci matsaloli game da amincin kayan gwajin a farkon barkewar cutar, ƙari kuma, waɗannan ƙasashe tare da Ostiraliya sun kasa samar da isasshen kayan aiki don biyan buƙatun da shawarwarin gwaji da aka yi ta hanyar ƙwararrun likitocin lafiya.
A madadin haka, masana sun ce, samun damar gwada cutar a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta ƙarfafa ƙarfin gwajin, da yawa daga cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta nuna karfafa shirye-shiryen gwaji a matsayin hanya mafi kyau don jinkirta ci gaban annobar COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ta haifar da jinkirin gwajin ɗaruruwan dubban a cikin dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da kayan kwalliya da sinadarai sun shafar.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsaloli a cikin kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta haɓaka sun nuna "rashin aiki"; sai gwamnati ta cire shinge na hukuma wanda ke hana gwajin mutum.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya kasancewa sakamakon rashin nasarar tattara samfurori ko kuma rashin amfani da kayan aikin.
Ministan Spain ya ce zai soke kayan aikin da suka samar da sakamako mara kyau kuma ya maye gurbin su da wani kayan aikin gwaji daban wanda Shenzhen Bioeasy ta samar. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun samar da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China da aka ɗauka ba daidai ba.
Firayim Minista Matovic ya ba da shawarar cewa za a watsar da su a cikin Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin Turkiyya da aka saya daga China suna da "ƙimar kuskure" kuma ba zai "yi amfani da su ba".
Ana gudanar da gwaji, sannan ana killace wadanda suka samu cutar ta SARS-CoV-2 da kuma bin diddigin wadanda suka samu cutar ta SARS-CoV-2 sun samu sakamako mai kyau.
Masu binciken da ke aiki a garin Vò na Italiya, inda aka fara mutuwar COVID-19 a Italiya, sun gudanar da matakai biyu na gwaji na dukan jama'a na kimanin mutane 3,400, a tsakanin kwanaki goma.
Kimanin rabin mutanen da suka samu cutar ba su da wata alama, kuma an killace duk wadanda aka gano.
Da yake an hana shi zuwa cikin gari, hakan ya kawar da sababbin cututtuka gaba ɗaya.
Tare da sa ido kan lamba, takunkumin tafiye-tafiye zuwa kasar, gwaji da killacewa, annobar coronavirus a shekarar 2020 a Singapore ta ci gaba da tafiya a hankali fiye da sauran ƙasashe masu tasowa, kuma ba tare da takunkumin tsattsauran ra'ayi kamar rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke taron da yawa, kuma Singapore ta fara ba da shawara sosai ga mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a cikin lokacin da aka tsara bayan hutu a ranar 23 ga Maris.
Kasashe da dama sun kuma yi amfani da rigakafin cutar ta hanyar sa ido kan mutane, da takunkumin tafiye-tafiye, da gwaji da killacewa, amma tare da kulle-kulle da ba su da ƙarfi kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa kasashen da suka yi gwaje-gwaje da yawa, dangane da yawan mutuwar, sun fi samun ƙananan mutuwar, wataƙila saboda waɗannan ƙasashen sun fi iya gano waɗanda ba su da alamun cutar ko kuma marasa alamu.
WHO ta ba da shawarar cewa ƙasashe da ba su da damar gwaji kuma suna da dakunan gwaje-gwaje na ƙasa da ƙarancin gogewa a COVID-19 su aika da samfuransu biyar na farko masu kyau da kuma samfurori goma na farko marasa kyau zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
A cikin teburin da ke gaba, shafi na "Abin da ya dace a cikin kashi na gwaji" yana rinjayar manufofin gwaji na ƙasashe.
Kasar da ke gwada mutanen da ke asibiti ne kawai za ta samu kashi mafi yawa na gwajin da suka dace fiye da kasar da ta gwada dukkan 'yan kasar, ko suna da alamun cutar ko a'a, sauran halaye suna daidai.
Wanke hannu (ko tsabtace hannu), wanda aka fi sani da tsabtace hannu, shi ne yin wanke hannu don cire datti, kitse, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Yin wanka da sabulu a kai a kai a wasu "lokaci masu muhimmanci" a rana yana hana yaduwar cututtuka da yawa, kamar su fitsari da kuma zazzabi, da ake watsawa ta hanyar zinariya.
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko sanyi na yau da kullum, misali, idan ba su wanke hannuwansu kafin su taɓa idanunsu, hanci ko bakinsu (watau mucous membranes).
Abubuwa biyar masu muhimmanci a rana da ake bukatar a yi wa hannuwanka wanka da sabulu sun haɗa da kafin da bayan ka zubar da ciki, bayan ka tsabtace ƙwanƙolin yaron ko ka canja tufafinsa, kafin ka ciyar da yaro, kafin ka ci abinci, da kuma kafin ka shirya abinci ko ka yi amfani da nama, naman alade ko kifi.
Idan babu sabulu da ruwa, za a iya wanke hannuwanka da toka.
Kafin, a lokacin da kuma bayan da ake dafa abinci.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan ka canja tufafinka ko kuma ka wanke wani yaro da ya yi amfani da gidan wanka.
Bayan ka yi ta zub da hanci, ka yi tari ko ka yi ta numfashi.
Bayan ka taɓa dabba, abinci ko kuma dabba da aka zubar.
Hanyar tsabtace hannu na hannu tana nufin ayyukan tsabtace hannu da suka shafi hanyoyin likita.
Yin wanka kafin ka ba da magani ko kuma ka kula da lafiyarka zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu shi ne tsabtace hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da za su iya haifar da cuta) da kuma sunadarai da za su iya haifar da lahani ko cuta.
Wannan abu ne mai muhimmanci ga masu cin abinci ko kuma masu aikin likita, amma kuma yana da muhimmanci ga jama'a.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtuka na cututtuka; rage cututtukan numfashi;
kuma rage yawan mutuwar yara a cikin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin wanka da hannu zai iya sa yara da ba su kai shekara biyar su yi girma sosai ba.
A ƙasashe masu tasowa, ana iya rage yawan yaran da ke mutuwa daga cututtukan numfashi da kuma na fitsari ta wajen sauya halayensu kamar wanke hannu da sabulu.
Wannan hali mai sauƙi zai iya rage yawan mutuwa daga waɗannan cututtuka da kusan kashi 50.
Yin amfani da hannayen hannu wajen wanke hannu zai iya rage yawan cututtukan da ke faruwa a cikin jiki da kashi ɗaya bisa uku, wanda zai iya kwatanta da samar da ruwa mai tsabta ga wuraren da ba su da isashen ruwa.
Kashi 48 cikin 100 na rage yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ciwon huhu, wanda shi ne babban ciwon da ake kashewa a cikin yara da ba su kai shekara biyar ba, yana kashe yara miliyan 1.8 a kowace shekara.
A kowace shekara, kusan yara miliyan 3.5 ne suke mutuwa sakamakon ciwon daji da kumburi.
UNICEF ta ce yin wanka da sabulu kafin cin abinci da kuma bayan yin amfani da gidan wanka ya zama al'ada mai tsanani da za ta iya ceton rayuka fiye da kowane magani ko allurar rigakafi, ta rage mutuwar da ke tattare da fitsari da kuma mutuwa daga kamuwa da cututtukan numfashi a cikin ɗaki ɗaya.
Ana haɗa wanke hannu da sauran ayyukan kiwon lafiya a matsayin ɓangare na shirye-shiryen ruwa, tsabtace jiki da kuma tsabtace jiki (WASH).
Yin wanka da hannu yana kāre ka daga rashin ƙarfi da ake samu ta hanyar yin jima'i da kai tsaye.
Wani mummunan sakamako na wanke hannu da yawa shi ne, wanke hannu sau da yawa zai iya haifar da rauni a fata saboda bushewar fata.
Wani bincike na Denmark a shekara ta 2012 ya gano cewa yin wanka sosai a hannu zai iya haifar da yanayin da ake kira eczema ko kuma hannu na fata, wanda ya fi kowa a tsakanin ma'aikatan kiwon lafiya.
Ana kuma lura da yawan wanke hannu a matsayin ɗaya daga cikin alamun rashin lafiyar jiki.
Akwai muhimman lokatai guda biyar a rana da wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cututtuka ta hanyar magunguna: bayan yin amfani da gidan wanka (sanya, zubar da ciki), bayan wanke ƙwanƙwasa na yaro (canja yadudduka), kafin ciyar da yaro, kafin cin abinci, da kuma kafin/bayan shirya abinci ko kuma cin nama, kifi ko kaza mai naman kaza.
Sauran yanayi da ya kamata a yi amfani da fasaha mai kyau na wanke hannu don hana yaduwar cututtuka sun haɗa da kafin da bayan yin aiki da yanke ko rauni; bayan yin taushi, tari ko kuma yin hanci; bayan taɓa shara ko dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, an rage yawan wanke hannu da sabulu.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa, a matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani binciken da aka yi a shekarar 2014 ya nuna cewa Saudiyya ce ta fi yawan wanke hannu da kashi 97 cikin dari; Amurka ta fi kusa da matsakaici da kashi 77 cikin dari; da kuma China da ta fi ƙasa da kashi 23 cikin dari. Akwai hanyoyin sauye-sauyen hali daban-daban a halin yanzu don kara karɓar karbuwa game da wanke hannu da sabulu a lokutan mawuyacin lokaci.
Shirin "Mafi Muhimmanci na Kiwon Lafiya" da Ma'aikatar Ilimi ta Philippines ta kafa misali ne na babban mataki na inganta lafiyar yara da kuma ilimi.
Ana yin amfani da sabulu don wanke hannu a kullum, da kuma wanke hakora a kullum da fluorine a cikin wannan shirin na kasa.
An yi amfani da shi sosai a Indonesia.
Ana ƙara cire ƙwayoyin cuta daga fata ta wajen ƙara sabulu da kuma wanke-wanke zuwa ruwa.
Babban abin da sabulu da kuma kayan wankewa suke yi shi ne rage shingen da ke hana ruwa yin ruwa, kuma su ƙara narkewa.
Ruwa shi kaɗai ba shi da amfani wajen tsabtace fata, domin kitse da furotin, wato, abubuwan da ke cikin ƙazantar da aka yi da su, ba su da sauƙi a narke su cikin ruwa.
Amma, ana samun ruwa mai kyau don a tsabtace shi.
Sabulu a cikin sanduna, saboda yadda ake sake amfani da shi, zai iya riƙe ƙwayoyin cuta da aka tara daga amfani da su a baya.
Ƙananan bincike da aka yi game da yadda ake watsa kwayoyin daga sabulu a cikin sandar da aka gurɓata sun nuna cewa ba zai yiwu ba domin an yi amfani da kumfa don yin amfani da su.
Hukumar ta sake cewa "abincin sabulu mai ruwa da kuma sarrafawa na atomatik na maganin ya fi kyau".
An yi amfani da sabulu na maganin rigakafi sosai ga jama'a masu sanarwa.
Har yanzu babu wata alama da ta nuna cewa yin amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta da aka ba da shawarar zai iya haifar da zaɓaɓɓun kwayoyin da ke da ƙarfin maganin rigakafi a cikin yanayi.
Duk da haka, sabulu na antibacterial sun ƙunshi wasu kwayoyin antibacterial kamar triclosan, wanda ke da jerin sunayen kwayoyin da ke da ƙarfi.
Saboda haka, ko da yake ba a zaɓa wa kwayoyin da ke hana maganin rigakafi ba, ƙila ba su da tasiri sosai kamar yadda ake tallata su.
Baya ga surfactants da kuma masu kare fata, kayan aiki masu mahimmanci na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid mai aiki na antimicrobial, da sauran masu ba da ruwa ga fata (aloe vera, bitamin, mentol, kayan lambu). Wani bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullum suna da tasiri sosai wajen hana cututtuka da kuma kawar da ƙwayoyin cuta daga hannayen kamar sabulu na antibacterial da ke nufin ƙarshen mai amfani da triclosan.
Ruwan da ke da zafi da zai dace da wanke hannuwanku ba shi da zafi sosai don kashe ƙwayoyin cuta.
Baƙon yana girma da sauri a jiki (37 °C).
Amma, ruwan sanyi da sabulu ya fi ruwan sanyi da sabulu kyau wajen kawar da man fetur da ke riƙe da ƙazanta da ƙwayoyin cuta.
Amma, ba kamar yadda mutane suke tunani ba, binciken kimiyya ya nuna cewa yin amfani da ruwa mai zafi ba ya rage yawan ƙwayoyin cuta a hannayenmu.
Mai tsabtace hannu ko maganin hana kamuwa da cutar hannu shine mai tsabtace hannu na asali wanda ba mai ruwa ba.
A ƙarshen shekarun 1990 da kuma farkon karni na 21, kayan aikin tsabtace hannu na tushen ruwa ba tare da barasa ba (wanda aka fi sani da kayan tsabtace hannu na tushen giya, kayan tsabtace hannu na antiseptic, ko tsabtace hannu) sun fara samun karbuwa.
Yawancin su ne isopropyl alcohol ko ethanol da aka yi da wani abu mai narkewa kamar carbomer (polymer ko acrylic acid), a cikin gel, ko kuma wani mai ƙonewa kamar glycerine, a cikin ruwa, ko a cikin kumfa don sauƙaƙe amfani da kuma rage tasirin bushewar barasa.
Ƙara hydrogen peroxide yana ƙara ƙwayoyin cuta. Masu tsabtace hannu da suka ƙunshi barasa da kashi 60 zuwa 95% suna kashe kwayoyin da kyau.
Masu tsabtace jiki da ke amfani da barasa suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙonewa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da kuma cutar hanta) da kuma fungi.
Masu tsabtace giya da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% (rage na 3.5 logarithms, kwatankwacin rage na 35 decibels) na ƙwayoyin cuta a hannayenmu, a cikin dakika 30 bayan amfani da su, da kuma kashi 99.99% zuwa 99.999% (rage na 4 zuwa 5 logarithms) na ƙwayoyin cuta a hannayenmu minti 1 bayan amfani da su.
Ana iya amfani da maganin hana shan magani da kuma maganin hana shan giya don yin wanka ko kuma rufe hannuwan biyu.
A yi wa baya da hannuwanka, tsakanin yatsunsu da kuma gefuna su shafe na tsawon dakika 30 har sai ruwa, kumfa ko gel sun bushe.
Ƙananan yatsunsu kuma ya kamata a wanke su sosai, a shafa su da hannuwan hannu biyu. Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta ba da shawarar yin wanka da hannu da kayan tsabtace hannu, musamman ma idan hannuwan suna da tsabta.
Ana amfani da waɗannan magunguna sosai don su kasance da sauƙi da kuma saurin kashewa a kan ƙwayoyin cuta; duk da haka, kada su maye gurbin wanke hannu da kyau, sai dai idan sabulu da ruwa ba su da.
Yin amfani da kayan tsabtace hannu da yawa da barasa zai iya sa fata ta bushe sai dai idan an ƙara mai sanyaya fata da/ko mai sanyaya fata ga kayan aiki.
Ana iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da/ko wasu masu sanyaya a cikin formula.
A cikin gwaji na asibiti, kayan tsabtace hannu na giya da ke dauke da maganin shafawa sun haifar da rashin haushi da bushewar fata fiye da sabulu ko kayan wankewa na antimicrobial.
Alamu na tuntuɓar fata, ciwon hanci na tuntuɓar jiki, ko kuma rashin jin daɗin barasa ko kuma ƙarin abubuwa a cikin kayan tsabtace hannayenmu na barasa ba sa faruwa.
Ƙananan yanayin da zai iya haifar da cututtukan fata na fuska ya zama abin sha'awa idan aka kwatanta da wanke hannu da ruwa da sabulu.
Duk da yadda suke da tasiri, kayan aiki na asali ba su wanke hannayenmu da kayan halitta ba, suna kashe su ne kawai.
Wannan shi ne dalilin da ya sa tsabtace hannu ba su da tasiri kamar ruwa da sabulu wajen hana kamuwa da cutar da yawa, tun da yake har yanzu akwai cutar a hannayenmu.
Aikin tsabtace hannayenmu ba tare da giya ba ya dogara sosai da abubuwa da kuma yadda ake yin shi, kuma a tarihi ya kasance ƙasa da giya da kuma tsabtace hannayenmu.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da kuma ci gaba da maganin antimicrobial bayan amfani, ba kamar barasa ba, wanda ya nuna rage ingancinsa bayan amfani da shi sau da yawa, mai yiwuwa saboda karuwar sakamako masu illa a fata.
Mutane da yawa a yankunan da ba su da kuɗi sosai ba za su iya sayan sabulu ba, amma za su yi amfani da toka ko ƙasa.
Ash ko ƙasa za su iya yin aiki fiye da ruwa mai tsabta, amma ba su da amfani fiye da sabulu.
Wani abin da ya damu shi ne, idan ƙasa ko toka sun kamu da ƙwayoyin cuta, za a iya ƙara yaduwar cutar maimakon ragewa.
Kamar sabulu, toka kuma yana da tsabtace jiki, domin idan ya zo ruwa, yana da ƙarfi sosai.
Hukumar ta duniya ta ba da shawarar cewa a maimakon sabulu, a yi amfani da toka da yashi a lokacin da babu sabulu.
Hanyar da ta dace ta wanke hannu da Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cututtuka ta ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwan sanyi ko ruwan zafi.
Ana ba da shawarar ruwa mai gudana tun da yake wanka na iya zama mai gurɓataccen ruwa, amma zafin ruwan ba shi da muhimmanci.
Ka wanke hannunka, ka shafa su da sabulu mai yawa, har da baya, tsakanin yatsanka da ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannuwansu sosai sa'ad da suke amfani da sabulu maimakon ruwa mai tsabta.
Ka shafe ta aƙalla na dakika 20.
Yin shafawa yana sa mutum ya yi ta yin taƙaici, kuma hakan yana taimaka wa mutum ya kawar da ƙwayoyin cuta daga fata, kuma yin shafawa na dogon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka wanke shi da ruwa mai gudana.
Yin wanka a wanka zai iya sake gurɓata hannayenku.
Ka bushe da tawul mai busassun bushewa ko kuma ka bar shi ya bushe a waje.
Hannun da suka yi ruwa ko kuma suka yi ruwa suna da sauƙi su sake kamuwa da cutar. Wuraren da aka fi manta da su su ne yatsan hannu, da wuyan hannu, da kuma wuraren da ke tsakanin yatsunsu da kuma ƙarƙashin kusoshi.
Ƙwaƙwalwa da kuma ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ana yawan ba da shawarar yin amfani da maganin shafawa don kiyaye hannayenka suna da ruwa; fata mai bushewa na iya haifar da raunuka a fata da za su iya ƙara haɗarin kamuwa da cuta.
Za a iya yin zaɓuɓɓukan da yawa masu ƙarancin kuɗi don sauƙaƙe wanke hannu inda babu ruwan sha da/ko sabulu, misali, zubar da ruwa mai ɗimbin yawa ko wanda ke da ramuka masu dacewa da/ko amfani da toka idan ya cancanta a ƙasashen da ke tasowa. A cikin yanayi da ke da ƙarancin samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin adana ruwa kamar "ƙirar ƙirar" da sauran zaɓuɓɓukan ƙarancin kuɗi.
Fita mai wucin gadi fasaha ce mai sauƙi da ke amfani da tukunya da aka rataye ta igiya, da kuma wata tarkon da ƙafafunsu ke motsawa don zuba ruwa kaɗan a hannayenmu da kuma sabulu.
Yin bushewar hannu a zahiri muhimmin ɓangare ne na tsarin tsabtace hannu, amma akwai muhawara game da yadda za a yi bushewa a cikin wanka na jama'a.
Ƙari ga haka, bincike da ake yi a kan littattafan da ake amfani da su a wanka ya nuna cewa suna da tsabta sosai fiye da na'urorin wanka da ake amfani da su a wanka.
A shekara ta 2008, Jami'ar Westminster ta London ta gudanar da wani bincike da masana'antar takarda ta bayar da tallafi, wato, European Tissue Symposium, don kwatanta matakan tsabta da takarda ta tanada, masu bushewa da iska mai zafi da kuma masu bushewa da iska mai iska na zamani.
Bayan an wanke hannuwanmu kuma an bushe su da iska mai zafi, an ƙayyade adadin ƙwayoyin cuta a matsakaita da kashi 194 cikin ɗari a yankin da ke kusa da yatsunsu kuma kashi 254 cikin ɗari a sauran hannayenmu.
Yin busassun da aka yi da iska ta iska ya sa adadin kwayoyin ya ƙaru da kashi 42 cikin ɗari a yankin da ke kusa da yatsunsu kuma ya ƙaru da kashi 15 cikin ɗari a sauran dabino.
Bayan wanke da kuma bushe hannuwan da takarda, an rage adadin kwayoyin cuta da matsakaita har zuwa kashi 76 cikin 100 a yankin dabino kusa da yatsunsu da har zuwa kashi 77 cikin 100 a sauran dabino. Masu bincike sun kuma gudanar da gwaje-gwaje don tantance ko akwai yiwuwar kamuwa da cutar tsakanin sauran masu amfani da kuma yanayin gidan wanka sakamakon kowane irin hanyar bushewa.
Jirgin saman iska mai bushewa, wanda ke fitar da iska daga cikin na'urar a hanzarin gudu da aka nuna na 180 m/s (650 km/h; 400 mph), ya sami damar fitar da ƙwayoyin cuta daga hannayensu da na'urar da ke gurɓata sauran masu amfani da gidan wanka da kuma muhalli har zuwa mita 2 daga nesa.
Yin amfani da mai bushewa da iska mai zafi yana sa ƙwayoyin cuta su yada zuwa mita 0.25 daga cikin mai bushewa.
A shekara ta 2005, a cikin wani bincike da TÜV Produkt da Umwelt suka gudanar, an yi nazarin hanyoyin daban-daban na bushewa na hannu.
An lura da canje-canje a cikin adadin kwayoyin bayan an bushe hannu:
Akwai masana'antun bushewa da yawa, kuma an kwatanta bushewa da takarda.
Yin wanka da hannu da takalma masu tsabtace hannu mai danshi wani zaɓi ne na rashin sabulu da ruwa a lokacin tafiya.
Kayan tsabtace hannu da aka yi amfani da giya dole ne su ƙunshi aƙalla kashi 60 cikin ɗari na giya.
Yin wanka hannu a asibiti ya zama wajibi ne bayan da likitan Hungary Ignaz Semmelweis ya gano (a shekara ta 1846) cewa yana da tasiri wajen hana cututtuka a asibiti.
Akwai na'urorin lantarki da ke ba da bayanai don tunatar da ma'aikatan asibiti su wanke hannu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cuta ya ragu da amfani da shi.
A lokacin da aka yi amfani da sabulu da ruwa ko gel, ana wanke hannuwanmu na tsawon dakika 15 don a shafa da kuma shafa dukan sassan hannu.
Dole ne a shafa hannayen hannu a lokaci guda tare da haɗa yatsunsu.
Idan akwai wasu abubuwa da suka rage a ƙarƙashin ƙusa, za a iya amfani da goga don cire su.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannayenku, yana da muhimmanci ku wanke su sosai kuma ku bushe su da tawul mai tsabta.
Bayan an bushe, towel paper ya kamata a yi amfani da shi don rufe famfo (da kuma bude kofa idan ya cancanta).
Wannan zai hana a sake gurɓata hannayensu ta waɗannan wurare.
Manufar wanke hannu a cikin yanayin kula da lafiya shine cire kwayoyin cuta (kayan cuta) da kuma hana su watsawa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu yana da wuya a yawancin wuraren kiwon lafiya, da yawa daga cikin likitoci da ma'aikatan jinya suna manta da wanke hannu kafin su taɓa marasa lafiya, suna ba da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi suna iya rage yawan cututtukan da ke faruwa a cikin jini da suka shafi catheter da kashi 66 cikin ɗari.
Za a iya samun tsarin kula da tsabtace hannu na ƙungiyar a wannan shafin don yin tsokaci.
Wani bita mai amfani da shi ya yi da Whitby et al.
Kayan aiki na kasuwanci na iya auna da kuma tabbatar da tsabtace hannu idan ana buƙatar tabbatar da bin doka.
Hukumar Lafiya ta Duniya ta bayyana "Lokaci Biyar" don wanke hannu:
bayan an yi masa jinin jiki/jininsa
kafin aikin ascetic, kuma
Ƙara sinadarai masu maganin hana kamuwa da cutar a cikin sabulu (sabo na " magani " ko " maganin kwayoyin cuta ") yana ba da aikin kisa ga mai wanke hannu.
Irin wannan aikin kisa zai iya zama da kyau kafin a yi tiyata ko kuma a yanayin da kwayoyin da ke da tsayayyar maganin rigakafi suka fi yawa. Don "tsabtace" hannayen hannu don tiyata, dole ne a sami famfo wanda za a iya buɗewa da rufe ba tare da taɓa shi da hannu ba, wasu maganin kashe-kashe na chloride ko iodine, tawul ɗin da aka hana a bushe hannayen bayan wanka, da kuma goga mai hana a tsabtace da sauran kayan aikin da aka hana a tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
Wannan aikin yana bukatar wanke hannuwanka da hannuwanka har zuwa gwiwoyinka, yawanci na tsawon minti 2-6.
Ba a bukatar tsawan lokacin tsaftacewa (minti 10) ba.
A lokacin wankewa, kada ruwa ya shiga hannayenka.
Bayan an gama wanke hannu, ana wanke hannuwan da tawul mai hana haihuwa kuma ana saka rigar tiyata.
Don rage yaduwar kwayoyin, ya fi kyau a wanke hannuwanku ko kuma a yi amfani da maganin hana kamuwa da cutar kafin kuma bayan kun kula da wani mai ciwo.
Don kula da cututtukan cutar ta hanyar shan magani a asibitoci, an gano cewa an sami ƙarin amfani daga tsabtace hannu a farkon 20% na wanka, kuma an sami ƙarin amfani mai mahimmanci lokacin da yawan tsabtace ya wuce 35%.
Yin wanka da sabulu na yau da kullum ya ninka adadin cututtukan cuta na kwayar cuta da ake watsawa zuwa abinci fiye da sau uku idan aka kwatanta da wanke hannu da sabulu mai ƙonewa. Idan aka kwatanta wanke hannu da maganin barasa da wanke hannu da sabulu mai ƙonewa na tsawon dakika 30 ga kowane mutum, an gano cewa wanke hannu da aka yi da giya ya rage kamuwa da kwayoyin cuta da kashi 26 cikin dari fiye da wanke hannu da sabulu mai ƙonewa.
Duk da haka, sabulu da ruwa sun fi inganci fiye da kayan tsabtace hannu na barasa don rage cutar mura ta A, H1N1, da kuma spores na Clostridium difficile a hannayen. Hanyoyin da za a kara tsabtace hannu a asibitoci na iya haɗawa da wayar da kan ma'aikatan game da wanke hannu, ƙara yawan wadatar kayan tsabtace hannu na barasa, da kuma gargaɗi na magana da rubuce ga ma'aikatan.
Ana bukatar ƙarin bincike game da irin hanyoyin da suka fi dacewa a wurare dabam dabam na kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin muhimmin kayan aiki mai amfani don samun lafiya da kuma abinci mai gina jiki.
Amma rashin wadataccen ruwa, sabulu ko kuma kayan aiki don wanke hannu a gidajen mutane, a makarantu da wuraren aiki ya sa hakan ya zama ƙalubale ga samun aikin wanke hannu a duniya.
Alal misali, a mafi yawan yankunan karkara na Afirka, famfo don wanke hannu kusa da wani gidan wanka na gwamnati ko na masu zaman kansu ba su da yawa, duk da cewa akwai zaɓuɓɓukan da ba su da tsada don gina tashoshin wanke hannu.
Amma, ƙananan yawan wanke hannu zai iya zama sakamakon halayen da suka yi sanyi, ba rashin sabulu da ruwa ba.
Ƙarfafawa da kuma kare wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, ya haifar da wayar da kan jama'a game da amfanin wanke hannu, kuma ya haifar da canjin halayyar mutane na dogon lokaci.
Domin wannan ya yi aiki sosai, ana bukatar saka idanu da kuma tantancewa.
Wani nazari na tsarin bincike na 70 ya gano cewa hanyoyin da ke kan al'umma suna da tasiri wajen kara wanke hannu a kasashe masu karamin da matsakaitan kudin shiga, yayin da kamfen din talla na zamantakewa ba shi da tasiri. Misali na inganta wanke hannu a makarantu shine "Yanar taurari uku" ta UNICEF wanda ke karfafa makarantu su dauki matakai masu sauki da arha don tabbatar da cewa dalibai suna wanke hannu da sabulu, da sauran bukatun kiwon lafiya.
Idan aka kai ga ƙaramar matakin, za a iya samun makarantar daga taurari ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na talla don wanke hannu da aka yi don rage cututtukan yara da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani yunkurin wayar da kan jama'a da ke kokarin kawo sauyi a dabi'a. A sakamakon annobar coronavirus ta 2019-2020, UNICEF ta sanar da karɓar emoji don wanke hannu.
Kadan ne suka yi la'akari da yadda ake amfani da wanke hannu a ƙasashen da ke tasowa a duniya a kan darajar DALY.
Amma, wani bincike ya nuna cewa yin amfani da sabulu wajen wanke hannu yana da amfani sosai fiye da yin amfani da ruwa da kuma tsabtace jiki.
Muhimmancin wanke hannu ga lafiyar mutum  musamman ga mutanen da ke cikin yanayi mai rauni kamar uwaye da suka haifi jarirai ko kuma sojojin da aka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 ta biyu masu tsinkayar tsabtace hannu: Ignaz Semmelweis, likitan Hungary wanda ya yi aiki a Vienna, Austria, da Florence Nightingale, "mahimmanciyar aikin jinya na zamani" na Ingila.
A lokacin, mutane suna ganin cewa miyagun ƙwayoyi ne suke sa mutane su kamu da cutar.
A shekarun 1980, ɓarkewar abinci da cututtuka da ke tattare da kula da lafiya sun sa Cibiyar Kula da Cututtuka ta Ƙasar Amirka ta ƙara ƙarfafa tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cututtuka.
Cutar da aka yi wa alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun jawo karuwar wayar da kan jama'a a ƙasashe da yawa game da muhimmancin wanke hannu da sabulu don kare kansu daga irin waɗannan cututtukan cututtuka.
Alal misali, an rataye wasu alamomi da ke ɗauke da "Hanyar da ta dace ta wanke hannu" a kusa da wuraren wanka a wuraren wanka na jama'a da kuma a wankan ofisoshi da kuma filin jirgin sama a Jamus.
Kalmar nan "wanke hannu" tana nufin nuna rashin son kai ga yin alhakin wani abu ko kuma yin tarayya da wani abu.
An samo asali ne daga nassi a littafin Matta, inda Bilatus ya wanke hannayensa daga shawarar da aka yi na gicciye Yesu Kristi, amma ya zama magana da aka fi amfani da ita a wasu al'ummomin Turanci.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannuwanta a cikin ƙoƙari na tsabtace tabo na tunani, yana wakiltar lamirinta da ke da laifi game da laifukan da ta aikata kuma ya sa mijinta ya aikata.
An kuma lura cewa bayan mutane sun tuna ko sun ga wasu ayyuka marasa kyau, suna wanke hannuwansu fiye da wasu, kuma suna ɗaukan kayan wanke hannu da muhimmanci sosai.
Bugu da ƙari, waɗanda suka iya wanke hannuwansu bayan wannan hangen nesa ba su da wataƙila za su yi wasu ayyuka na "tsabtace" kamar su aikin sa kai.
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, ta amfani da ruwa, amma ba sabulu ba, don wanke hannu yana daga cikin al'ada na wanke hannu wanda ya kasance a cikin addinai da yawa, gami da Baha'i, Hindu, tevilah da netilat yadayim a cikin Yahudanci, wankewa a cikin Kiristanci, da wankewa a cikin Islama. Addinai kuma suna nuna wanke hannu mai tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudawa, da Musulunci sun ba da izinin wanke hannu bayan yin amfani da gidan wanka.
Addinin Hindu, Buddha, Sikh, da Musulunci sun ba da izinin wanke hannu kafin da kuma bayan cin abinci.
Kula da haɗari a wurin aiki don COVID-19
Kula da haɗari a wurin aiki don COVID-19 shine aikace-aikacen hanyoyin kiwon lafiya da aminci a wurin aiki don kula da haɗari don hana cutar coronavirus ta 2019 (COVID-19).
Kula da haɗari mai kyau a wurin aiki ya dogara da wurin aiki da kuma aikin da kansa, bisa ga kimanta haɗarin tushen fallasa, tsanani na cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na mutum, waɗanda zasu iya zama masu rauni ga kamuwa da COVID-19.
A cewar Ma'aikatar Lafiya da Tsaro a Aiki (OSHA), ayyukan da ke da ƙananan haɗarin fallasa suna da ƙarancin hulɗa na aiki tare da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan hana kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kula da alamar numfashi da kuma tsabtace da kuma tsabtace aikin.
Ayyuka masu haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar sau da yawa ko kai tsaye tare da mutanen da ba a san su da cutar ko waɗanda ake zargin suna da cutar COVID-19 ba, amma suna iya kamuwa da cutar saboda watsawar al'umma ko tafiya zuwa ƙasashen waje.
Wannan ya haɗa da ma'aikata da ke tuntuɓar jama'a a makaranta, a wuraren aiki masu yawan jama'a, da kuma kasuwa mai girma.
Abubuwan da ke hana wannan rukunin haɗari, ban da matakan hana kamuwa da cuta na asali, sun haɗa da iska mai amfani da matattarar iska mai inganci, rufin kariya, da kuma samar da kayan kariya na mutum idan an tabbatar da mutum yana da COVID-19.
OSHA ta yi imanin cewa ma'aikatan kiwon lafiya da na gawawwakin da suka fuskanci mutanen da ke da COVID-19 da aka tabbatar ko ake zargi da su suna da haɗarin haɗari sosai, wanda ke ƙara haɗarin haɗari sosai idan ma'aikata suka yi aiki a kan mutanen da ke da COVID-19 da aka tabbatar ko ake zargi da samar da aerosols kuma suka tattara ko kuma suka yi amfani da samfurori daga waɗannan mutanen.
Ƙarin haɗari ga waɗannan ma'aikata ya haɗa da sarrafa injiniya kamar dakunan iska masu ƙarancin matsa lamba da kuma kayan kariya na mutum wanda ya dace da aikin da aka yi.
Cutar COVID-19 na iya haifar da sakamako mai yawa a wurin aiki.
Ma'aikata za su iya barin aiki don rashin lafiya, kula da wasu, ko kuma tsoron haɗari.
Yanayin kasuwanci na iya canzawa, duka game da abin da ake buƙata da kuma hanyoyin da za a saya waɗannan kayayyakin (kamar yin sayayya a waje da lokacin da aka yi amfani da su ko don sabis na isarwa ko drive-thru.
A ƙarshe, ana iya dakatar da aika abubuwa daga yankunan da COVID-19 ke shafar su sosai. Ana iya amfani da shirin aiki da shirye-shirye don kamuwa da cuta don jagorantar ayyukan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, gami da tushen haɗari, abubuwan haɗari da ke tasowa a gida da kuma cikin al'umma, da abubuwan haɗari ga ma'aikata kamar tsufa ko yanayin rashin lafiya.
Suna kuma tsara matakan da za su iya magance waɗannan haɗarin, da kuma tsare-tsaren gaggawa don yanayin da zai iya tasowa sakamakon annoba.
Shirye-shiryen aiki da shirye-shiryen cututtuka na cututtuka na iya zama batun shawarwari na kasa ko na yanki.
Manufofin daukar mataki kan annobar sun hada da rage watsawa tsakanin ma'aikata, kare mutanen da ke da mafi girman haɗarin samun rikitarwa na kiwon lafiya, kula da ayyukan kasuwanci da kuma rage tasirin illa ga sauran kamfanoni a cikin sarkar samarwa.
Matsayin da ake fama da cutar a cikin al'ummar da kamfanin yake, yana shafar ayyukan da ake yi.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a fannin lafiya da aminci a wurin aiki don haɗa haɗari a cikin tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, ingantattun sarrafawa sune sarrafawa na injiniya, sannan na gudanarwa, kuma ƙarshe, na kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da la'akari da halayen ma'aikaci ba, kuma yana iya zama mafi kyawun maganin aiwatarwa.
Gudanar da aikin injiniya canje-canje ne a cikin manufofin aiki ko hanyoyin aiki da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Ana ganin cewa kayan aikin kariya na mutum (EPI) ba su da tasiri fiye da na aikin injiniya da na gwamnati, amma suna iya taimakawa wajen hana wasu bayyanar.
Duk nau'ikan PPE za a zaɓa bisa ga haɗarin da ke tattare da ma'aikaci, za a daidaita su yadda ya kamata kamar yadda ake buƙata (misali masu numfashi), za a yi amfani da su yadda ya kamata kuma a ci gaba da amfani da su, a bincika su a kai a kai, a kiyaye su kuma a maye gurbin su kamar yadda ake buƙata, kuma a cire su, a tsabtace su kuma a adana su ko a zubar da su yadda ya kamata don hana gurɓata.
A cewar Ma'aikatar Kiwon Lafiya da Tsaro a Aikin Aiki ta Amirka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙarancin aiki tare da jama'a da sauran abokan aiki.
Abubuwan da ake bukata don hana kamuwa da cuta a wuraren aiki sun hada da wanke hannu sosai da kuma yin aiki sosai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya da kuma yin amfani da alamar numfashi, ciki har da rufe numfashi da tari, shirya kwantena don labule da shara, shirya don aiki na waya ko kuma sauye-sauye idan ya cancanta, hana yin amfani da kayan aiki da kayan aiki na sauran ma'aikata da kuma kula da tsabtace da kuma tsabtace aikin aiki.
Gano da kuma ware masu cutar da sauri yana da muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da kuma sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka ta Amirka (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun daina samun zazzabi, alamun zazzabi, ko wasu alamun aƙalla sa'o'i 24 ba tare da yin amfani da magani don rage zazzabi ko kuma magance wasu alamun ba, kuma ta ba da shawarar cewa manufofin izinin rashin lafiya su kasance masu sassauƙa, su ba ma'aikata damar zama a gida don kula da wani mai rashin lafiya na iyali, kuma su san waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar haɗuwa da mutane sau da yawa ko kai tsaye na mita 6 (1.8 m) tare da mutanen da ba a san su da haƙuri ko waɗanda ake zargi da COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda watsawar al'umma ta yanzu a wurin kamfanin, ko kuma saboda mutumin yana da tarihin kwanan nan na tafiya a ƙasashen waje, a cikin ƙasa da ke da yawan watsa COVID-19.
Waɗannan sun haɗa da ma'aikata da ke da hulɗa da jama'a gaba ɗaya kamar a makarantu, wuraren aiki masu yawan aiki da wasu shagunan sayar da kaya masu sayarwa. Kulawa na injiniya ga wannan rukuni da kuma ga ƙungiyoyin haɗari sun haɗa da shigar da matatun iska mai inganci, haɓaka iska, shigar da shinge na zahiri kamar shimfidar filastik mai tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace
Ma'aikata a wannan rukunin da ke cikin haɗari ba sa bukatar na'urorin numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, kula da ya dace don kare ma'aikata da sauran fasinjoji sun haɗa da keɓe mai ciwon daga sauran mutane na ƙafa 6, tare da sanya wani ɗan jirgin don ya yi wa mai ciwon hidima kuma ya ba shi abin rufe fuska, ko kuma ya nemi mai ciwon ya rufe bakinsa da hancinsa da tawada lokacin da yake tari ko yin numfashi.
Ma'aikatan jirgin su sa sa safofin hannu na likita da za a iya amfani da su lokacin da suke kula da wani mai haƙuri mai haƙuri ko kuma suna taɓa jiki ko wurare da za su iya zama masu cutarwa, kuma, a yiwuwar, su sa ƙarin kayan kariya idan mai haƙuri yana da zazzabi, ciwon kai ko wahalar numfashi.
Dole ne a ajiye safar hannu da sauran abubuwa masu jefawa a cikin jaka don sharar gida mai haɗari, sannan a tsabtace da kuma tsabtace wuraren da suka lalace. Don sufuri na kasuwanci, gami da jiragen ruwa da sauran jiragen ruwa masu fasinjoji, matakan haɗari sun haɗa da jinkirta tafiya ga mai haƙuri, keɓewa da kai tsaye da kuma sanar da cibiyar likita a cikin jirgin idan wani ya sami zazzabi ko wasu alamun a lokacin tafiya.
A matsayin mai kyau, ana kula da likitoci a cikin ɗakin da ke keɓewa. Don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na wucin gadi don tsaftacewa da kashe kamuwa da cuta idan mutum mai kamuwa da cutar ya kasance a cikin ginin, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba.
A lokacin da akwai karamin watsawa zuwa matsakaiciyar watsawa ta al'umma, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke tafiye-tafiye na filin, taro, da sauran manyan ƙungiyoyi kamar darussan ilimin jiki ko kuma taron kide-kide, ko cin abinci a cikin abincin dare, ƙara sarari tsakanin tebur, tsauraran lokutan isowa da tashi, iyakance baƙi marasa mahimmanci, da amfani da wuri na daban na kula da lafiya ga yara da ke fama da alamun mura.
Idan akwai yaduwar yaduwar cutar a cikin al'ummar gida, ban da dabarun nisantar zamantakewa, ana iya yin la'akari da jinkirin barin makaranta. Ga hukumomin da ke aiwatar da ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar kai tsaye a matsayin ƙasa.
Ana ba da shawarar cewa jami'an 'yan sanda da ke tuntuɓar mutane da ake zargi da COVID-19 ko kuma waɗanda suka tabbatar da cutar su bi waɗannan jagororin da masu aikin likita na gaggawa suka bi, gami da amfani da kayan kariya na mutum.
Idan lamba ta kai tsaye ta faru a lokacin kamawa, ma'aikata su tsabtace da kuma lalata belinsu da sauran kayan haɗi kafin su sake amfani da su ta amfani da spray ko masana'anta na gida na yau da kullun kuma su bi hanyoyin aiki na yau da kullun don riƙewa da shirya EPI da aka yi amfani da shi da kuma riƙewa da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da na gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin gawawwakin.
Ayyuka masu haɗarin haɗari sun haɗa da ma'aikatan isar da magunguna, kulawar likita, dakunan gwaje-gwaje, da kuma jigilar kayayyaki, waɗanda ke fuskantar marasa lafiya da aka tabbatar ko ake zargin suna da COVID-19.
Hadarin haɗari ya zama mai girma idan ma'aikata suka yi aikin samar da sinadarai a cikin marasa lafiya da aka tabbatar ko ake zargin suna da COVID-19, ko kuma suka tattara ko kuma suka yi amfani da samfurori daga waɗannan marasa lafiya.
Ayyukan samar da aerosols sun hada da allura, ayyukan cough-induction, bronchoscopy, wasu hanyoyin hakori da kuma jarrabawa ko kuma tattara samfurori.
Ayyuka a cikin gawawwakin da ke da haɗari mai yawa sun haɗa da ma'aikata da ke aiki da shirya gawarwakin mutanen da ke da COVID-19 da aka tabbatar ko kuma waɗanda ake zargin cutar a lokacin mutuwarsu; haɗarin haɗarin haɗari ya zama mai girma idan sun yi autopsy. Ƙarin aikin injiniya don waɗannan rukunin haɗari sun haɗa da ɗakunan keɓewa don marasa lafiya da COVID-19 da aka tabbatar ko waɗanda ake zargin cutar, gami da lokacin da aka gudanar da hanyoyin samar da aerosols.
Ƙarfin iska mai ƙarancin ƙarfi zai iya zama da kyau a wasu wuraren jana'izar da kuma a fannin kiwon lafiya.
Dole ne a yi amfani da jinsunan da kyau a matakin 3 na lafiyar halittu.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya da ke shiga asibiti a raba su zuwa wurare biyu na jiran jiran daban dangane da ko suna da wata sanannen hali ga COVID-19. Baya ga sauran EPIs, OSHA ta ba da shawarar masu numfashi ga masu sana'a da ke aiki a nesa da ƙafa 6 daga marasa lafiya da aka tabbatar ko ake zargin suna da cutar SARS-CoV-2, da kuma masu sana'a da ke yin ayyukan samar da aerosols.
A Amurka, an amince da N95 mai tacewa na fuska, wanda aka amince da shi ta NIOSH, ko kuma mafi ingancin numfashi, don amfani a cikin tsarin tsarin kula da numfashi mai zurfi wanda ya hada da gwajin daidaitawa, horo da kuma duba likita.
Sauran nau'ikan masu numfashi na iya samar da kariya da inganta kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar yin amfani da macaques ba, tun da COVID-19 cuta ce ta numfashi, kuma ba ta yaduwa ta hanyar ruwan jiki ba.
Hukumar ta duniya ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan bincike a wurin shiga.
Ga masu sana'a da ke tattara samfurin numfashi, kula da ko jigilar marasa lafiya da COVID-19 ba tare da hanyoyin samar da aerosols ba, WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata, tabarau na kariya ko kariya ta fuska, da kuma safofin hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska na tiyata da numfashi na N95 ko FFP2.
Ganin cewa samar da EPIs a duniya bai isa ba, WHO ta ba da shawarar rage bukatar EPIs ta hanyar telemedicine, shinge na zahiri kamar windows masu haske, ba da damar waɗanda ke da hannu a kula da marasa lafiya kai tsaye su shiga cikin ɗaki tare da mai haƙuri da COVID-19, ta amfani da EPI kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da numfashi ɗaya ba tare da cire shi ba yayin da yake kula da marasa lafiya da yawa tare da ganewar asali ɗaya, saka idanu da daidaita sarkar samar da EPI, da hana amfani da masks ta mutane marasa alamar.
DE: Katherine Maher, Shugaba na Gidauniyar Wikimedia
DUK ma'aikatan Wikimedia Foundation
HASUMIYAR: [Covid-19] Yin amfani da matsalar da kuma shirya don nan gaba
DATA/LAMAR AIKO: 14 ga Maris, 2020, 00:24 UTC
LISANCE: CC0: Babu wani haƙƙin da aka tanada
Muna fuskantar yanayi na musamman a wannan watan.
Cutar COVID-19 wani abu ne da ke bayyana yadda mutane suke hulɗa da juna a duniya da kuma yadda muke da alhakin juna.
Kalubalen da suke fuskanta ba su da misaltuwa, amma mun san cewa ayyukanmu mafi kyau suna tafiya tare da tausayi na duniya, hadin kai da kuma gina al'ummomi, waɗanda su ne tushen wannan ƙungiyar.
Abokantaka da kuma damuwar da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira da tattaunawa, tabbaci ne mai ban mamaki na mutane masu ban mamaki da muke da gatan aiki tare.
Ina farin ciki sosai da kuma alfahari da ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya ba ni labarin yadda yake godiya ga aikinmu.
Wannan mutumin ya tuna min yadda yake da muhimmanci ga duniya ta samu damar shiga Wikipedia a yanzu, da kuma yadda yake da alama mai girma cewa wannan muhimmin kayan aiki na ci gaba da kasancewa a kan layi kuma yana samuwa ga kowa.
Aikinku yana sa hakan ya yiwu, domin kuna sa wuraren aikinmu su yi aiki, kuna biyan abokan aikinmu kuma kuna sa al'ummominmu su kasance cikin aminci.
Duniya tana bukatar bayanan da Wikipedia ta bayar fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da yake takawa a ciki, za mu yi wasu canje-canje masu muhimmanci ga yadda muke aiki tare, farawa a mako mai zuwa.
Gyara Ayyukanmu da Sa'o'inmu
Kamar yadda Robyn ta ambata a baya, tawagar C ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan taron, mun tattauna abin da muke ganin ya dace da abin da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da tsari a wannan lokacin.
Muna son mu kawar da damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka tafi na ɗan lokaci, ba matsala.
Ga dukan ma'aikata, masu ba da sabis da ma'aikata na kwangila:
Za mu yi aiki na sa'o'i 4 a kowace rana, ko kuma 20 a mako, har sai an ba mu umarni.
Idan ka yi aiki a lokacin da ake bukata, za ka iya taimaka wa aikinmu.
Amma, duniya ba ta da tabbas a yanzu, kuma idan kana bukatar ka kula da ƙaunatattunka, ka sayi abinci, ko ka je wurin likita, lafiyarka ita ce abin da muke fifitawa.
Ba mu lura da lokutanku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba za a iya bayyana wannan dokar ba, amma mun yanke shawarar bayyana ta.
Ba a bukatar takardar shaidar aiki ko hutu mai kyau, sai ka gaya wa manajanka ya taimaka wa ma'aikatanka su duba jadawalin da lokutan da za su yi aiki don a tabbata an kula da muhimman wuraren aikin.
(Idan an gano cewa kana da COVID-19, ka sanar da Bryan daga sashen horo da takaddama don sashensa ya taimake ka kuma ya tabbatar da cewa an kula da yanayinka yadda ya kamata daga gwamnati).
Ma'aikatan da ke aiki a kowane lokaci za su samu cikakken albashin.
Mun riga mun faɗi haka, kuma muna da tabbacin cika alkawarinmu ga 'yan kwangila da ma'aikatanmu da ke aiki a kowane lokaci.
Kowa zai karɓi albashinsa bisa ga aikinsa na yau da kullum a yanayi na yau da kullum.
Albashi ya dogara da rashin lafiya da rashin iya aiki.
Idan kana son ka yi aiki, muna goyon bayanka sosai.
Mutane da yawa suna ganin aiki a matsayin hanyar da za su kawar da damuwa saboda yanayin da ake ciki a duniya.
Aikin da muke yi yana iya zama da amfani sosai, musamman a lokatai kamar waɗannan.
Ka tuna cewa lafiyarka ta fi muhimmanci.
Muna roƙon ka ka sanar da manajanka, don mu san abin da za mu yi tsammani kuma mu taimaka wa ayyukan yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai ayyukan da ya kamata mu ci gaba da yi.
Ƙungiyoyin Injiniya na Amincewa da Yanar Gizo, HR, Amintaccen Tsaro da Tsaro da kuma Tattalin Arziki (a.s.) suna yin ayyuka masu muhimmanci waɗanda zasu iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu da kuma sauya hankalinmu don tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi wa dukanmu, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin sa.
Ba mu da niyyar "aiki sau biyu don dawo da lokacin da aka ɓata" bayan annobar ta ƙare.
Ba za a sa ran ka yi aiki na tsawon lokaci ba don ka cika lokacin da ba za ka iya cim ma ba.
Mun amince cewa yanayin ya canja, kuma za mu yi aiki don kafa sababbin manufofi da kuma kwanan wata, kamar yadda ya dace.
Mene ne zai faru da shirin shekara-shekara?
Don daidaitawa da sabon yanayinmu da kuma tsammanin sa'o'i da muke aiki a kowace rana, muna son daidaita jadawalin don isar da Shirin Shekararmu na 2020-2021.
Muna da niyyar ba da shawarar tsawaita shirinmu na 2019-2020, wanda zai ba da ƙarin lokaci ga kasafin kuɗi, kuma ya sa ma'aikata su ba da fifiko ga aikin da ya fi muhimmanci, kula da kansu da kula da ƙaunatattunsu, yayin da muke ba da damar waɗanda suke bukatar ko suna son yin aiki a cikin rage yawan aiki a cikin makonni masu zuwa.
Ƙaddamar da jadawalin ya rage yawan ayyukan tsarawa da kuma matsa lamba a dukan ƙungiyar.
Za mu gabatar da shawarwarinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilan da kuma kungiyoyin game da matakai na gaba da zarar mun samu tabbaci.
Muna godiya ga ƙungiyar shirin shekara-shekara don jagorancin da suka yi a wannan aikin.
Yanayin, bayyanar da kuma tsabtace ofishin
A makon da ya gabata, mun san cewa wani abokin aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
Saboda haka, mun yi amfani da ƙungiyar tsabtace ƙwayoyin cuta don tsabtace dukan wuraren da ke ofis ɗinmu a birnin San Francisco.
Sun yi amfani da maganin rigakafi na musamman don asibitoci don kashe ƙwayoyin cuta a kan dukan farfajiyar da ke ciki da kuma a kan dukan ɗakunan da ke shiga ɗakinmu.
Ginin yana amfani da tsarin kulawar kansa ta amfani da kayayyakin da ke da aminci ga masu zuwa.
Mun sami sauƙi cewa ofishin zai kasance a shirye don lokacin da muka yanke shawarar komawa.
Ofishinmu a Washington yana cikin wani WeWork, wanda ya raba yarjejeniyar COVID-19 da mu da kuma dukkan ma'aikatan Washington.
A makon da ya gabata, ofishinmu a Washington ya koma wani wuri mai nisa, bisa ga jagorar da aka raba da San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, muna tattaunawa game da hayar ofishin a Brooklyn.
Waɗannan tattaunawar suna ci gaba, amma za su iya jinkiri.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka yi aiki a nesa sun san cewa zai iya zama gyara, kuma suna so su ba da wasu shawarwari:
Ka rage tsawon taron zuwa sa'a ɗaya ko biyu.
Idan ana bukatar zaman da zai fi tsayi, ka yi la'akari da raba shi zuwa kwanaki da yawa.
Ka tsara taron, ka shirya lokacin da za ka yi taro, kuma ka aika da littattafan da za ka karanta a gaba.
Ka yi amfani da bidiyo a matsayin misali, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗi a ainihin lokacin.
Ka sami jagora don sauƙaƙa taron, wani wanda zai lura da tambayoyin tattaunawa da jerin mahalarta, kuma wani wanda zai taimaka maka ka rubuta (ko kuma ka rubuta bayanin haɗin kai).
Ka aika wa goyon bayan fasaha imel idan kana bukatar na'urar kunne mai kyau.
Ku yi amfani da taimakon gaggawa don ku sayi abincin dare.
Ka shiga tashar #remoties don tattaunawa da abokan aikinka game da aikin nesa
Ƙungiyar HR tana bincike kan jagororin ergonomics a cikin shafin yanar gizon don taimakawa wajen ƙara aikin nesa a Gidauniyar.
A makon da ya gabata, mun bukaci duk masu karbar taimakon al'umma su soke taron jama'a da Wikimedia ke tallafawa, kamar bukukuwan edita, har sai WHO ta bayyana ƙarshen annobar.
Mun yi musu gargaɗi cewa mun fahimci cewa nemanmu na sokewa da kuma wasu ƙuntatawa na iya hana su kammala ayyukan tallafin da suka amince da su, kuma ba za a hukunta kowa ba don tsawaita ko gyara manufofin su.
A mako mai zuwa, za mu ci gaba da ba da ƙarin jagora game da Wikimania da kuma sauran taron yanki da kuma taron jama'a.
A cikin al'ummar duniya, ana ganin rashin tausayi ne game da wannan katsewar, amma kuma akwai taimako game da bayyanar da kuma iyawar da za su iya ci gaba da mayar da hankali ga al'ummomin su, Wikimedia da sauran yanayi.
Ƙungiyar masu samar da hanyoyin sadarwa na aiki a kan ƙirƙirar shafi a Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasiri da kuma karɓar sanarwarmu a gare ta.
Kasancewa da sabuntawa kan batutuwan da suka shafi COVID-19
Za mu aika da gayyatar zuwa kalandarku a ranar Alhamis mai zuwa a karfe 14:00 UTC/ 07:00 PT don ganawa ta musamman da ma'aikatan.
Za mu yi amfani da wannan lokacin don mu raba ƙarin sabuntawa, mu amsa tambayoyinku kuma mu ciyar da lokaci muna haɗa kai da juna.
Muna cikin wannan tare kuma za mu taimaka da duk abin da ake bukata.
A halin yanzu, za ka iya ci gaba da samun bayanan wannan imel ɗin da duk sauran bayanan da suka shafi COVID-19 a kan shafin yanar gizon.
Ƙungiyar masu ba da labari za ta sabunta waɗannan shafuka da dukan bayanan a wuri guda.
Muna kuma aiki don mu ci gaba da sadarwa da ma'aikatan da ke zama a ƙasashen da ake fama da cutar sosai a yanzu.
Idan kana da wata tambaya game da tafiya, abubuwan da suka faru, babban aiki, ko kuma ƙalubalen ɗaukar hoto, ko wani abu da za ka iya buƙatar taimako da shi, ka tabbata ka sanar da ita kuma ka yi aiki tare da ƙungiyar albarkatun sadarwa.
Muna nan don taimaka muku wajen tallafawa da kuma ba da haɗin kai a duk lokacin da kuke bukata.
Idan kana da wata matsala mai rikitarwa ko kuma mai tsanani, ka aika wa Bryan Judan, Darakta na Ayyukan Hulɗa da Mutane a Duniya, imel.
Babu wani irin wannan canji da ya kamata a ɗauka a matsayin watsi da aikinmu da kuma ayyukanmu.
Amma, sun nuna cewa a wannan lokacin, aikinmu da kuma ayyukanmu suna bukatar su daidaita a hanyar da ba mu yi ba a baya.
Waɗannan su ne matakan da muke ganin suna da muhimmanci a matsayin tallafi a wannan lokacin, domin mu ci gaba da aiki, samar da goyon bayan da ƙungiyoyinmu suke bukata da kuma samar da sabis ɗin da duniya ke dogara da shi.
Aikinmu da muka tsara zai jira mu a lokacin da ya dace.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu samar da sarari don muhimmin aikin da za a yi a cikin makonni, kuma wata-wata.
Muna bukatar ku duka domin wannan ya faru, don haka muna bukatar ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayi a lokacin da ake bukata.
Ka wanke hannunka kuma kada ka taɓa fuskarka!
Katherine, tawagar kafofin watsa labarai (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran tawagar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Angiotensin converting enzyme type 2 (ECA2) wani enzyme ne wanda aka haɗa zuwa farfajiya ta waje (ƙwayoyin halitta) na ƙwayoyin huhu, jijiyoyi, zuciya, koda, da hanji.
ECA2 yana hana aikin angiotensin mai canzawa (ECA) ta rage adadin angiotensin II da kuma ƙara Ang (1-7), yana zama magani mai alƙawarin da aka yi niyya don magance cututtukan zuciya. ECA2 kuma yana aiki a matsayin hanyar shiga cikin ƙwayoyin halitta don wasu ƙwayoyin coronaviruses.
Ana kiran wannan ƙwayar a matsayin hECA2.
Angiotensin converting enzyme type 2 wani enzyme ne mai dauke da zinc wanda yake a farfajiyar endothelial da sauran kwayoyin halitta.
Protein ECA2 yana dauke da wani yanki na N-terminal M2 peptidase da kuma wani yanki na C-terminal wanda ke dauke da amino acid da colectin a cikin tsarin koda.
ECA2 wani furotin ne mai ɗauke da membrane mai ɗauke da nau'i na 1 wanda ke da ƙwayar ƙwayar cuta a jikin jikinsa a cikin huhu da kuma sauran kayan jiki.
Ƙarƙashin ECA2 na ƙwayoyin halitta yana ƙetare daga ƙirar transmembrane ta wani enzyme da ake kira sheddase, kuma an saki furotin mai narkewa a cikin jini kuma an fitar da shi cikin fitsari.
ECA2 yana cikin gabobin da yawa: ECA2 yana da alaƙa da ƙwayoyin halitta na manyan ƙwayoyin huhu na jini na II, ƙwayoyin cuta na hanji, ƙwayoyin jini da na jini, da ƙwayoyin jijiyoyin jini a yawancin gabobin.
Ana kuma samun furcin ECA2 mRNA a cikin ƙwaƙwalwar kwakwalwa, jikin da ke cikin jijiya, da kuma ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa.
Babban aikin ECA2 shine ya zama ma'auni ga ECA.
ECA ta haɗa angiotensin na nau'i na 1 zuwa angiotensin na nau'i na 2, ta sa a yi vasokonstrus.
ECA2 kuma yana haɗa phenylalanine na amino acid carboxiterminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da hydrolysis a cikin vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-Gist-Pro-OH).
ECA2 kuma yana ɗaure wasu wasu peptides, ciki har da [des-Arg9]-bradicinine, apelin, neurotensin, dinorphine A, da ghrelin.
ECA2 kuma yana daidaita motsi ta membrane na amino acid mai tsaka tsaki SLC6A19 kuma yana da hannu a cikin cutar Hartnup.
A matsayin furotin mai ƙwayar cuta, ECA2 yana aiki a matsayin babban hanyar shiga cikin ƙwayoyin halitta don wasu ƙwayoyin cuta na coronavirus, gami da HCoV-NL63; SARS-CoV (virus da ke haifar da SARS); da SARS-CoV-2 (virus da ke haifar da COVID-19).
Ƙari ga haka, haɗuwa da ƙwayar ƙwayar cuta S1 na SARS-CoV da SARS-CoV2 zuwa yankin ECA2 na enzymatic a saman sel yana haifar da endocytosis da kuma translocation na cutar da enzyme zuwa endosomes a cikin sel.
Wannan tsarin shigarwa kuma yana bukatar samar da furotin S ta hanyar mai masaukinsa TMPRSS2, wanda ake bincike a kan hana shi a matsayin magani mai yiwuwa. Wannan ya sa wasu suka yi zaton cewa rage matakan ECA2 a cikin kwayoyin zai iya taimakawa wajen yaki da kamuwa da cuta.
Duk da haka, kungiyoyi da hukumomi da dama sun ba da shawarar ci gaba da yin amfani da maganin hana ECA da ARB.
A cikin wani bincike da aka yi a kan tsarin da aka yi a ranar 11 ga Yuli, 2012, an gano cewa 'sake amfani da ECA inhibitors an danganta shi da raguwa mai mahimmanci na 34% na hadarin cutar huhu a cikin tsarin kulawa.'
Bugu da ƙari, "hadarin kamuwa da cutar ta huhu ya ragu a cikin marasa lafiya da ake amfani da su da kuma masu hana ECA da ke da haɗarin kamuwa da cutar ta huhu, musamman waɗanda ke fama da bugun jini da kuma rashin karfin zuciya.
Ana kuma danganta amfani da ECA inhibitors ga rage yawan mutuwa da ke tattare da cutar huhu, ko da yake sakamakon ya kasance da kasa da ƙarfi fiye da haɗarin cutar huhu gaba ɗaya.'
Ana ganin ECA2 na mutum (rhACE2) sabon magani ne don cutar huhu mai tsanani, kuma ya inganta haemodynamics na huhu da kuma saturated oxygen a cikin aladu da ke fama da cutar lipopolysaccharide-induced acute respiratory distress syndrome.
Rayuwar rhACE2 a cikin mutane kusan awa 10 ne, kuma aikinsa ya fara minti 30 bayan an samu tsawon sa'o'i 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ba su yarda da tsarin tsarin renin-angiotensin mai hanawa (RAS inhibitors) ba ko kuma a cikin cututtuka inda angiotensin II da ke gudana yana da girma.
Aikace-aikacen COVID-19 aikace-aikacen software ne na hannu don taimakawa sa ido kan cutar coronavirus ta 2019-2020, wato, tsarin gano mutane ("tabbata") waɗanda zasu iya tuntuɓar mutane masu kamuwa da cutar.
An yi amfani da aikace-aikace da yawa ko kuma an gabatar da su, tare da goyon bayan gwamnati a wasu yankuna da kuma yankuna.
An kirkiro tsarin da yawa don ƙirƙirar aikace-aikacen saka idanu na tuntuɓar.
An yi tambaya game da batun tsare sirri, musamman game da tsarin da ke bin diddigin yanayin masu amfani da aikace-aikacen.
Wasu zaɓuɓɓuka da ba su da wuya su yi amfani da siginar Bluetooth don yin rikodin yadda mai amfani yake kusa da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa aikin don tallafawa irin waɗannan aikace-aikacen da ke dogara da Bluetooth kai tsaye zuwa tsarin aikin Android da iOS.
A kasar Sin, gwamnatin kasar Sin tare da kamfanin Alipay sun kafa wani aikace-aikace da ke ba 'yan kasar damar duba ko sun yi hulɗa da wani wanda ke dauke da COVID-19.
Ana amfani da shi a birane sama da 200 a kasar Sin. A Singapore, ana amfani da wani app da ake kira TraceTogether.
Kungiyar IT ta ci gaba da samar da wannan app din, ta saki shi a matsayin bude-ruwa kuma za a mika shi ga gwamnati. Macedonia ta Arewa ta kaddamar da "StopKorona!", wani app na Bluetooth don bin diddigin abubuwan da ke faruwa ga mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin lafiya.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Kiwon Lafiya ne suka kirkiro wannan aikace-aikacen.
Tun daga 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnatin ta bayyana cewa aikace-aikacen bin diddigin lamba yana cikin ci gaba, kuma zai kasance a shirye don rarrabawa a cikin makonni.
Ostiraliya da New Zealand suna shirin aikace-aikace dangane da aikace-aikacen TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na shirin aiwatar da aikace-aikacen iyakance ƙasa don marasa lafiya da aka gano suna da COVID-19 suna zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, wani farfesa a jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin da ke amfani da aikace-aikacen, ciki har da rashin tabbataccen sakamako da kuma rashin tasiri idan karɓar aikace-aikacen ya iyakance ga ƙananan ɓangaren jama'a.
A cikin martani ga damuwar game da yaduwar aikace-aikacen "coronavirus" na karya ko cutarwa, Apple ya kafa iyakoki ga nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance su ne kawai ga ƙungiyoyi "masu hukuma" ko kuma wasu ƙungiyoyi masu daraja.
Google da Amazon sun yi irin wannan takunkumin.
Masu kare sirrin sun nuna damuwa game da tasirin saka idanu na taro ta amfani da aikace-aikacen coronavirus, musamman game da ko za a soke kayan aikin saka idanu da aka gina don magance cutar coronavirus lokacin da barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa inda suka nemi a takaita irin wannan sa ido.
Ƙungiyoyi sun bayyana sharuɗɗa takwas don ayyukan gwamnati:
Dole ne a yi amfani da wannan hanyar don yin amfani da kayan aiki.
Ana bukatar a yi amfani da takardun dakatar da ayyukan sa ido da kuma sa ido don a tsawaita su.
Ana buƙatar a yi amfani da bayanan don dalilai na COVID-19;
Ana buƙatar tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa an tabbatar da cewa cewa an tabbatar da cewa an tabbatar da cewa cewa cewa cewa an tabbatar da cewa cewa an tabbatar da cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa an tabbatar da cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa an tabbatar da cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa cewa
Ana buƙatar yin amfani da bayanan sirri don tabbatar da cewa an sami damar yin amfani da bayanan sirri.
duk wani raba bayanai tare da wasu ya kamata a tanada shi ta hanyar doka;
ya kamata a samar da kariya kan cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi;
An bukaci a samu muhimmiyar shiga daga dukkan 'masu sha'awar da suka dace' ciki har da na masana kiwon lafiya da kuma kungiyoyin da ba su da dangantaka da jama'a.
A cikin wannan rahoton, an bayyana cewa, a cikin rahoton da aka gabatar a watan Janairun 2013, an samu karuwar adadin masu amfani da kayan aikin da aka yi amfani da su a cikin masana'antar.
Wasu ƙasashe sun yi amfani da bin diddigin wuri na yanar gizo maimakon aikace-aikace, suna kawar da buƙatar sauke aikace-aikace da ikon guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da ke kan layi.
Yanar gizo masu amfani da hanyoyin sadarwa da ke samun damar samun bayanai na wuri suna da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin tsakiya ba ne ke buƙatar samun damar samun bayanan wurin mutum; an tsara tsarin da ke kiyaye sirrin don amfani da sabobin tsakiya don sadarwa kawai (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba ya dogara da aikace-aikace don yin bin diddigin lamba.
Maimakon yin amfani da aikace-aikace na musamman, tsarin ya tattara bayanan bin sawu daga tushe da yawa, gami da bayanan bin sawu na na na'urorin hannu da bayanan ma'amala na katin, yana haɗa su don samar da faɗakarwa ta saƙon rubutu ga mutanen da ke da cutar.
Baya ga yin amfani da wannan bayanin don faɗakar da masu iya magana, gwamnati ta kuma sanya bayanin wurin a fili, wanda aka ba da izini saboda canje-canje masu yawa ga dokokin sirrin bayanai bayan barkewar cutar MERS a ƙasar.
Ƙasashe, ciki har da Jamus, suna tunanin yin amfani da tsarin tsare sirri da kuma tsarin tsare sirri.
Har zuwa ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba tukuna.
Kula da lamba tare da kiyaye sirrin mutum yana da ma'ana mai kyau, tare da mahimmin ilimin kimiyya da ke komawa zuwa aƙalla 2013. Tun daga ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyin masana goma sha biyu sun yi aiki a kan hanyoyin da ke girmama sirrin mutum, ta amfani da Bluetooth Low Energy (BLE) don yin rikodin kusanci mai amfani da wasu na'urorin hannu.
Duk da haka, PEPP-PT wani aiki ne na daidaitawa wanda ya shafi hanyoyin da aka tsara da kuma rarraba, kuma ba yarjejeniya guda ba.
A cikin waɗannan yarjejeniyoyi, bayanan sirri da za a iya ganowa ba za su taɓa fita daga na'urar ba, kuma ana yin kowane haɗuwa a cikin na'urar.
Kungiyar Tsaro a MIT Media Lab ta haɓaka Safe Paths, dandamali don amfani da fasahohin kiyaye sirrin yayin tattarawa da amfani da bayanan wuri ko haɗuwa da hanyoyi don bin diddigin yaduwar COVID-19.
Ya dogara ne akan bincike daga littafin fasaha "Apps Play Dirty: Maintaining Personal Privacy in an Epidemic" wanda aka fitar a watan Maris na 2020. Wani irin wannan ƙoƙari shine dandamali na SafeTrace na Enigma MPC, wani kamfani wanda ke haɓaka fasahar tsare sirri kuma an kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki masu aminci don ba masu amfani damar raba bayanai masu mahimmanci na wuri da kiwon lafiya tare da sauran masu amfani da masu kula ba tare da yin amfani da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da suka haɗu da abin da ke da mahimmanci iri ɗaya da kuma tsarin da aka haɗa da yawa don rage rarrabuwa, da kuma ba da damar haɗin kai na aikace-aikacen faɗakarwa da bin diddigin, wani muhimmin ɓangare na samun karbuwa ta yau da kullun.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa yarjejeniyar BlueTrace, wanda aikace-aikacen gwamnati na hukuma ke amfani da shi, ya zama buɗe tushen.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da dandamali na Android da iOS, sun sanar da wani shiri don bin diddigin lamba, inda suka yi ikirarin cewa za su kiyaye sirrin kansu, bisa haɗuwa da fasahar Bluetooth Low Energy da ɓoye sirrin don kiyaye sirrin.
Sun kuma wallafa takaddun fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana shirin aiwatar da shi a matakai uku:
ci gaban kayan aiki don ba gwamnati damar ƙirƙirar aikace-aikacen bin diddigin coronavirus na hukuma yayin kiyaye sirrin
Haɗa wannan aikin kai tsaye zuwa iOS da Android; Google da Apple suna shirin magance matsalolin tsaro na yau da kullun da suka ɗauka ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan daga baya cire shi kamar yadda barazanar ta ƙare.
Sake sanya magani (wanda aka fi sani da sake tsara magani, sake tsarawa, sake sanyawa ko maye gurbin magani) shine sake tsara magani wanda aka amince dashi don magance yanayin likita ko cuta daban da wanda aka fara samar dashi.
Wannan shi ne daya daga cikin hanyoyin bincike na kimiyya da ake amfani da su a yanzu don samar da lafiya da ingantattun hanyoyin magance COVID-19.
Sauran hanyoyin bincike sun hada da samar da kwayar cutar ta plasma da kuma allurar rigakafi don COVID-19. SARS-CoV-2 yana da kimanin sunadarai 66 masu amfani da kwayoyi, kowannensu yana da wuraren haɗin kai da yawa.
Binciken waɗannan hanyoyin haɗin gwiwa yana ba da kyakkyawan shiri don haɓaka ingantaccen maganin rigakafin cutar kan furotin COVID-19.
Daga cikin manyan sunadarai masu amfani da SARS-CoV-2 sun hada da protease irin na papain, RNA polymerase mai dogaro da RNA, helicase, S protein, da ADP ribophosphatease.
Hussein A. A., et al., ya yi nazarin wasu magungunan masu neman magani wanda ya kammala kuma ya bincika su ta hanyar kamanceceniya na tsarin su da magungunan da aka amince da su don hanzarta ci gaban magungunan da ke da ƙarfi a kan SARS-CoV-2 a cikin binciken sa na farko don a ba da shawarar don ƙirar binciken asibiti.
Chloroquine magani ne na malaria wanda ake amfani da shi wajen magance wasu cututtukan da ke hana kamuwa da cutar.
A ranar 18 ga Maris, WHO ta sanar da cewa chlorine da hydroxychloroquine da ke da alaƙa za su kasance a cikin magunguna huɗu da aka yi nazari a matsayin wani ɓangare na gwajin gwaji na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwaje-gwaje tare da chlorine da hydroxychloroquine na jihar New York za su fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfate na hydroxychloroquine da phosphate na chlorine ta hanyar Izinin Amfani da Gaggawa (AUE).
Ba a amince da maganin ba ta hanyar gwajin gwaji na FDA kuma an ba da izinin ta hanyar EU kawai a matsayin gwaji don gaggawa a cikin marasa lafiya da ke asibiti waɗanda ba za su iya karɓar magani a cikin gwajin gwaji ba.
Hukumar ta ce "amfani da hydroxychloroquine, sashi ko tsawon lokacin da za a yi amfani da shi don hana cutar SARS-CoV-2 ko kuma magance cutar" ba a riga an kafa ba.
Likitoci sun ce suna amfani da miyagun ƙwayoyi a lokacin da "ba su da wani zaɓi".
A birnin Istanbul, wata ƙungiyar bincike ta Turkiyya tana gudanar da wani karamin bincike game da amfani da chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Ana ci gaba da nazarin manyan abubuwa a Jami'ar Duke da Jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwaji game da amincin da kuma ingancin amfani da hydroxychloroquine a hanyar rigakafi.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun bayyana cewa favipiravir ya kasance "mai tasiri sosai".
A birnin Shenzhen, marasa lafiya 35 sun samu sakamako mara kyau a cikin kwanaki hudu, yayin da marasa lafiya 45 da ba su samu ba sun samu kwanaki 11.
A wani bincike da aka gudanar a Wuhan da aka yi da marasa lafiya 240 da ke fama da cutar huhu, an yi wa rabin su magani da favipiravir, kuma an yi wa rabin su magani da umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa akwai karancin shaidu da suka nuna cewa maganin ba shi da kyau.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adana shi kuma za ta yi amfani da sojojin don isar da shi asibitocin jami'a, inda za a yi amfani da shi wajen kula da marasa lafiya da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump ta'aziyya game da sayen maganin. Maganin na iya zama da kasa tasiri a cikin mummunan yanayin cutar, lokacin da cutar ta riga ta ninka.
Yana iya zama da haɗari ga mata masu ciki ko kuma mata da suke ƙoƙarin yin ciki.
Wani bincike na lopinavir/ ritonavir (Kaletra), wani nau'i na maganin lopinavir da ritonavir, ya kammala cewa "ba a lura da wani amfani ba".
An yi amfani da miyagun ƙwayoyi don hana kwayar cutar HIV ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na ƙoƙarin gyara magunguna don nemo wani fili wanda ke ɗaure da protease na SARS-CoV-2. Akwai ƙiyayya a cikin ƙungiyar kimiyya game da tura albarkatu don sake samar da magunguna da aka haɓaka musamman don HIV / AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta kirkiro kuma ta ci gaba da yin amfani da shi a matsayin magani don cutar Ebola da kuma kamuwa da cutar Marburg. Gilead Sciences ta gano cewa remdesivir yana da aikin antiviral in vitro a kan fil, pneumonia, paramyx, da kuma coronavirus.
Ɗaya daga cikin matsalolin da ake fuskanta a maganin rigakafi shi ne rashin ƙarfi da ake samu daga canjin da zai iya haifar da cututtuka ko kuma cututtuka masu tsanani.
Wasu bincike na farko sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin halitta ga juriya. Akwai gwaje-gwaje na asibiti da yawa a yanzu, ciki har da biyu da Cleveland University Hospitals suka gudanar, ɗaya ga mutanen da ke da matsakaiciyar cuta da kuma wani ga waɗanda ke da mummunan cuta.
Akwai gwaje-gwaje uku na intravenous vitamin C da ke faruwa ga mutanen da ke asibiti da waɗanda ke fama da cutar COVID-19: biyu daga cikinsu suna sarrafawa ta placebo (a China da Kanada), yayin da ɗayan ba ya nuna ƙungiyar kulawa (Italiya).
Jihar New York ta fara gwajin azithromycin, maganin rigakafi, a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Lafiya ta Kasa (NCGM) ta Japan na shirin yin gwajin asibiti na Alvesco (ciclesonide), na kamfanin Teijin, wanda shine corticosteroid mai hana shan asma.
Wani bincike na mataki na biyu na wani nau'in angiotensin 2 mai canzawa yana gudana a cikin marasa lafiya 200, wanda za a karɓa daga cikin marasa lafiya masu tsanani da ke asibiti a Denmark, Jamus, da kuma Austria don a iya ganin yadda magani yake da tasiri.
A halin yanzu, masu bincike a Cibiyar Zuciya ta Kanada suna bincike kan aikin colchicine wajen rage rikitarwa da kumburi a cikin marasa lafiya da ke da alamun COVID-19.
Wannan binciken, mai suna COLCORONA, yana daukar manya 6,000 da suka wuce shekara 40, waɗanda aka gano suna da COVID-19 kuma suna da alamun bayyanar cututtuka, kuma ba su buƙatar zuwa asibiti.
Ba a haɗa mata masu ciki ba, masu shayarwa, ko kuma waɗanda ba su yi amfani da maganin hana haihuwa.
Ana gwada wasu magungunan hana jini a Italiya.
Ana amfani da heparin da ke da ƙananan nauyin kwayoyin halitta a yawancin mutane don magance cututtukan da ke cikin jiki, kuma hakan ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa jagororin da za a bi.
Wani bincike mai yawa da aka yi da marasa lafiya 300 yana nazarin amfani da sodium enoxaparin a cikin rigakafi da kuma maganin maganin. An sanar da wannan binciken a ranar 14 ga Afrilu a Italiya.
Saboda gaskiyar cewa SARS-CoV-2 kwayar cuta ce, hankalin masana kimiyya ya kasance mai girma wajen sake amfani da magungunan rigakafin cutar da aka amince da su da aka haɓaka don magance barkewar cutar da ta gabata, kamar ta MERS, SARS, da West Nile virus.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19, bisa ga fitowar 7 na jagororin kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19, bisa ga fitowar 7 na jagororin kasar Sin
An gano wasu maganin rigakafi da za su iya samun sabon amfani ga maganin marasa lafiya da COVID-19:
Tocilizumab (mai karɓar maganin IL-6): an amince da shi a kasar Sin.
Ana kuma yin gwaje-gwaje a Italiya da China.
Allurar rigakafin COVID-19 allurar rigakafi ce ta cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu allurar rigakafi da aka kammala gwajin asibiti, akwai wasu ƙoƙarin da ake yi na samar da ita.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba za ta yi tsammanin samun allurar rigakafin cutar SARS-CoV-2 ba, cutar da ke haifar da cutar, a cikin watanni 18 ba.
Mutane biyar da suka nemi rigakafin sun shiga gwajin lafiya na farko a watan Afrilu.
An gano COVID-19 a watan Disambar 2019.
An yi gagarumin yaduwar cutar a shekarar 2020, wanda ya haifar da saka hannun jari mai yawa da ayyukan bincike don haɓaka allurar rigakafi.
Ƙungiyoyi da dama suna amfani da bayanan da aka wallafa don samar da alluran rigakafin SARS-CoV-2.
Taron Innovation Coalition in Epidemic Preparedness, CEPI, a watan Afrilu ya bayyana cewa bukatun ci gaban allurar rigakafi shine saurin, ƙarfin samarwa, ci gaban sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton dandamali 10 na fasaha daban-daban da ake bincike da ci gaba a farkon shekarar 2020 don ƙirƙirar allurar rigakafin COVID-19.
Manufofin manyan dandamali da suka ci gaba da nazarin tsaro na Phase I sun hada da:
nucleic acid (DNA ko RNA) (mai ci gaba na mataki na 1 da kuma mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka mataki na 1 da mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimillar masu neman rigakafin 115 suna cikin matakai na farko na ci gaba, tare da 78 daga cikinsu da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken).
Wani gwaji na mataki na I zuwa na II yana gwada lafiyar farko da kuma rigakafin rigakafi. Yana da daidaituwa, ana sarrafa shi ta hanyar placebo da kuma cibiyoyin sadarwa, yayin da yake ƙayyade mafi daidaito da ingantattun sashi.
Gwaje-gwaje na mataki na uku na musamman sun ƙunshi ƙarin masu halarta a cikin rukuni na kulawa. Suna gwada tasirin allurar rigakafin cutar yayin lura da sakamako masu illa a cikin mafi kyawun sashi.
Daga cikin masu neman allurar rigakafi 79 da ke ci gaba da aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su da gwajin mutum (suna ci gaba da bincike na preclinical).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland ta Australia ta sanar da cewa tana bincike kan yiwuwar allurar rigakafi da ƙwayoyin cuta, wanda zai iya canza kwayoyin ƙwayoyin cuta don motsa halayyar rigakafi.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin a kan allurar rigakafi, da nufin gwadawa a cikin mutane a 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar hana cututtuka da kula da cutar ta kasar Sin a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Company, wanda Hanneke Schuitemaker ke jagorantar, ya sanar da fara aikinta don haɓaka allurar rigakafi.
Janssen tana haɗin gwiwar samar da allurar baki tare da abokinta na fasaha ta zamani Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairun 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa wani takarda game da samar da allurar rigakafi tare da fasahar da ta yi amfani da ita don maganin allurar rigakafi na neoantigen.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada-hadar allurar kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin mallakar Generex, NuGenerex Immnuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar li-Key peptide na COVID-19.
Sun so su samar da takardar neman rigakafin da za a iya gwadawa a kan mutane "a cikin kwanaki 90 masu zuwa".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Kula da Bincike da Ci gaban Likitoci ta Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yankin yammacin Maryland, sun sanar da cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
a wajen samar da rigakafi.
A cikin watan Yuli na shekarar 2020, abokan hulɗa sun sanar da shirye-shirye don gwajin preclinical da Phase I na nazarin asibiti.
A ranar 12 ga watan Maris na shekarar 2020, ma'aikatar lafiya ta Indiya ta sanar da cewa suna aiki da mutane 11 da ke zaman kansu kuma ko da a cikin saurin gudu, zai dauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu kafin su samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a birnin Quebec, ya ba da rahoton ci gaban wani abu mai kama da Coronavirus a karkashin wani ɓangare na kudaden shiga daga Cibiyoyin Nazarin Lafiya na Kanada.
Matar da ta nemi rigakafin tana cikin bincike a dakin gwaje-gwaje, kuma ana shirin gwada ta a jikin mutum a watan Yuli ko Agusta na shekarar 2020.
A farkon wannan makon, jaridar The Guardian ta bayyana cewa shugaban Amurka Donald Trump ya ba CureVac "babban kudade don samun damar yin amfani da allurar COVID-19" a kan zanga-zangar gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin Pharmaceutical Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA tare.
BNT162, allurar da ke neman neman magani ta mRNA, a halin yanzu tana cikin gwaji na farko, ana sa ran gwaji na asibiti zai fara a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, kamfanin kimiyyar halittu na Italiya ya sanar da cewa za ta sami sakamakon gwajin gwaji a watan Afrilu na 2020 kuma mai neman allurar ta ƙarshe zai iya tashi don gwajin ɗan adam a kaka.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovation (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike don allurar COVID-19 ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, yana kawo cikakken saka hannun jari na CEPI a cikin haɓaka allurar COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI na samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na masu neman allurar rigakafi guda shida.
Masu bincike a Kwalejin Imperial a London sun sanar a ranar 20 ga Maris, 2020 cewa suna ci gaba da samar da allurar RNA mai karfafa kanta don COVID-19.
An yi amfani da takardar neman allurar a cikin kwanaki 14 bayan an samu jerin sunayen daga kasar Sin.
A karshen watan Maris, gwamnatin Kanada ta sanar da kudade na C$275 miliyan don ayyukan bincike 96 na maganin rigakafin COVID-19, ciki har da takardun neman allurar rigakafi a kamfanoni da jami'o'in Kanada kamar su Medicago da kuma ayyukan Jami'ar Saskatchewan.
A kusan wannan lokacin, gwamnatin Kanada ta sanar da dala miliyan 192 musamman don bunkasa allurar rigakafin COVID-19, tare da shirin kafa "tashar allurar rigakafi" na kasa na sabbin alluran rigakafi da za a iya amfani da su idan wasu barkewar cutar ta Coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna cewa "MNA ta ba da alluran SARS-CoV-2 S1 wanda ya haifar da amsa mai ƙarfi na antibody na musamman ga antigens [a cikin beraye] wanda ya bayyana a bayyane cewa an fara shi makonni 2 bayan allurar".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da samar da takarar allurar rigakafin DNA a matsayin mai yiwuwa nasal spray.
Ta amfani da kwayoyin cuta, za a tsara DNA don ta sake yin kwafi a cikin kwayar cutar mutum don samar da ƙwayoyin cutar da ba su da lahani kamar cutar, wanda zai iya motsa tsarin garkuwar jiki ya samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnati, masana'antu da jami'o'i uku a Amurka sun haɗa kai don samun damar kwamfutocin IBM, a hade da kwamfutar girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako dabam dabam, wanda ake kira sakamako marar musamman.
Hakan yana nufin cewa za su iya amfanar da mutane fiye da cututtukan da suke hana su.
Wani gwaji na gaba da aka yi a Ostiraliya yana neman a karɓi ma'aikatan kiwon lafiya 4,170.
Alurar riga kafi da ake ci gaba da samarwa ba za su iya zama lafiya ko tasiri ba.
Binciken farko na tantance ingancin allurar ta amfani da samfurin dabbobi na musamman don COVID-19, kamar linzamin ACE2-transgenic, sauran dabbobi na dakin gwaje-gwaje, da primates ba mutane, ya nuna bukatar matakan hana kariya na matakin 3 don sarrafa kwayar cutar mai rai, da kuma daidaitaccen tsari na duniya don tabbatar da daidaitattun hanyoyin tsaro.
An riga an gwada alluran rigakafin SARS da MERS a kan dabbobi ba mutane ba.
A shekarar 2020, babu magani ko allurar rigakafi da za ta kare cutar SARS da ta tabbatar da cewa tana da lafiya da tasiri a kan mutane.
Bisa ga takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sababbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da MERS ya zama sananne, an yi imanin cewa binciken SARS na yanzu zai iya samar da samfurin da zai taimaka wajen samar da alluran rigakafi da kuma maganin maganin cutar MERS-CoV.
Tun daga watan Maris na shekarar 2020, an samu allurar rigakafin MERS (wanda aka yi amfani da DNA) da ta kammala Phase I na nazarin asibiti a kan mutane, da kuma wasu uku a ci gaba, dukansu alluran rigakafi ne na virus, biyu da ke da vector adenoviral (ChAdOx1-MERS, BVRS-GamVac), da kuma wanda ke da vector MVA (MVA-MERS-S).
Labaran kafofin watsa labarun sun gabatar da ka'idar ta'addanci da ke cewa an san cutar da ke bayan COVID-19 kuma riga an sami allurar rigakafi.
Patents da wasu kafofin watsa labarun suka ambata sun nuna patents na yanzu don kwayoyin halitta da kuma alluran rigakafi ga sauran strains na Coronavirus kamar Coronavirus SARS.
Cutar BetaCoronavirus 2019 (COVID-19) cuta ce mai kamuwa da cuta da cutar ta Coronavirus 2 (SARS-CoV-2) ta haifar.
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari, da kuma wahalar numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, fitsari, ciwon wuya, rashin wari, da ciwon ciki.
Lokaci na bayyanar cututtuka har zuwa bayyanar cututtuka yana kimanin kwanaki 5, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna haifar da bayyanar cututtuka masu sauƙi, wasu suna ci gaba da kamuwa da cutar huhu da kuma rashin aiki da gabobin jiki.
Tun daga ranar 17 ga Afrilu, 2020, an samu karin shari'o'i miliyan 2.24 a kasashe da yankuna 210 da suka haifar da mutuwar sama da 153,000.
Mutane fiye da dubu 568 ne suka warke, kuma ana yada cutar tsakanin mutane ne ta hanyar tuntuɓar kai tsaye, yawanci ta hanyar saukad da ke fitowa daga tari ko kuma ta hanyar magana.
Ko da yake ana yin waɗannan saukad da a lokacin numfashi, yawanci sukan fāɗi a ƙasa ko kuma su zauna a kan farfajiya maimakon su zama masu kamuwa da cuta a nesa.
Mutane za su iya kamuwa da cutar ta hanyar taɓa wasu wurare da suka kamu da cutar, sa'an nan su taɓa idanunsu ko hancinsu ko bakinsu.
Wannan kwayar cutar tana iya rayuwa a saman ƙasa har tsawon sa'o'i 72.
Yana da matukar cutarwa a cikin kwanaki 3 na farko bayan bayyanar cututtuka, ko da yake yaduwar zai iya faruwa kafin bayyanar cututtuka ta bayyana da kuma a cikin matakan da suka gabata na cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargin suna da cutar da kuma waɗanda ke kula da su.
Shawarwarin yin amfani da abin rufe fuska ga jama'a a gaba ɗaya sun bambanta, inda wasu hukumomi suka ba da shawarar kada a yi amfani da shi, wasu sun ba da shawarar yin amfani da shi, wasu kuma sun tilasta yin amfani da shi.
A halin yanzu babu takamaiman allurar rigakafi ko maganin rigakafin cutar COVID-19.
An samu kamuwa da cutar a gida a mafi yawan ƙasashe a dukan yankuna shida na WHO.
Waɗanda suka kamu da cutar za su iya zama marasa alamar cututtuka ko kuma su sami alamun da suka yi kama da mura, tari, gajiya, da kuma wahalar numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko matsa lamba a kirji, rikicewa, rashin tsaro, fuska ko lebe mai launin shuɗi.
Ba a yawan ganin cututtukan sama ba kamar su sneeze, hanci da ke zubar da jini ko kuma ciwon wuya.
An lura da cututtukan gastrointestinal kamar nausy, vomiting, da kuma diarrhea a kashi daban-daban.
Wasu a ƙasar Sin sun fara jin ƙin zuciya da kuma bugun jini.
A wasu, cutar tana iya sa mutum ya kamu da ciwon huhu, ya yi rashin ƙarfi a gabobin jikinsa, kuma ya mutu.
Wannan shi ne abin da ake kira lokacin yin amfani da shi.
Lokacin yin amfani da COVID-19 yawanci kwanaki shida ne, amma zai iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5 cikin 100 na mutanen da suka kamu da cututtuka za su kamu da su a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar za su kamu da cututtuka ba.
Ba a san cikakken aikin da waɗannan marasa alamar suke yi wajen watsawa ba tukuna; duk da haka, akwai shaidar farko da ta nuna cewa za su iya taimakawa wajen yada cutar.
Yawan mutanen da suka kamu da cutar da ba su da alamun cutar a yanzu ba a san su ba kuma ana nazarin su, kuma Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) sun ba da rahoton cewa kashi 20 cikin dari na duk waɗanda aka tabbatar da cutar sun kasance marasa alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta fara haɗa marasa alamar cututtuka a cikin cututtukan ta yau da kullum a ranar 1 ga Afrilu; daga cikin cututtuka 166 da aka kamu da su a wannan rana, 130 (78%) sun kasance marasa alamar cututtuka a lokacin gwaji.
Ƙarƙashin ƙanƙara da saliva suna iya ɗaukar manyan ƙwayoyin cuta.
Yin magana da babbar murya yana fitar da ƙarin saukad da fiye da yin magana a al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi tari ba tare da ya rufe bakinsa ba, zai iya sa ya kai ƙafa 15 a jikinsa.
Ko da yake ba a yawan ɗaukar kwayar ta iska, Masana kimiyya na ƙasa sun nuna cewa watsa ta bio-aerosol zai yiwu kuma masu karɓar iska da aka sanya a cikin hallways a waje da dakunan mutane sun ƙunshi samfurori masu kyau na RNA na kwayar cutar.
Wasu hanyoyin likita, kamar su bugun jini da kuma karyar zuciya (CPR), na iya haifar da numfashi wanda za a yayyafa kuma a sakamakon haka za a iya watsa shi ta iska.
Ko da yake akwai damuwa cewa za a iya watsa shi ta hanyar fitsari, idan an yi imani da cewa haɗarin yana da ƙasa. Kwayar cutar tana da haɗari sosai lokacin da mutane ke da alamun. Ko da yake yana yiwuwa a iya watsa ta kafin bayyanar cututtuka, haɗarin yana da ƙasa.
Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda za a iya yada cutar ba, yawanci mutum ɗaya ko biyu ne ke kamuwa da cutar.
Musamman, an gano cewa cutar tana iya ganowa na kwana ɗaya a cikin kwali, har zuwa kwana uku a cikin filastik (polypropylene) da bakin karfe (AISI 304) da har zuwa sa'o'i huɗu a cikin 99% jan ƙarfe.
Amma, hakan ya dangana ne ga yanayin zafi da kuma yanayin zafi.
Sabulu da kuma wanke-wanke suna da tasiri idan aka yi amfani da su yadda ya kamata. Abincin da ke da sabulu yana lalata ƙwayar ƙwayar ƙwayoyin cuta mai kariya, yana hana shi aiki, kuma yana kawar da shi daga fata da kuma wasu farfajiya.
Wasu hanyoyin, kamar su benzalkonium chloride da chloride glycoside (mai maganin kashe cuta na tiyata), ba su da tasiri sosai. A wani bincike da aka yi a Hong Kong, an tattara samfurori na saliva a matsakaici kwana biyu bayan an fara asibiti.
A cikin mutum biyar daga cikin mutum shida, samfurin farko ya nuna mafi yawan ƙwayar cutar, yayin da mutum na shida ya nuna mafi yawan ƙwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus ta cutar respiratory acute syndrome 2 (SARS-CoV-2) sabuwar cuta ce ta coronavirus ta cutar respiratory acute wanda aka fara warewa a cikin mutane uku da ke fama da cutar huhu wadanda suka shafi wasu cututtukan cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon SARS-CoV-2 suna faruwa ne a cikin yanayi, a cikin coronavirus masu alaƙa.
A waje da jikin mutum, kwayar cutar tana mutuwa ta hanyar tuntuɓar sabulu na gida, wanda ke karya farantin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Fushi sune gabobin da COVID-19 ya fi shafa saboda kwayar ta shiga cikin ƙwayoyin mai masaukin ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Kwayar ta yi amfani da wani glycoprotein na musamman da ake kira "specilla" (peplomer) don ta haɗa da ACE2 kuma ta shiga cikin ƙwayoyin da ke ba da izinin.
An lura da raunin zuciya a kashi 12 cikin 100 na mutanen da suka kamu da cutar da aka kwantar a asibiti a birnin Wuhan, China, kuma ya fi yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya suna da yawa saboda amsawar kumburi da kuma rashin lafiyar tsarin garkuwar jiki a yayin da cutar ke ci gaba, amma rauni na zuciya na iya kasancewa yana da alaƙa da masu karɓar ACE2 a zuciya.
Masu karɓar ACE2 suna da ƙarfi sosai a cikin zuciya kuma suna da hannu a aikin zuciya.
An samu karuwar cutar hawan jini (31%) da kuma hawan jini (25%) a cikin marasa lafiya a cikin UTI da ke da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa.
Ko da yake SARS-CoV-2 yana da tropism ga ƙwayoyin epithelial na numfashi waɗanda ke bayyana ACE2, marasa lafiya da ke fama da COVID-19 suna nuna alamun ciwon hanta na tsarin.
Musamman, an nuna cewa kwayoyin T masu cutarwa da ke fitar da GM-CSF suna da alaƙa da karɓar kwayoyin IL-6 masu ƙwayar cuta da kuma mummunan cututtukan huhu a cikin marasa lafiya da COVID-19.
An kuma samu rahoton yin amfani da kwayoyin halitta a jikin mutum a lokacin binciken.
Hukumar ta WHO ta wallafa wasu takardun shaida don gano cutar.
Hanyar gwajin misali ita ce yin amfani da polymerase ta hanyar real-time reverse transcription (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samu ta hanyar nasopharyngeal swab, duk da haka ana iya amfani da nasal swab ko kuma samfur na cataract.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i ko kwanaki biyu.
Ana iya yin amfani da gwajin jini, amma don haka sai a ɗauki jini biyu da suka bambanta makonni biyu, kuma sakamakon ba shi da muhimmanci a nan gaba.
Masana kimiyya na kasar Sin sun iya ware wani nau'in coronavirus kuma su wallafa tsarin kwayoyinsa don dakunan gwaje-gwaje a duniya su iya ci gaba da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
Tun daga ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) amma har yanzu ba a yi amfani da su sosai ba.
Gwajin da 'yan kasar Sin suka yi na gwadawa ya nuna cewa suna da daidaito tsakanin kashi 60 zuwa 70 cikin ɗari.
Hukumar kula da lafiyar Amurka ta Amurka ta amince da gwajin dakin gwaje-gwaje na farko a watan Maris 21, 2020, don amfani a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga hanyoyin asibiti da haɗarin annoba.
Abubuwan da ke faruwa a cikin gilashin multilobar mai duhu na biyu tare da rarraba ta gefe, asymmetrical da baya suna da yawa a farkon kamuwa da cuta.
Ƙarƙashin ƙwayoyin cuta, mosaic fashewa (mai kauri lobular septum tare da maye gurbin alveolar filling) da kuma karfafawa na iya bayyana yayin da cutar ta ci gaba.
Akwai bayanai kadan game da cutar ta cutar COVID-19 da kuma cututtukan jiki.
Abubuwan da aka gano a lokacin binciken gawa sune:
Macroscopy: pleurisy, pericarditis, karfafawa da kumburi na huhu
Ana iya lura da nau'i hudu na cutar huhu ta kwayar cuta:
cututtukan huhu: kumburi na huhu, hyperplasia na huhu, manyan kwayoyin huhu marasa kyau, kumburi na tsakiya tare da shigar da lymphocyte da kuma samar da kwayoyin giant multinuclear
cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttuk
DAD yana haifar da ciwon hankula na numfashi (ADHS) da kuma rashin ƙarfi mai tsanani.
cututtukan da aka yi wa huhu: tsarin exudate a cikin rami na alveolar da pulmonary interstitial fibrosis
Jini: Ƙarƙashin jini mai yaduwa (CID);
Abubuwan da za a iya yi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane da yawa suke, wanke hannuwanka da sabulu da ruwa a kai a kai na akalla dakika 20, yin tsabtace numfashi da kuma guje wa taɓa idanu, hanci da baki da hannayenka ba tare da wanke ba.
CDC ta ba da shawarar rufe bakinka da hancinka da tawada lokacin da kake tari ko kuma yin numfashi, da kuma rufe bakinka da gefen ciki na kugu idan tawada ba ta samuwa.
Ana ƙarfafa tsabtace hannu da kyau bayan ka yi tari ko kuma ka yi numfashi.
Hukumar ta CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, a wani ɓangare don iyakance watsawa ta mutane marasa alamomi. Dabarun nesa da zamantakewa suna nufin rage haɗuwa da mutane masu kamuwa da cuta tare da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiya da soke manyan tarurruka na jama'a.
Dokokin nesa kuma sun ce mutane su kasance a tsakanin juna aƙalla mita 1.8 (6 feet).
Babu wani magani da ya dace don hana COVID-19 da aka sani. Tun da ba a fara yin allurar rigakafi ba kafin 2021, wani muhimmin abu don sarrafa COVID-19 shine ƙoƙarin rage ƙaruwar annobar, wanda aka fi sani da "ƙaddamar da ƙuƙwalwar".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu sau da yawa ta amfani da sabulu da ruwa na akalla dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun yi datti sosai, kafin su ci abinci da kuma bayan sun yi ta wanke hanci ko su yi tari ko su yi ta numfashi.
Ya kuma ba da shawarar yin amfani da maganin hana hana shan maganin hana shan magani na hannu wanda ya ƙunshi giya aƙalla kashi 60 cikin ɗari, amma kawai idan sabulu da ruwa ba su kasance a shirye ba. Don wuraren da maganin hana shan maganin hana shan magani na hannu ba su kasance a shirye ba, WHO ta ba da maganganu biyu don samarwa a gida.
A cikin waɗannan maganganun, ana yin aikin antimicrobial ta hanyar ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin giya; ba "wani abu mai aiki ba ne don shan shan hannaye".
Ana ƙara glycerol a matsayin mai narkewa.
Ana kula da mutane ta hanyar kulawar da ta rage yawan damuwa, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon sauran gabobin da suka shafi rayuwa.
Hukumar ta ce duk wanda ya yi zargin cewa yana dauke da cutar ya kamata ya saka abin rufe fuska mai sauki.
An yi amfani da Oxygenated Extrasound Membrane (ECMO) wajen magance matsalar rashin numfashi, amma amfanin da ake samu a nan gaba ba a yi bincike ba.
Ana ba da shawarar tsabtace jiki da kuma salon rayuwa mai kyau da kuma cin abinci mai kyau don inganta rigakafi.
Maganin tallafi na iya zama da amfani ga waɗanda ke da alamun bayyanar cututtuka da kuma farkon matakan kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun wallafa shawarwari don kula da mutanen da ke asibiti da COVID-19.
Likitoci masu kula da gaggawa da likitocin huhu a Amirka sun haɗa shawarwari na magani daga hukumomi dabam-dabam a cikin wata hanya kyauta, wato, IBCC.
Har zuwa watan Afrilu na shekarar 2020, babu takamaiman magani ga COVID-19.
Wasu masu kula da lafiya sun ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko don bayyanar cututtuka.
Ya kamata a yi la'akari da yadda za a rage haɗarin watsa kwayar cutar, musamman a cikin yanayin kiwon lafiya, lokacin da ake gudanar da hanyoyin da za su iya haifar da aerosols kamar su allura da numfashi na hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutane da COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakunan keɓewa na kamuwa da cutar ta iska (SIIA) ban da ɗaukar matakan tsaro na yau da kullun, matakan tuntuɓar, da kuma matakan tsaro na iska. CDC ta ta taƙaita jagororin don amfani da kayan kariya na mutum (EPI) yayin annobar.
Kayan aikin da aka ba da shawarar su ne: EPI manta, numfashi ko mask, kariya ga gani da kuma safar hannu na likita.
An amince da N95 respirators don yanayin masana'antu, amma FDA ta amince da masks don amfani a ƙarƙashin Izinin Amfani da Gaggawa (Amurka).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancinsu a kan takamaiman wakili na halitta don amfani da ba a bayyana ba.
Idan ba a iya samun abin rufe fuska ba, CDC ta ba da shawarar yin amfani da rigunan fuska ko kuma, a matsayin mafita, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai don buƙatar iska ta inji ko madadin, amma kashi ɗaya cikin ɗari na shari'o'in suna da tsanani.
Ana nazarin irin taimakon numfashi ga mutanen da ke fama da matsalar numfashi da ke da alaƙa da COVID-19 ga mutanen da ke asibitoci, tare da wasu shaidu cewa ana iya kauce wa allura ta hanyar tsokoki na hanci mai tsananin gudu ko kuma matsa lamba mai kyau a cikin hanyoyin iska a matakan biyu.
Idan waɗannan abubuwa biyu sun amfane mutane da suke da ciwo mai tsanani, ba a san ko za su amfane su ba.
Wasu likitoci sun fi son samun iska mai iska mai iska mai iska lokacin da ta kasance saboda wannan fasaha ta iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da ƙwayoyin hanci masu tsananin gudu.
Kasashe masu tasowa da yawa ba su da isasshen asibiti a kan mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar kwatsam na yawan shari'o'in COVID-19 masu tsanani don buƙatar asibiti.
Wani bincike a ƙasar Sin ya nuna cewa kashi 5 cikin 100 sun shiga cibiyoyin kula da mutane masu tsanani, kashi 2.3 cikin 100 sun bukaci taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kimanin kashi 30 cikin dari na mutanen da ke asibiti da COVID-19 an kai su ga ICU.
Hanyar iska ta zama mai rikitarwa yayin da cutar ta shan numfashi ta gaggawa (SDRA) ta bunkasa a cikin COVID-19 kuma oxygenation ya zama da wuya.
Ana buƙatar masu iska da ke da yanayin kula da matsa lamba da kuma babban matakin PEEP don haɓaka isar da iskar oxygen yayin rage haɗarin cutar huhu da pneumothorax da ke tattare da iska.
Za a iya samun PEEP mai yawa a tsofaffin fan.
Binciken yiwuwar maganin ya fara ne a watan Janairun 2020 kuma ana gudanar da gwaje-gwaje na asibiti da magungunan rigakafin cutar daban-daban.
Remdesivir ya yi alkawari sosai.
Ko da yake sabon magani zai iya ɗaukar har zuwa 2021 don ci gaba, an riga an amince da wasu magunguna da aka gwada don wasu amfani ko kuma suna cikin gwaji na gaba.
Ana iya gwada maganin rigakafi a kan mutane da ke fama da cututtuka dabam-dabam.
Hukumar ta ba da izini na wucin gadi na yin amfani da jini na mutane da ke warkewa a lokacin da rayuwarsu ke cikin haɗari.
Har yanzu ba a gudanar da bincike na asibiti ba don nuna amincinsa da kuma tasirinsa a kan cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da aikace-aikacen wayar hannu don magance barkewar cutar.
Ana bukatar masu amfani su ba da sunayensu da lambar ID.
Aikace-aikacen yana iya gano "ƙusoshi" ta amfani da bayanan saka idanu, don haka yana iya gano yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano wata barazana, ba wai kawai aikace-aikacen yana ba da shawarar yin rigakafi ba amma kuma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da bincike na manyan bayanai na bayanan wayar hannu, fasahar gane fuska, bin diddigin wayar hannu da kuma ilimin kere-kere don bin diddigin mutanen da suka kamu da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su bincika bayanan wayar hannu na mutanen da ake zargin suna da cutar coronavirus.
An dauki wannan matakin ne don karfafa killacewa da kuma kare mutanen da za su iya yin hulɗa da 'yan ƙasa da suka kamu da cutar.
A watan Maris na shekarar 2020, kamfanin dillancin labarai na Deutsche Telekom ya raba bayanan da aka tattara na inda ake kiran waya da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don gudanar da bincike da hana watsa cutar.
Rasha ta tura fasahar gano fuska don gano wanda ya saba da keɓewa.
Kwamishinan lafiya na ƙasar Italiya, Giulio Gallera, ya ce an gaya masa daga masu amfani da wayoyin hannu cewa "kashi 40 cikin 100 na mutane suna ci gaba da yin yawo".
Gwamnatin Jamus ta gudanar da wani hackaton na tsawon sa'o'i 48 a karshen mako tare da masu halarta sama da 42,000.
Bugu da ƙari, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane za su iya fuskantar matsaloli a cikin killacewa, ƙuntatawa a tafiya, sakamako na magani, ko kuma tsoron kamuwa da cutar.
BBC ta yi ƙaulin Rory O'Connor, wanda ya ce: "Ƙara yawan zaman zaman lafiya, kaɗaici, damuwa ta likita, damuwa, da kuma matsalar tattalin arziki, babban hadari ne da zai iya ɓata lafiyar mutum da kuma lafiyar jikinsa".
Cutar tana iya ci gaba da sauƙi, ba ta da alamun bayyanar cututtuka, kamar sauran cututtukan da ke sama da numfashi, kamar sanyi.
A yawancin lokaci, marasa lafiya masu sauƙi suna warkewa cikin makonni biyu, yayin da waɗanda suke da ciwo mai tsanani ko kuma tsanani za su iya ɗaukar makonni uku zuwa shida kafin su warke.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani, bisa ga bayanan wasu irin ƙwayoyin cuta, kamar SARS da MERS, amma babu bayanan COVID-19. A wasu mutane, COVID-19 na iya shafar huhu, yana haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya ci gaba da sauri zuwa ciwon rashin numfashi na manya (ARDS), yana haifar da rashin numfashi, bugun jini ko rashin ƙarfi na gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin
Abubuwan da ke tattare da COVID-19 sun haɗa da cutar sepsis, cututtukan hawan jini, da kuma cutar zuciya, koda da hanta.
Rashin hawan jini, musamman karuwar prothrombin lokaci, an bayyana shi a cikin kashi 6% na asibitocin da ke da COVID-19, yayin da rashin aikin koda ya bayyana a cikin kashi 4% na wannan rukuni.
Kimanin kashi 20 zuwa 30 cikin 100 na mutanen da ke da COVID-19 suna da yawan ƙwayar hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da aka nuna alamun cutar da mutuwa ya kai kwanaki goma, biyar daga cikinsu kuma asibiti ne.
Duk da haka, marasa lafiya da aka yi amfani da su wajen yin UTI sun yi matsakaici na kwana bakwai tsakanin yin asibiti da mutuwa.
A cikin wani bincike na farko, matsakaicin bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, tare da jimillar kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, maza sun samu kashi 2.8 cikin dari na mutuwa, yayin da mata suka samu kashi 1.7 cikin dari.
Binciken da aka yi wa samfurori na huhu bayan mutuwa ya nuna cewa an yi wa alveolar cutar ta hanyar cututtukan sel na fibromyxoid a cikin huhu biyu.
An lura da cututtukan cytopathic na cutar a cikin ƙwayoyin cuta.
Binciken da aka yi wa huhu ya nuna cewa yana da cutar rashin numfashi mai tsanani (ARDS).
A cikin kashi 11.8 cikin 100 na mutuwar da Hukumar Lafiya ta kasar Sin ta bayar, an gano cutar zuciya saboda yawan yawan troponin ko kuma asarar zuciya.
A cewar wani rahoto na watan Maris na Amirka, kashi 89 cikin 100 na waɗanda aka yi musu asibiti suna da ciwon da ba su da lafiya.
An kiyasta cewa mutuwar ta hanyar haɗuwa ta bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin da ake fuskanta.
Rashin bayar da rahoto na ƙananan cututtuka na iya sa a yi la'akari da yawan mutuwar.
Amma, mutuwar da aka yi a dā na iya nufin cewa an yi kasa da yawan mutuwar da ake yi a yanzu.
Masu shan sigari sun ninka yiwuwar samun alamun COVID-19 mai tsanani sau 1.4 kuma sun ninka yiwuwar bukatar magani mai tsanani ko mutuwa sau 2.4 idan aka kwatanta da waɗanda ba sa shan sigari.
Hukumar asibitin Hong Kong ta lura da raguwar kashi 20 zuwa 30 cikin 100 na ƙarfin huhu a wasu mutanen da suka warke daga cutar, kuma gwajin huhu ya nuna lalacewar gabobin.
Hakan kuma zai iya kai ga ciwon ciwon hanzari bayan an warke.
Har zuwa watan Maris na shekarar 2020, ba a san ko kamuwa da cutar da ta gabata za ta ba da rigakafi mai dorewa ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafin yana yiwuwa, bisa ga halayyar sauran coronavirus, amma an ruwaito lokuta inda dawowar COVID-19 ta biyo bayan gwajin coronavirus a wani lokaci.
An yi imanin cewa waɗannan cututtukan sun fi muni daga ciwon da ya daɗe maimakon sake kamuwa da cutar.
An yi imanin cewa kwayar halitta ce kuma ta fito ne daga dabbobi ta hanyar kamuwa da cutar ta hanyar zubar da jini.
Ba a san ainihin asalinsa ba, amma tun daga watan Disamba na 2019, yaduwar kamuwa da cuta ta zama kusan gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Wani bincike da aka yi da mutane 41 da aka fara tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya nuna cewa kwanan watan farko da alamun cutar suka fara ne a ranar 1 ga Disamba, 2019.
Bayanai na WHO sun nuna cewa farkon ranar bayyanar cututtuka shine 8 ga Disamba, 2019.
Ana amfani da wasu matakan da yawa don a ƙayyade mutuwar.
Wadannan lambobi sun bambanta bisa ga yankuna da lokaci kuma suna rinjayar yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokaci tun lokacin fara barkewar cutar da kuma halaye na al'umma kamar shekaru, jima'i da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin cutar ta gaggawa ta CID-10 U07.1 don mutuwar sakamakon kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje da U07.2 don mutuwar COVID-19 tare da bincike na asibiti ko na annoba, ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje ba.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano da suka mutu daga cutar, da kuma yawan mutuwar mutum (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (masu gano da marasa ganowa) da suka mutu daga cutar.
Waɗannan kididdigar ba su da iyaka a kan lokaci kuma suna bin wani mutum na musamman daga kamuwa da cuta har zuwa warwarewar.
Ko da yake ba dukan mutanen da suka kamu da cutar suke samun rigakafi ba, kasancewa da rigakafi zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin gari na mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, an yada cutar ta wurin bukukuwan Carnival kuma ta bazu tsakanin matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba za a iya yin rajistar su a matsayin haka.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai yi aiki ba.
A ƙasar Netherlands, kusan kashi 3 cikin 100 na mutanen da ke da jini suna iya samun rigakafi, kamar yadda aka gani a cikin masu ba da jini.
69 (0.004% na yawan jama'a) sun mutu daga COVID-19 da aka tabbatar.
Sakamakon annobar da kuma mutuwar ta bambanta ga maza da mata.
A cikin bincike da aka yi a kasar Sin da Italiya, mutuwar maza ta fi girma.
Mafi yawan haɗarin ga maza suna cikin shekaru 50, kuma bambancin tsakanin maza da mata ya kusan kusan 90.
A ƙasar Sin, mace-mace sun mutu da kashi 2.8 cikin ɗari a tsakanin maza da kuma kashi 1.7 cikin ɗari a tsakanin mata.
Ba a san ainihin dalilan bambancin tsakanin jinsi ba, amma ana iya ganin cewa akwai wasu dalilai na halitta da kuma halaye.
Bambancin rigakafi ta hanyar jima'i, rage yawan mata masu shan sigari, da kuma ci gaban maza da cututtukan jiki kamar hawan jini a ƙarami fiye da mata na iya taimakawa wajen yawan mutuwar maza.
A Turai, kashi 57 cikin 100 na mutanen da suka kamu da cutar maza ne, kuma kashi 72 cikin 100 na mutanen da suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta gano bayanan kamuwa da cutar COVID-19 da ke da alaƙa da jima'i ba.
Bincike ya nuna cewa cututtukan cuta kamar Ebola, HIV, mura da kuma SARS suna shafar maza da mata a hanyoyi dabam dabam.
Mata ne suka fi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, kuma suna da mafi yawan haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar shi ne "COVID-19".
Shugaban WHO Tedros Adhanon Ghebreyesus ya bayyana cewa "CO" na "Corona", "VI", "virus", "D", cutar, kuma "19" na lokacin da aka gano barkewar cutar: 31 ga Disamba, 2019.
An zabi sunan don kauce wa tunani game da wani wuri na musamman (misali: China), nau'in dabba, ko rukuni na mutane, daidai da shawarwarin ƙididdigar ƙasashen duniya don hana lalata.
Hukumar ta WHO ta kuma yi amfani da "COVID-19" da "COVID-19" a cikin sadarwa ga jama'a.
Ana kiran cutar da kuma kwayar cutar "coronavirus".
A lokacin da cutar ta fara barkewa a birnin Wuhan da ke kasar Sin, ana kiran cutar da cutar "coronavirus" da kuma "coronavirus na Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar "2019-nCov" da "2019-nCoV acute respiratory disease" a matsayin sunayen rikon kwarya don cutar da cutar, daidai da jagorar 2015 game da amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An bayyana sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su nasopharyngeal warts da kuma sassan numfashi.
Alal misali, a lokacin da asibiti na Italiya ya bukaci kwandon numfashi da gaggawa, kuma mai ba da kayayyaki bai iya ba da kayayyakin a kan lokaci ba, wani kamfani na gida ya yi aikin injiniya kuma ya buga kwandon da ake bukata na 100 a rana.
Bayan barkewar cutar COVID-19, ka'idodin makirci, rashin fahimta, da rashin fahimta game da asalin, girman, rigakafi, magani da sauran fannoni na cutar sun taso, kuma sun bazu cikin sauri ta Intanet.
A bayyane yake, mutane suna iya watsa kwayar cutar zuwa wasu dabbobi.
Binciken bai samu tabbacin karuwar kwayar cutar a cikin alade da ducks da kaji ba.
Babu wani magani ko allurar rigakafi da aka amince da su don magance cutar.
Bincike na duniya game da alluran rigakafi da magunguna don COVID-19 na gudana a cikin ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin 'SOLIDARITY Trial' don tantance tasirin maganin da ke dauke da abubuwa hudu na riga-kafi da suka fi tasiri.
Babu allurar rigakafi a duniya, amma hukumomi da dama suna aiki sosai wajen samar da takardun rigakafi.
An yi amfani da ayyukan da aka yi a baya kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Ana bincike kan dabarun rigakafi guda uku.
Na farko, masu bincike suna son su yi allurar rigakafi da cutar gaba ɗaya.
Yin amfani da wannan kwayar cutar, ko ta kasance ba ta aiki ko ta mutu, yana nufin haifar da amsawar rigakafin jikin mutum cikin sauri ga sabon kamuwa da COVID-19.
Hanyar biyu, wato allurar rigakafi, ita ce samar da allurar rigakafi da za ta sa tsarin garkuwar mutum ya san wasu sassan cutar.
A cikin SARS-CoV-2, wannan bincike ya mai da hankali ne kan furotin na spindle wanda ke taimakawa kwayar cutar shiga mai karɓar ACE2.
Hanyar uku ita ce yin allurar nucleic acid (DNA ko RNA, sabuwar fasaha don yin allurar).
A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar rigakafi tare da masu sa kai hudu a Seattle.
An nuna cewa ingantaccen maganin rigakafi zai iya zama ƙalubale ga samar da allurar rigakafi don SARS-CoV-2, amma wannan abu ne mai ban mamaki.
An gudanar da gwaje-gwaje na asibiti sama da 300 tun watan Afrilu na shekarar 2020.
Gwaje-gwaje bakwai sun tantance hanyoyin da aka amince da su don magance zazzabin cizon sauro, ciki har da gwaje-gwaje hudu game da hydroxychloroquine ko chloroquine.
Ana yin bincike sosai a kasar Sin a kan maganin rigakafi, inda ake gudanar da gwaji tara a cikin wani mataki na uku na rigakafin a kasashe da dama, bisa ga rahoton da aka bayar a karshen watan Afrilu.
Ana gudanar da bincike mai zurfi kan ci gaban asibiti na masu neman magani da allurar rigakafi don COVID-19 a watan Afrilu na 2020. Ana kimanta wasu magungunan riga-kafi na yanzu don magance COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade da interferon beta.
An yi ƙoƙari a tabbatar da ingancin remdesivir tun watan Maris na shekarar 2020.
An samu ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da shi don yin amfani da shi.
Ana gudanar da gwaje-gwaje na III a Amurka, China da Italiya. An yi nazarin chloroquine a kasar Sin a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, ana neman a yi nazari a kan binciken.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Duk da haka, Cibiyar Kwayar cutar Wuhan, ko da yake tana ba da shawarar kashi ɗaya na gram a kowace rana, ta yi gargadin cewa sau biyu na wannan kashi yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chlorophyll bisa ga shawarar likitoci da ke kula da mutane da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban ribavirin don hana SARS-CoV-2 in vitro.
An ba da shawarar yin nazarin in vivo na nitazoxanide bayan da ya nuna ƙananan ƙwayar hana SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na sararin samaniya na samar da protease 2 transmembrane protease (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitanci ɗaukar waɗannan magunguna ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 in vitro kuma ba shi da aikin da aka sani a cikin maganin COVID-19.
Guguwar cytokine na iya zama rikitarwa a cikin matakan COVID-19 mai tsanani.
Akwai hujja cewa hydroxychloroquine na iya nuna tasirin tasirin cytocin. Tocilzumab an haɗa shi a cikin jagororin kula da shi ta Hukumar Lafiya ta kasar Sin bayan kammala wani karamin bincike.
Ana gudanar da wani gwaji na kasa a matakin mataki na 2 a Italiya, bayan da ya nuna sakamako mai kyau a cikin mutanen da ke fama da cutar.
Idan aka haɗa da gwajin jini na ferritin na jini don gano hadari na cytokine, ana sa ran zai kawar da waɗannan ci gaban, wanda ake ganin ya sa wasu mutane suka mutu.
FDA ta amince da interleukin-6 receptor antagonist bisa ga nazarin binciken baya game da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan
Har yanzu babu wata hujja ta bazuwar da ta nuna cewa tocilzumab yana da tasiri wajen magance CRS.
Ana bincike kan canja wurin antibodies masu tsaftacewa da kuma masu karfafawa da tsarin rigakafin mutum ya samar wa mutanen da suka warke daga COVID-19 zuwa ga mutanen da suke bukatar su a matsayin hanyar da ba ta da allurar rigakafi.
An gwada wannan dabarar a kan SARS, amma ba a samu sakamako mai kyau ba.
Rashin ƙwayar cuta shine tsarin aikin da ake tsammani wanda maganin antibody mai aiki zai iya daidaita kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar su cytotoxicity na ƙwayoyin halitta da ke dogara da antibodies da/ ko phagocytosis, suna iya yiwuwa.
Ana ci gaba da yin amfani da wasu hanyoyin maganin rigakafi na jiki, misali, yin amfani da rigakafin monoclonal da aka yi.
Ana iya ƙara samar da ƙwayar ƙwayar cuta, wadda ta ƙunshi jinin marasa lafiya da aka dawo da su daga jini kuma tana dauke da maganin rigakafi na musamman ga wannan kwayar cutar don saurin aiwatarwa.
Cutar coronavirus, wata ƙungiya ta cututtuka masu alaƙa
Li Wenliang, likitan asibitin Wuhan na tsakiya, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya san game da yaduwar cutar.
